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Abstract	  
Hematopoietic	  stem	  and	  progenitor	  cells	  (HSPCs)	  repopulate	  the	  blood	  system	  upon	  transplantation.	  A	  large-­‐scale	  genetic	  approach	  to	  understand	  the	  factors	  that	  participate	   in	   successful	   engraftment	   has	   not	   been	   undertaken.	   In	   this	   thesis,	   I	  present	   the	   development	   of	   a	   novel	   live	   imaging-­‐based	   competitive	   marrow	  repopulation	   assay	   in	   adult	   zebrafish,	   which	   allows	   fast	   and	   quantitative	  measurement	   of	  HSPC	   engraftment	   capability.	   Using	   this	   assay,	   a	   transplantation-­‐based	  chemical	  screen	  was	  performed,	  which	  led	  to	  the	  discovery	  of	  10	  compounds	  that	  can	  enhance	  the	  marrow	  engraftment	  capability	  in	  zebrafish.	  Among	  them,	  the	  arachidonic	  acid-­‐derived	  epoxyeicosatrienoic	  acids	  (EET),	  had	  conserved	  effects	  on	  both	   short-­‐	   and	   long-­‐term	   bone	  marrow	   engraftment	   in	  mice.	   Genetic	   analysis	   in	  zebrafish	   embryos	   demonstrated	   that	   EET	   acts	   through	   a	   Gα12/13-­‐mediated	  receptor,	  which	  activates	  PI3K	  and	  induces	  transcription	  factors	  of	  the	  AP-­‐1	  family.	  This	  PI3K/AP-­‐1	  pathway	  directly	  induced	  the	  transcription	  of	  HSC	  marker,	  runx1,	  in	  embryos.	  The	  activation	  of	  PI3K	  by	  EET	  promoted	  HSPC	  migration	  and	  interactions	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with	  niche	  cells.	  Our	  studies	  define	  a	  role	  for	  EETs	  in	  the	  development	  of	  blood	  stem	  cells	   during	   embryogenesis,	   and	   in	   engraftment	   in	   adult	   vertebrates.	   The	   other	  compounds	  discovered	  in	  the	  screen	  implicate	  additional	  novel	  signaling	  pathways	  involved	   in	   the	  HSPC	  engraftment	  process,	  which	   require	   further	   investigation.	   In	  summary,	   this	   thesis	   elucidated	  an	   important	   role	  of	  bioactive	   lipids	   in	   regulating	  HSC	   engraftment	   in	   adults	   and	   during	   embryo	   development.	   Systematically	  mapping	   out	   the	   regulatory	   network	   will	   tremendously	   benefit	   both	   the	   basic	  understanding	  of	  stem	  cell	  biology	  and	  the	  clinical	  manipulation	  to	  generate	  better	  stem	  cells	  for	  transplantation.	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Introduction	  	   Somatic	  stem	  cells	  are	  specified	  during	  embryo	  development	  and	  assume	  their	  responsibility	   of	   regenerating	   damaged	   tissue	   in	   adults.	   	   Understanding	   this	  phenomenon	  is	  essential	  for	  improving	  stem	  cell-­‐based	  therapy	  for	  treating	  patients	  with	  degenerative	  diseases	  or	  acutely	  damaged	  tissue.	  The	  hematopoietic	  system	  is	  truly	   the	  pioneer	  of	   stem	  cell-­‐based	   therapy.	  Over	   the	  past	  decades	  hematopoietic	  stem	  cells	  (HSC)	  have	  been	  widely	  used	  for	  transplantation	  to	  treat	  life-­‐threatening	  diseases,	   such	   as	   leukemia	   and	   bone	   marrow	   failure.	   Despite	   the	   successes	   of	  transplantation,	   unpredictable	   engraftment	   failure	   still	   jeopardizes	   patients’	   life.	  The	   fascinating	   nature	   of	   HSCs	   and	   the	   clinical	   needs	   for	   more	   reliable	  transplantation	   outcomes	   motivated	   me	   to	   study	   what	   factors	   regulate	   the	  engraftment	  processes	  of	  transplanted	  HSCs.	  
	  
Hematopoietic	  Stem	  Cells	  	  The	   hallmark	   of	   hematopoietic	   stem	   cells	   (HSCs)	   is	   their	   capability	   of	   being	  transplanted	   to	   engraft	   recipients	   and	   giving	   rise	   to	   all	   blood	   lineages,	   including	  erythroid,	  myeloid	  and	  lymphoid	  cells.	  Such	  bona	  fide	  HSCs	  are	  specified	  at	  an	  early	  stage	  during	  embryo	  development,	  in	  an	  evolutionarily	  conserved	  tissue,	  the	  aorta-­‐gonad-­‐mesonephro	   (AGM)	   region	   (Dzierzak	   and	  Speck,	   2008).	   In	   the	  human	   fetus	  this	  takes	  place	  between	  day	  27	  and	  day	  40	  (Tavian	  et	  al.,	  2010).	  In	  mice,	  a	  similar	  developmental	   process	   happens	   around	   embryonic	   day	   (E)	   10.5,	   when	   the	   cells	  from	   the	   embryonic	   tissue	   can	   be	   transplanted	   to	   repopulate	   adult	   recipients	  (Biosset	  and	  Robin,	  2012).	  These	  cells	  first	  emerge	  from	  endothelial	  cells	  and	  form	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hematopoietic	  clusters	  along	  the	  luminal	  side	  of	  the	  aortic	  wall.	  Later,	  they	  bud	  off	  the	  endothelial	  wall	  and	  travel	   to	   the	   fetal	   liver	   through	  circulation.	   	  Slightly	   later,	  transplantable	  HSCs	  are	  also	  found	  in	  other	  highly	  vascularized	  sites,	  including	  the	  placenta	  and	  yolk	  sac.	  In	  these	  transient	  hematopoietic	  tissues,	  HSCs	  undergo	  rapid	  proliferation.	  The	  number	  of	  HSCs	  is	  dramatically	  expanded	  by	  about	  14-­‐fold.	  After	  the	   expansion,	   HSCs	   migrate	   to	   the	   bone	  marrow,	   and	   finish	   this	   heroic	   odyssey	  (Dzierzak	  &	  Speck,	  2008).	  	   	  The	   bone	   marrow	   is	   composed	   of	   diverse	   types	   of	   cells,	   such	   as	   endothelial	  cells,	   stromal	   cells,	   adipocytes,	   osteoblasts	   and	   mature	   blood	   cells,	   which	   form	   a	  regulatory	   environment	   called	   the	   niche	   (Mercier	   et	   al.,	   2011).	   Upon	   receiving	  extrinsic	   signals	   from	   the	   niche,	   and	   under	   the	   control	   of	   an	   intrinsic	   regulatory	  network,	  HSCs	  make	  important	  decisions	  to	  either	  remain	  as	  a	  stem	  cell	  through	  the	  
self-­‐renewal	   mechanism,	   or	   differentiate	   into	   progenitor	   cells,	   which	   further	  become	  mature	  blood	  cells	  (Zon,	  2010).	  In	  adult	  humans,	  the	  daily	  demand	  for	  HSCs	  to	  differentiate	  into	  different	  types	  of	  mature	  blood	  cells	  is	  amazing.	  For	  example,	  an	  adult	  has	  20-­‐30	  trillion	  red	  blood	  cells	   circulating,	   which	   count	   for	   about	   one	   quarter	   of	   the	   total	   human	   body	   cell	  number.	  These	  cells	  need	   to	  be	  completely	  replaced	  every	  100-­‐120	  days.	  An	  adult	  also	  produces	  about	  1011	  neutrophils	  per	  day,	  most	  of	  which	  circulate	  in	  the	  blood	  for	  a	  mere	  6	  hours	  (Abass	  et	  al.,	  2012).	  Although	  the	  astronomical	  number	  of	  mature	  blood	   cells	   primarily	   arises	   from	   the	   rapid	   proliferation	   of	   lineage-­‐specific	  
progenitors	   or	   precursors,	   HSCs	   are	   the	   ultimate	   source	   of	   maintaining	   the	  appropriate	   ratio	   among	   different	   types	   of	   cells	   on	   the	   hematopoietic	   hierarchy.	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Though	  under	  such	  high	  demand,	   this	  pool	  of	  stem	  cells	  generated	  during	  embryo	  development	   still	   lasts	   throughout	   the	   entire	   adult	   life	   without	   additional	  replenishment.	  How	  HSCs	  maintain	   their	   long	   lifetime,	   compared	   to	  differentiated	  blood	  cells,	  is	  still	  a	  mystery.	  	  
	  
Hematopoietic	  Stem	  Cell	  Transplantation	  and	  Engraftment	  	  	   Stem	  cell	   therapy	   is	   considered	   to	  be	   the	  Holy	  Grail	   for	   curing	  many	   types	  of	  otherwise	   incurable	   diseases.	   The	  most	   successful	   example	   is	   hematopoietic	   stem	  cells	   (HSC).	  HSCs	  have	  been	  widely	  used	   to	   treat	   life-­‐threatening	  diseases,	   such	  as	  leukemia	  and	  bone	  marrow	  failure.	  The	  transplantation	  procedure	   is	   fairly	  simple.	  Recipients	   are	   previously	   conditioned	   with	   total	   body	   irradiation	   and/or	  chemotherapy	   to	   clear	   the	   niche.	   Purified	   HSCs	   or	   whole	   bone	   marrow	   cells	   are	  intravenously	  transfused.	  Once	  injected,	  the	  cells	  can	  find	  their	  way	  back	  to	  the	  bone	  marrow	   (BM),	   and	   lodge	   in	   the	   BM	   medullary	   cavity	   in	   less	   than	   48	   hours;	   this	  process	   is	   referred	   to	  as	  homing	   (Lapidot	  et	  al.,	  2005).	  HSC	  homing	  has	  not	  been	  observed	   in	   real	   time	   in	   vivo	   yet,	   but	   it	   is	   thought	   that	   this	   process	   shares	  similarities	   with	   neutrophil	   trans-­‐endothelial	   migration	   during	   inflammatory	  responses	   and	   lymphocytes	   homing	   to	   lymphoid	   tissues.	   	   Existing	   genetic	   data	  support	   the	   hypothesis	   that	   the	   homing	   process	   involves	   chemokine	   attraction,	  reciprocal	  HSC-­‐endothelial	  cell	  communication,	  active	  cell	  morphology	  changes	  and	  migration	   (Yang	   et	   al.,	   2001;	   Lapidot	   et	   al.,	   2005).	   Once	   entering	   the	   medullary	  cavity,	   whether	   HSCs	   and	  multipotent	   progenitors	   (MPPs)	   can	   be	   retained	   in	   the	  appropriate	   marrow	   space	   depends	   on	   various	   factors,	   which	   are	   not	   very	   well	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understood.	  It	  is	  hypothesized	  that	  HSCs	  can	  also	  reenter	  the	  circulation,	  which	  has	  been	   observed	   even	   under	   homeostatic	   states	   to	   potentially	   serve	   the	   function	   of	  immune	  surveillance	  (Mazo	  et	  al.,	  2011).	  HSCs	  that	  successfully	  lodge	  into	  the	  niche	  can	   choose	   to	   undergo	   short-­‐term	   and/or	   long-­‐term	   self-­‐renewal	   and	  differentiation;	   this	   is	   called	   repopulation	   or	   engraftment,	   and	   lasts	   months	   or	  years	   (Figure	   1.1).	   However,	   some	   HSCs	   might	   also	   stay	   quiescent	   for	   various	  periods	  of	  time.	  	  	  	   Hematopoietic	   stem	   cells	   can	   be	   obtained	   from	   different	   sources.	   The	   most	  common	  sources	  are	  either	  directly	  from	  bone	  marrow	  or	  mobilized	  HSCs	  from	  the	  peripheral	   blood.	   These	   HSCs	   usually	   require	   perfectly	  matched	   immune	   systems	  between	   the	   donor	   and	   recipient	   as	   characterized	   by	   the	   types	   of	   HLA	   (human	  leukecyte	   antigen),	  which	  makes	   the	   search	   for	   the	   appropriate	   donor	   a	   daunting	  task	   (Abass	  et	  al.,	  2012).	  Recently,	  HSCs	  were	  successfully	  purified	   from	  umbilical	  cord	   blood,	   and	   proven	   capable	   of	   engrafting	   recipients.	   Because	   of	   the	   relative	  immature	   features,	   the	   cord	   blood	  HSCs	   can	   be	  more	   compatible	  with	   recipients’	  immune	  system	  than	  bone	  marrow	  HSCs;	  therefore,	  only	  a	  partial	  matched	  HLA	  type	  is	  needed.	  Cord	  blood	  HSCs	  have	  been	  successfully	  used	   for	   treating	  children	  with	  leukemia.	   However,	   the	   insufficient	   number	   of	   HSCs	   per	   cord	   and	   delayed	  engraftment	   impair	   the	   application	   of	   cord	   blood	   to	   treating	   adult	   patients	  (Gluckman,	  2011).	  The	  fascinating	  phenomena	  that	  HSCs	  can	  find	  their	  way	  home	  in	  the	  maze	  of	  the	  human	  body	  and	  the	  clinical	  demand	  for	  improving	  the	  engraftment	  capability	  of	  HSCs	  have	  attracted	  major	  research	  attention.	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Figure	  1.1	  Illustration	  of	  human	  HSC	  transplantation	  and	  engraftment	  	  HSCs	  or	  bone	  marrow	  cells	  are	  transfused	  intravenously.	  HSCs	  can	  then	  home	  to	  and	  lodge	   in	   the	   marrow	   niche,	   which	   is	   composed	   of	   multiple	   cell	   types,	   such	   as	  endothelium,	  stroma,	  osteoblasts,	  and	  many	  other	  cell	  types.	  This	  process	  involves	  active	  adhesion	  and	  migration.	  Once	  in	  the	  niche,	  HSCs	  make	  fate	  decisions	  among	  staying	   quiescence	   or	   entering	   self-­‐renewal.	   Eventually,	   the	   final	   engraftment	  requires	  the	  differentiation	  of	  HSCs	  into	  multiple	  lineages	  of	  mature	  blood	  cells.	  	  	  	  
	  
Regulators	  of	  HSC	  Engraftment	  	   Thus	   far,	   the	   live	   process	   of	   a	   single	  HSC	   homing	   to	   and	   engrafting	   the	   bone	  marrow	  has	   not	   been	   observed.	  Many	   of	   the	  major	   breakthroughs	   that	   facilitated	  the	   understanding	   of	   the	   engraftment	   process	   were	   made	   using	   analogous	  processes	  in	  other	  cell	  types,	  such	  as	  lymphocytes	  and	  myelomonocytes.	  First,	  HSCs	  need	   to	  detect	   the	  correct	  environment	   to	  enter.	  The	  signaling	  by	  stromal-­‐derived	  factor	   1	   (SDF-­‐1)	   guides	   HSCs,	   which	   express	   the	   receptor	   CXCR4	   to	   home	   to	   the	  marrow.	   The	   SDF-­‐1/CXCR4	   axis	   was	   originally	   discovered	   to	   be	   essential	   for	   the	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attraction	   and	   retention	   of	   lymphocytes	   in	   the	   lymphoid	   organ.	   Genetic	   knockout	  mice	  also	  further	  demonstrated	  the	  requirement	  of	  this	  signaling	  for	  the	  trafficking	  of	  HSCs	  from	  fetal	  liver	  to	  bone	  marrow	  during	  embryo	  development	  in	  mice	  (Zou	  et	  al.,	  1998).	  Later	  on,	  it	  was	  also	  shown	  to	  play	  an	  important	  role	  in	  adult	  HSC	  homing	  to	  the	  bone	  marrow	  (Laird	  et	  al.,	  2008).	  This	  discovery	  led	  to	  the	  application	  of	  the	  opposite	  process,	  HSC	  mobilization.	  By	  blocking	   the	   SDF-­‐1/CXCR4	   signaling,	  HSCs	  can	  be	  mobilized	  into	  peripheral	  blood,	  and	  collected	  for	  transplantation	  (Lapidot	  et	  al.,	  2005).	  This	  chemokine	  guidance	  is	  also	  important	  for	  tumor	  cells	  to	  metastasize	  to	  a	  secondary	  site	  (Zlotnik	  et	  al.,	  2011).	  In	  addition	  to	  the	  SDF-­‐1/CXCR4	  signaling,	  stem	   cell	   factor	   (SCF)	   and	   its	   receptor,	   c-­‐Kit	   also	   plays	   an	   important	   role	   in	   HSC	  homing,	  as	  well	  proliferation	  and	  cell-­‐renewal	  (Kent	  et	  al.,	  2008).	  	  	   Besides	  external	   signaling,	  homing	  also	   requires	  cell-­‐cell	   interaction	  mediated	  by	  adhesion	  molecules.	   Integrins	  and	  very	   late	  antigen-­‐4	  (VLA-­‐4)/the	  vascular	  cell	  adhesion	   molecule-­‐1	   (VCAM-­‐1)	   mediate	   the	   HSC-­‐endothelial	   interaction	   required	  for	  entering	   the	  marrow	  (Mazo	  et	   al.,	   1998;	  Papayannopoulou	  et	   al.,	   1995).	  These	  interactions	  were	  originally	  found	  to	  be	  essential	  for	  leukocytes	  slowing	  down	  and	  rolling	  on	  the	  endothelial	  wall	  before	  they	  undergo	  extravasation.	   	   Intra-­‐cellularly,	  small	   GTPases,	   such	   as	   Rac,	   Cdc42	   and	   Rho,	   are	   required	   to	   orchestrate	   the	   cell	  movement	  for	  efficient	  homing,	  retention	  and	  localization	  in	  the	  marrow	  (Cancelas	  et	   al.,	   2005;	   Gu	   et	   al.,	   2003;	  Williams	   et	   al.,	   2008;	   Yang	   et	   al.,	   2001).	   These	   small	  GTPases	   are	   the	   intermediate	   players	   in	   translating	   extracellular	   signals	   from	   cell	  membrane	  to	  the	  cytoskeleton,	  as	  well	  as	  regulating	  gene	  transcription	  in	  the	  nuclei.	  Another	  signaling	  component	  required	  for	  marrow	  engraftment	  is	  Gαs	  (Adams	  et	  al,	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2009).	   Gαs	  mediates	   the	   signaling	   from	   hundreds	   of	   G	   protein-­‐coupled	   receptors	  (GPCR),	  which	  are	  one	  of	  the	  most	  abundant	  cell	  surface	  receptors.	  Although	  many	  GPCRs	   utilize	   the	   same	   G	   trimeric	   protein	   complex	   composed	   of	   Gαs,	   β	   and	   γ	  subunits,	   how	   different	   ligand-­‐receptor	   interactions	   lead	   to	   different	   cellular	  responses	  is	  unclear.	  	  	   Once	  HSCs	  enter	  the	  bone	  marrow	  niche,	  extrinsic	  signaling	  from	  various	  niche	  cells,	   such	   as	   vascular	   and	  mesenchymal	   cells,	   influence	  HSC	   cell	   fate	  decisions	   to	  maintain	  quiescence,	  proliferate	  or	  differentiate.	  Signaling	   from	  the	  niche	   includes	  Angiopoietin/Tie2,	   Notch,	   etc	   (Arai	   et	   al.,	   2004;	   Bigas	   and	   Espinosa,	   2012).	  Intrinsically,	  transcription	  factors	  and	  chromatin	  modifiers,	  such	  as	  Hox	  genes	  and	  polycomb	  group	  proteins	  mediate	  transcription	  repression	  thereby	  maintaining	  the	  self-­‐renewal	  capabilities	  of	  HSCs.	  Reciprocally,	  HSCs	  might	  also	  participate	  in	  niche	  formation,	   although	   no	   published	   data	   have	   formally	   tested	   this	   hypothesis	   yet	  (Mercier	  et	  al.,	  2011).	  	   Based	   on	   the	   studies	   in	   the	   past	   two	   decades,	   the	   complex	   steps	   leading	   to	  successful	  engraftment	  require	  finely	  tuned	  cellular	  responses.	  Each	  step	  involves	  a	  response	  to	  diverse	  external	  signals	  in	  the	  niche,	  dramatic	  cellular	  changes,	  and	  cell-­‐cell	   interactions	   (Laird	  et	  al.,	  2008).	  Although	  some	  signaling	  pathways	  have	  been	  selected	  for	  study	  in	  the	  setting	  of	  hematopoietic	  stem	  cell	  transplantation,	  a	  large-­‐scale	   forward	   genetic	   approach	   to	   systematically	   understand	   the	   factors	   that	  participate	   in	   successful	   engraftment	   has	   not	   been	   undertaken.	   Because	   of	   the	  complexity	   of	   the	   biological	   processes	   involved	   in	   HSC	   engraftment,	   it	   has	   to	   be	  appropriately	   studied	  with	   an	   in	   vivo	   animal	  model.	  Mouse	  models	   of	  marrow	   or	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HSC	  transplantation	  can	  usually	  faithfully	  recapitulate	  the	  human	  process.	  However,	  the	   mouse	   is	   not	   the	   best	   model	   for	   large-­‐scale	   forward	   genetic	   screening.	  Therefore,	  an	  animal	  model	  suitable	  for	  this	  purpose	  is	  greatly	  needed.	  	  
	  
Zebrafish	  Hematopoiesis	  Models	  	  Signaling	   pathways	   controlling	   HSCs	   are	   largely	   conserved	   across	   vertebrate	  species.	   Zebrafish	   embryonic	   hematopoiesis	   greatly	   resembles	   mammalian	  embryonic	   hematopoiesis.	   Details	   about	   zebrafish	   hematopoiesis	   during	   embryo	  development	  have	  been	  thoroughly	  described	  in	  several	  reviews	  (Davidson	  and	  Zon,	  2004;	   Galloway	   and	   Zon,	   2003).	   In	   summary,	   zebrafish	   embryonic	   hematopoiesis	  happens	   in	   two	  overlapping	   stages.	  The	  primitive	  wave	  only	  gives	   rise	   to	   lineage-­‐committed	  erythroid	  and	  myeloid	  progenitors,	  while	  the	  definitive	  wave	  generates	  functional	   HSCs	   and	   all	   lineages	   found	   in	   the	   adult.	   The	   definitive	   HSCs	   can	   be	  identified	  by	  genetic	  markers,	  such	  as	  runx1,	  cmyb,	  and	  CD41	  (Kalev-­‐Zylinska	  et	  al.,	  2002;	  Ma	  et	  al.,	  2011;	  Thompson	  et	  al.,	  1998).	  After	  being	  born	  in	  the	  AGM	  (aorta-­‐gonad-­‐mesonephro)	  region,	  HSCs	  will	  migrate	  to	  the	  temporary	  hematopoietic	  site,	  the	   CHT	   (caudal	   hematopoietic	   tissue)	   in	   zebrafish	   (Murayama	   et	   al.,	   2006).	  Eventually,	  the	  HSCs	  will	  colonize	  the	  kidney	  marrow,	  the	  equivalent	  of	  mammalian	  bone	  marrow,	  and	  become	  the	  juvenile	  and	  adult	  hematopoietic	  tissue.	  	  Hematopoiesis	   in	   adult	   zebrafish	   is	   conserved	   with	  mammals	   (Davidson	   and	  Zon,	   2004;	   Traver	   et	   al.,	   2003b).	   Zebrafish	   kidney	   marrow	   can	   rescue	   lethally	  irradiated	   or	   mutant	   zebrafish	   with	   hematopoietic	   defects	   (Stachura	   et	   al.,	   2011;	  Traver	   et	   al.,	   2003b;	   Traver	   et	   al.,	   2004).	   Flow	   cytometry	   analysis	   shows	   that	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zebrafish	  WKM	  have	   similar	   forward	   scatter	   and	   side	   scatter	   profile	   to	  mouse	   or	  human	  bone	  marrow.	  Blood	  smear	  also	  confirms	  similar	  cellular	  features	  within	  the	  same	  type	  of	  blood	  cells	  between	  fish	  and	  mammals,	  with	  the	  exception	  of	  red	  blood	  cells,	  which	   still	   retain	   their	   nuclei	   after	   reaching	  maturation	   (Davidson	   and	   Zon,	  2004;	   Traver	   et	   al.,	   2003).	   	   Transplanting	   adult	   zebrafish	   whole	   kidney	   marrow	  (WKM),	  which	  contains	  all	  the	  hematopoietic	  stem	  and	  progenitor	  cells,	  into	  lethally	  
γ-­‐irradiated	   fish	   can	   rescue	   the	   recipients	   with	   all	   the	   blood	   lineages	   fully	  repopulated	   (Traver	  et	   al.,	   2004).	  This	  proves	   the	  existence	  of	  HSCs	   in	   the	  kidney	  marrow.	  Recently,	   White	   et	   al	   developed	   a	   transparent	   adult	   zebrafish,	   called	   casper,	  which	   is	   doubly	  mutant	   for	   nacre	   and	   roy,	   two	   genes	   essential	   for	   pigment	   cells.	  Organs	   such	   as	   the	   heart	   and	   blood	   vessels	   can	   be	   seen	   using	   standard	  stereomicroscopy.	   Using	   fluorescent	   transgenic	   zebrafish	   as	   marrow	   donors	   and	  
casper	  as	  recipients	  allows	   for	   in	  vivo	  visual	  assessment	  of	  engraftment	  within	   the	  kidney	   marrow	   region	   without	   sacrificing	   the	   recipients	   (White	   et	   al.,	   2008).	  However,	   there	   can	   still	   be	   large	   individual	   variations	   of	   engraftment	   efficiency,	  which	   is	   likely	   caused	   by	   variability	   in	   the	   transplantation	   procedure	   due	   to	   the	  small	   fish	   body	   size.	   Having	   an	   internal	   HSC	   control	   population	   in	   a	   competitive	  transplantation	  setting	  can	  help	  solve	  this	  problem	  and	  generate	  more	  reproducible	  results.	   Despite	   the	   caveats,	   the	   zebrafish	  WKM	   transplantation	  model	   is	   still	   the	  most	   promising	   in	   vivo	   model	   for	   large-­‐scale	   genetic	   or	   chemical	   genetic	   screens	  looking	  for	  regulators	  of	  HSC	  engraftment.	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Arachidonic	  Acid-­‐Derived	  Eicosanoids	  	  	   Arachidonic	   acid	   (AA)	   is	   an	   important	   component	   of	   the	   cell	   lipid	   bi-­‐layer	  membrane.	   It	   functions	   both	   as	   a	   structural	   component	   and	   signaling	   precursor.	  Upon	  extracellular	  stimulation,	  such	  as	  ligand	  binding	  to	  the	  IFN	  (Interferon)	  or	  5-­‐HT	   (5-­‐hydroxytryptamine)	   receptors,	   phospholipase	   A2	   (PLA2)	   is	   activated	   by	  phosphorylation	  and	  calcium	  influx.	  PLA2	  can	  release	  AA	  and/or	  lysophospholipids	  by	   catlytically	   hydrolyzing	   the	   sn-­‐2	   acyl	   bond	   of	   phospholipids	   from	   the	   cell	  membrane	  (Figure	  1.2)	  (Carroll	  and	  McGiff,	  2000).	  Free	  AA	  can	  be	  metabolized	  into	  versatile	   types	   of	   eicosanoids	   by	   different	   families	   of	   enzymes.	   Three	   major	  enzymatic	   pathways	   are	   involved	   in	   AA	   metabolism:	   cyclooxygenase	   (COX),	  lipoxygenase	  (LOX),	  and	  cytochrome	  P450	  (CYP)	  pathways	  (Figure	  1.2)	  (Carroll	  and	  McGiff,	   2000).	   COX	   is	   the	   first	   enzyme	   in	   the	   metabolic	   pathway	   responsible	   for	  converting	  AA	  into	  various	  prostanoids,	   including	  prostaglandins,	  prostacyclin	  and	  thromboxane.	  Two	  COX	  genes	  have	  been	  identified	  in	  the	  human	  genome:	  COX1	  and	  
COX2,	  the	  expression	  patterns	  of	  which	  are	  tissue-­‐specific.	  LOX	  enzymes	  metabolize	  AA	  first	  into	  hydroperoxyeicosatetraenoic	  acids,	  which	  then	  can	  be	  metabolized	  into	  various	   leukotrienes.	   The	   human	   LOX	   family	   that	   uses	   AA	   as	   the	   main	   substrate	  includes	  ALOX5,	  ALOX12,	  and	  ALOX15	  (Haeggstrom	  and	  Funk,	  2011).	  	  	  	   Compared	  to	  the	  long-­‐standing	  history	  of	  prostaglandins	  and	  leukotrienes,	  the	  finding	   that	   AA	   can	   be	   metabolized	   by	   CYP	   is	   relatively	   new.	   CYP	   is	   an	   enzyme	  superfamily,	   comprising	   hundreds	   of	   members,	   with	   varying	   enzymatic	   catalytic	  capabilities	   and	   substrate	   specificities.	   The	   majority	   of	   CYP	   enzymes	   are	  monooxygenase,	   which	   adds	   only	   one	   oxygen	   atom	   to	   the	   existing	   organic	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substrates	   (Carroll	   and	   McGiff,	   2000).	   In	   contrast,	   the	   enzymes	   involved	   in	  prostaglandin	  and	  leukotriene	  synthesis	  are	  mostly	  dioxygenases.	  Most	  of	  the	  well-­‐studied	  CYP	  enzymes	  are	   involved	   in	  drug	  degradation	  or	  activation.	  Early	  studies	  using	   kidney	   tissues	   showed	   that	   AA	   can	   be	   omega-­‐hydroxylated	   into	   mono-­‐hydroxyeicosatetraenoic	  acids	  (HETE)	  or	  epoxydated	  into	  epoxyeicosatrienoic	  acids	  (EET)	  (Oliw	  &	  Oates,	  1981;	  Oliw	  et	  al.,	  1982;	  Capdevila	  et	  al.,	  1981b,	  1982;	  Morrison	  &	  Pascoe,	  1981).	  These	  reactions	  are	  catalyzed	  by	  NADPH-­‐dependent	  CYP	  enzymes	  (Capdevila	  et	  al.,	  1981b).	  The	  enzyme	  converting	  AA	  into	  20-­‐	  or	  19-­‐HETE	  turned	  out	  to	   be	   ω	   or	   ω-­‐1	   hydrolase	   (Oliw	   et	   al.,	   1982).	   The	   CYP	   enzymes	   responsible	   for	  synthesizing	   EETs	   were	   found	   to	   localize	   to	   the	   microsomal	   fraction	   of	   cells	   in	  multiple	   tissues	   and	   cell	   types.	   In	   human,	   the	   2C	   and	  2J	   subfamily	   of	   CYP	   are	   the	  major	  enzymes	  generating	  EETs	  (Lee	  et	  al.,	  2010).	  EETs	  have	  very	  short	  half-­‐lives	  in	  
vivo,	  and	  are	  quickly	  hydrolyzed	  into	  dihydroxyeicosatrienoic	  acids	  (DiHET),	  which	  are	  considered	  much	  less	  potent	  than	  EETs	  (Panigrahy	  et	  al.,	  2011b).	  	  	   Interestingly,	   in	   normal	   rabbit	   kidney,	   the	   renal	   medulla	   can	   efficiently	  metabolize	  AA	   into	  prostaglandins.	   In	   contrast,	  with	  very	  minimal	  activity	  of	  COX,	  renal	  cortex	  predominantly	  converts	  AA	  into	  HETEs	  (Morrison	  et	  al,	  1981).	  This	  is	  a	  perfect	   example	   of	   how	   different	   tissues	   or	   cells	   utilize	   different	   eicosanoids	   to	  achieve	  unique	  biological	   functions.	  Besides	  the	  tissue-­‐specificity,	   the	  utilization	  of	  different	  CYP	  enzymes	  also	  shows	  species-­‐specificity	  (Nelson	  et	  al.,	  1996).	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Figure	  1.2	  Arachidonic	  acid	  (AA)-­‐derived	  eicosanoids	  	  	  Upon	   stimulation,	   AA	   is	   released	   from	   the	   cell	   membrane	   by	   phospholipase	   A2	  (PLA2),	   and	   further	   metabolized	   by	   different	   enzymes	   into	   different	   eicosanoids.	  COX:	  cyclooxygenase;	  CYP:	  cytochrome	  P450	  enzyme	  families;	  sEH:	  soluble	  epoxide	  hydrolase;	   LOX:	   lipoxygenase;	   PGG2:	   prostaglandin	   G2;	   PGH2:	   prostaglandin	   H2;	  HETE:	   hydroxyeicosatetraenoic	   acid;	   EET:	   epoxyeicosatrienoic	   acid;	   DiHET:	   di-­‐hydroxyeicosatrienoic	  acid;	  HpETE:	  hydroperoxyeicosatetraenoic	  acid.	  	  
	  
	  
Eicosanoids	  and	  Hematopoiesis	   	  	   AA-­‐derived	   eicosanoids	   play	   an	   important	   role	   in	   various	   physiological	  situations,	  especially	  in	  inflammatory	  and	  immune	  response.	  	  Therefore,	  most	  of	  the	  studies	  have	  centered	  on	  understanding	  how	  eicosanoids	  modulate	  the	  specialized	  cell	   functions	   of	   differentiated	  mature	   blood	   cells,	   such	   as	  macrophage	  migration	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and	   platelet	   aggregation.	   	   In	   addition,	   a	   second	   major	   focus	   has	   been	   on	   how	  eicosanoids	   regulate	   the	   differentiation	   of	   hematopoietic	   progenitors	   (Vore	   et	   al.,	  1989).	   Studies	   of	   hematopoietic	   differentiation	   have	   utilized	   both	   primary	  hematopoietic	   progenitor	   cells	   and	   human	   leukemic	   cell	   culture.	   Usually	   during	  myeloid	   differentiation,	   with	   enhanced	   oxidative	  metabolic	   activity,	   AA	  metabolic	  enzymes	  are	  upregulated,	  which	  leads	  to	  the	  increased	  level	  of	  multiple	  eicosanoids.	  In	   cultured	   cells,	   exogenously	   added	   eicosanoids	   can	   either	   promote	   or	   block	  differentiation	   of	   myeloid	   or	   erythroid	   progenitor	   cells	   at	   various	   differentiation	  stages	   (Figure	   1.3)	   (Ziboh	   et	   al.,	   1986).	   Similarly,	   chemically	   blocking	   certain	  metabolic	   enzymes	   can	   also	   block	   the	   terminal	   differentiation	   of	   progenitor	   cells	  (Visnjic	   et	   al.,	   1997).	   Although	   cytochrome	   P450-­‐dependent	   eicosanoids	   are	  relatively	   young	   members	   of	   the	   family,	   their	   physiological	   effects	   are	   closely	  associated	   with	   hematopoiesis.	   It	   was	   originally	   reported	   that	   human	   peripheral	  blood	  neutrophils	  and	  bone	  marrow	  cells	  can	  convert	  AA	  into	  19-­‐	  and	  20-­‐HETE,	  in	  a	  cytochrome	  P450	  and	  NADPH-­‐dependent	  manner.	   	  These	  metabolites	  have	  potent	  CFU-­‐E	   (colony	   forming	   unit	   erythroid)	   promoting	   activity	   on	   bone	   marrow	   cells	  within	  a	  nanomolar	  concentration	  range	  (Lutton	  et	  al.,	  1989).	  	   Eicosanoids	   regulate	   hematopoiesis	   at	   several	   different	   levels	   of	   cell	   biology.	  Beside	   differentiation,	   prostaglandins	   and	   leukotrienes	   also	   regulate	   stem	   and	  progenitor	  cell	  proliferation	  and	  survival	  vs.	  apoptosis	  (Rizzo,	  2002).	  In	  addition,	  it	  has	  been	  reported	  that	  bone	  marrow	  niche	  cells	  are	  also	  influenced	  by	  eicosanoids.	  Several	  growth	  factors,	  such	  as	  GM-­‐CSF,	  TNF-­‐α	  and	  IL-­‐1,	  can	  stimulate	  bone	  marrow	  stromal	   cells	   to	   release	   AA,	   which	   can	   be	   further	   metabolized	   into	   various	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eicosanoids	  (Geijsen	  et	  al.,	  2000;	  Rizzo	  et	  al.,	  1994).	  This	  might	  serve	  as	  one	  of	  the	  many	  mechanisms	  for	  niche	  cells	  to	  regulate	  hematopoiesis,	  or	  vice	  versa.	  However,	  thus	   far,	   studies	   on	   the	   role	   of	   eicosanoids	   on	   hematopoietic	   niche	   cells	   are	   very	  limited.	  This	  is	  a	  promising	  field	  to	  explore	  in	  the	  future.	  	  	  	  
Eicosanoids	  and	  Stem	  Cells	  	   Besides	  affecting	  more	  differentiated	  progenitors,	  several	  studies	  have	  begun	  to	  elucidate	   the	   important	   role	   of	   eicosanoids	   on	   the	   stem	   cell	   population.	   Recently,	  our	  lab	  discovered	  Prostaglandin	  E2	  (PGE2)	  could	  increase	  the	  HSC	  production	  in	  a	  chemical	   screen	   using	   the	   zebrafish	   embryo	   hematopoiesis	   model	   (North	   et	   al.,	  2007).	   	   Interesting,	   PGE2	   can	   also	   enhance	   adult	   bone	  marrow	   transplantation	   in	  mice.	   Currently,	   a	   degradation-­‐resistant	   derivative	   of	   PGE2,	   16,16-­‐dimethyl	  prostaglandin	   E2	   (dmPGE2)	   is	   under	   clinical	   trials	   to	   test	   its	   efficacy	   in	   human	  umbilical	   cord	  HSC	   transplantation	   (unpublished	   data).	   It	   is	   thought	   that	   dmPGE2	  achieves	   such	   biological	   function	   through	   elevating	   the	   intracellular	   cAMP	   level,	  which	   in	  turn	  enhances	  β-­‐catenin	  nuclear	  translocation	  by	   inhibiting	  GSK-­‐3	  kinase	  (North	  et	  al,	  2010).	  This	  mechanism	  might	  explain	  the	   increase	  of	  HSC	  production	  during	   embryogenesis,	   since	  Wnt/β-­‐catenin	   pathway	   is	   known	   to	   be	   essential	   for	  HSC	  specification	  in	  the	  AGM	  (Clements	  et	  al.,	  2011;	  Lengerke	  et	  al.,	  2008).	  However,	  the	  importance	  of	  Wnt	  in	  adult	  HSCs	  is	  quite	  controversial.	  Therefore,	  how	  dmPGE2	  enhances	  marrow	  engraftment	  and	  which	  cell	  population	  it	  directly	  acts	  on	  are	  less	  clear.	   Another	   group	   has	   shown	   pulse	   treatment	   with	   dmPGE2	   enhances	   HSC	  homing	   efficiency	   by	   two-­‐fold	   via	   increasing	   the	   CXCR4	   protein	   level	   on	   the	   cell	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surface	  (Hoggatt	  et	  al.,	  2009).	  Other	  factors	  might	  also	  contribute	  to	  the	  total	  four-­‐fold	   increase	  of	   competitive	   repopulating	  units	  by	  dmPGE2	   (Goessling	  et	  al.,	  2009;	  Hoggatt	  et	  al.,	  2009;	  North	  et	  al.,	  2007).	  	   LOX	  enzymes	  are	  also	  required	  for	  normal	  HSC	  functions.	  It	  has	  been	  reported	  that	   12/15-­‐LOX-­‐deficient	   HSCs	   are	   severely	   compromised	   in	   their	   reconstitution	  capability	  as	  measured	  by	  competitive	  and	  serial	  transplantation	  assays	  (Kindler	  et	  al.,	   2010).	   The	   study	   also	   showed	   that	   the	   defects	  were	  mainly	   due	   to	   the	   loss	   of	  quiescence	  of	   long-­‐term	  HSCs.	   Similarly,	  both	  prostaglandins	  and	   leukotrienes	  are	  also	  required	  for	  leukemia	  stem	  cells	  (LSC)	  to	  promote	  leukemia	  development.	  Loss	  of	   the	   5-­‐Lox	   gene	   in	   mice	   impairs	   BCR-­‐ABL-­‐induced	   chronic	   myeloid	   leukemia	  (CML)	   (Chen	   et	   al.,	   2009).	   In	   another	   study	   using	   an	   MLL-­‐AF9-­‐induced	   mouse	  myelogenous	   leukemia	   (AML)	   model,	   expression	   of	   Cox-­‐1	   and	   prostaglandin	   E	  receptor	  1	  (Ptger1)	  were	  upregulated	  in	  the	  leukemia	  stem	  cell	  population.	  Treating	  the	  mice	  with	  COX	  inhibitor,	  Indomethacin,	  dramatically	  reduced	  the	  LSC	  frequency	  (Wang	  et	  al.,	  2010).	  	  	   The	   exploration	   of	   the	   role	   of	   eicosanoids	   on	   stem	   cells	   has	   just	   started.	  Although	  LOX-­‐deficiency	  studies	   indicated	   the	   importance	  of	   leukotrienes	   in	  HSCs,	  the	   specific	   leukotriene(s)	  matching	   this	   role	   still	   need	   to	   be	   identified.	   Similarly,	  besides	  PGE2,	  it	  is	  unclear	  if	  other	  prostaglandins	  also	  affect	  HSCs.	  Finally,	  the	  CYP-­‐derived	  eicosanoids	  have	  not	  been	  studied	  in	  the	  context	  of	  HSCs.	  This	  aspect	  will	  be	  covered	  in	  this	  thesis.	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Figure	  1.3	  Arachidonic	  acid-­‐derived	  eicosanoids	  regulate	  hematopoiesis	  	  AA-­‐derived	   eicosanoids	   have	   pleiotropic	   effects	   on	   normal	   hematopoiesis,	   from	  terminal	  differentiation	  to	  progenitor	  proliferation.	  Green	  labels	  represent	  positive	  effects,	  while	   red	   represents	   negative	   effects.	   PGs:	   prostaglandins	   in	   general;	   LTs:	  leukotrienes	  in	  general;	  Tx:	  thromboxane;	  CFU:	  colony	  forming	  unit;	  E,	  erythrocyte;	  Meg:	   megakaryocyte;	   G,	   granulocyte;	   M:	   monocyte;	   CMP:	   common	   myeloid	  progenitor;	   CLP:	   common	   lymphoid	   progenitor;	   MEP:	   megakaryocyte-­‐erythroid	  progenitor;	  GMP:	  granulocyte-­‐monocyte	  progenitor.	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Summary	  of	  the	  Thesis	  
	   Understanding	   how	   HSCs	   achieve	   engraftment	   is	   important	   both	   as	   a	   basic	  biological	  question	  and	  for	  clinical	  application	  of	  stem	  cell	  therapy.	  In	  the	  following	  chapters	   of	   this	   thesis,	   I	   will	   describe	   the	   development	   of	   a	   competitive	   marrow	  transplantation	   assay	   in	   adult	   zebrafish,	   which	   allows	   quick	   visualization	   and	  quantification	  of	   the	  marrow	  engraftment	  capabilities	   in	  vivo.	  Using	   this	  assay,	   the	  first	  transplantation-­‐based	  chemical	  screen	  was	  performed	  with	  a	  known-­‐bioactive	  chemical	  library.	  The	  screen	  led	  to	  the	  discovery	  of	  ten	  chemicals	  involved	  in	  several	  novel	  pathways,	  which	  can	  enhance	  marrow	  engraftment.	  One	  example	  is	  a	  group	  of	  arachidonic	   acid-­‐derived	   eicosanoids,	   epoxyeicosatrienoic	   acids	   (EETs).	  Evolutionarily	   conserved	   EETs	   can	   also	   promote	   both	   short-­‐term	   and	   long-­‐term	  marrow	   engraftment	   in	  mice.	   Using	   genetic	   knockdown	   and	   chemical	   suppressor	  screening	   in	   zebrafish	   embryos,	   we	   found	   that	   EET	   acts	   through	   a	   Gα12/13-­‐mediated	  receptor,	  which	  activates	  PI3K	  and	  induces	  transcription	  factors	  of	  the	  AP-­‐1	   family.	   This	   PI3K/AP-­‐1	   pathway	   directly	   regulates	   the	   transcription	   of	   an	   HSC	  marker,	   runx1,	   in	   zebrafish	   embryos.	   Further	   study	   on	   the	   EET/PI3K	   pathway	  shows	   that	   PI3K	   activation	   is	   required	   for	   promoting	   HSPC	   migration	   and	  interactions	  with	  niche	  cells,	  and	  therefore	  engraftment.	  	  	   In	   addition	   to	   the	   blood	   phenotype,	   EET	   also	   caused	   cell	   morphological	   and	  gene	   expression	   changes	   in	   the	   developing	   tail	   bud	   of	   zebrafish	   embryos.	   	   This	  tissue	  also	  utilizes	  the	  PI3K/AP-­‐1	  signaling/transcription	  cascade	  to	  induce	  ectopic	  
runx1	   expression	   in	   the	   mesenchymal-­‐like	   cells.	   Suppressor	   screening	   also	  identified	   an	   additional	   signaling	   and	   transcription	   regulatory	   network,	   which	  
Chapter	  1:	  Introduction    
   
	  
19	  
shares	   some	   similarities	  with	   epithelial	  mesenchymal	   transition	   (EMT).	   This	   non-­‐hematopoietic	  study	  might	  help	  to	  explain	  the	  previously	  reported	  observation	  that	  EETs	  can	  promote	  tumor	  metastasis	  and	  angiogenesis	  (Panigrahy	  et	  al.,	  2011b).	  	  	   In	   summary,	  our	   studies	  define	  a	   role	   for	  EETs	   in	   the	  engraftment	  of	  HSCs	   in	  adult	   vertebrates,	   and	   HSC	   development	   during	   embryogenesis.	   The	   chemical	  screen	   also	   identified	   additional	   pathways	   important	   for	   regulating	   HSC	  engraftment.	   These	   discoveries	   may	   have	   clinical	   application	   in	   marrow	   or	   cord	  blood	   transplantation,	   as	   well	   as	   elucidate	   some	   basic	   regulatory	   mechanisms	   of	  stem	   cell	   engraftment.	   	   The	   success	   of	   the	   transplantation-­‐based	   chemical	   screen	  might	   encourage	   the	   use	   of	   chemical	   genetic	   screening	   approaches	   to	   study	  complicated	  biological	  processes	  in	  vivo.	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Introduction	  The	   signature	   characteristic	   of	   adult	   stem	  cells	   is	   the	   capability	   to	   regenerate	  damaged	   tissue	  while	  maintaining	   their	   identity.	   The	   best	   understood	   example	   is	  hematopoietic	  stem	  cells	  (HSC),	  which	  are	  a	  rare	  cell	  population	  that	  gives	  rise	  to	  all	  the	   blood	   cells	   in	   the	   body.	   HSCs	   have	   been	  widely	   used	   to	   treat	   life-­‐threatening	  diseases,	  such	  as	   leukemia	  and	  bone	  marrow	  failure.	  During	   transplantation,	  HSCs	  are	   intravenously	   transfused	   into	   patients	   previously	   conditioned	  with	   total	   body	  irradiation	  and/or	  chemotherapy	   to	  clear	   the	  niche.	  They	   travel	   in	   the	  circulation,	  home	   to	   the	   bone	   marrow,	   lodge	   into	   their	   niche,	   undergo	   proliferation	   and	  differentiation,	   and	   repopulate	   the	   blood	   system	   of	   the	   recipient.	   	   This	   process	   is	  termed	  engraftment	   (Laird	  et	   al.,	   2008).	  Clinical	  protocols	  have	  been	  well	  worked	  out	   for	   transplantation	   in	   humans,	   but	   unpredictable	   engraftment	   failure	   still	  jeopardizes	  the	  lives	  of	  patients.	  	  In	  order	  to	  minimize	  engraftment	  failure,	  a	  better	  understanding	  of	  how	  HSCs	  achieve	   engraftment	   is	   essential.	   To	   tackle	   this	   question,	   animal	   models	   that	   can	  recapitulate	   the	   biology	   of	   human	   HSC	   transplantation	   are	   needed.	   The	   mouse	  system	   has	   been	   extensively	   used	   for	   competitive	   transplantation.	   	   Briefly,	   two	  alleles	  differing	  at	  the	  CD45	  locus	  are	  used	  to	  distinguish	  among	  the	  two	  donors	  and	  the	  recipient.	  This	  proves	  to	  be	  the	  most	  quantitative	  method	  to	  determine	  whether	  a	  genetic	  mutation	  affects	  stem	  cell	  engraftment	  capability.	  However,	  because	  of	  the	  high	  cost	  and	   long	   latency,	   the	  mouse	  model	  has	  been	  mostly	  used	  to	  test	  a	  single	  hypothesis,	  such	  as	  the	  relative	  contribution	  of	  mutant	  to	  normal	  HSCs.	  In	  order	  to	  categorize	  pathways	  in	  relation	  to	  transplant	  engraftment	  in	  a	  more	  systematic	  way	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and	  discover	  novel	  pathways,	  chemical	  or	  genetic	  screens	  are	  required.	  In	  order	  to	  achieve	   this	   goal,	   a	   higher-­‐throughput	   and	   cost-­‐effective	   assay	   needs	   to	   be	  developed.	  	  The	  vertebrate	  model	  organism,	  Danio	  rerio	  (zebrafish),	  suits	  this	  purpose	  very	  well.	  Hematopoiesis	   in	   adult	   zebrafish	   is	   conserved	  with	  mammals	   (Davidson	  and	  Zon,	   2004;	   Traver	   et	   al.,	   2003b).	   Zebrafish	   kidney	   marrow,	   the	   equivalent	   of	  mammalian	  bone	  marrow,	   can	   rescue	   lethally	   irradiated	  or	  mutant	   zebrafish	  with	  hematopoietic	   defects	   (Stachura	   et	   al.,	   2011;	   Traver	   et	   al.,	   2003b;	   Traver	   et	   al.,	  2004).	   In	   the	   latest	   rendition	   of	   transplant	   experiments,	  we	   utilized	   a	  Tg(β-­‐actin:	  
GFP)	  fish	  as	  donor.	  The	  wild-­‐type	  recipient	  fish	  are	  irradiated	  at	  a	  sublethal	  dose	  of	  25	  Gy	  and	  are	   injected	   intra-­‐cardiacally	  with	   the	  GFP	  expressing	  marrow.	  From	  4	  weeks	  to	  3	  months,	  GFP	  expression	  can	  be	  analyzed	  in	  the	  recipient	  animal	  by	  flow	  cytometry.	   At	   4	   weeks,	   significant	   reconstitution	   of	   the	   myeloid	   compartment	   is	  evident.	   	   Because	   myeloid	   cells	   have	   a	   short	   half-­‐life,	   this	   gate	   gives	   the	   best	  estimate	  of	  engraftment	   in	  each	  animal.	   	  More	  recently,	  our	   lab	  has	  pioneered	   the	  use	   of	   casper,	   an	   adult	   zebrafish	   that	   is	   completely	   transparent.	   GFP+	   kidney	  marrow	  engrafted	  in	  casper	  can	  be	  directly	  visualized	  over	  a	  4	  week	  period	  of	  time	  (White	   et	   al.,	   2008).	   However,	   due	   to	   the	   variability	   of	   the	   transplantation	  technique,	   it	   has	   been	   difficult	   to	   directly	   compare	   the	   engraftment	   capability	   of	  donor	  marrow	  cells	  in	  a	  precise	  way.	  	  Driven	   by	   the	   needs	   of	   evaluating	   genetic	   and	   chemical	   effects	   on	   HSPCs	   in	  zebrafish,	   we	   took	   advantage	   of	   casper	   and	   developed	   a	   live	   imaging-­‐based	  competitive	  transplantation	  system	  that	  enables	  a	  quick	  and	  quantitative	  evaluation	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of	   the	  marrow	  engraftment	   capability.	  Pilot	   tests	  with	   chemicals	   targeting	  various	  important	  signaling	  pathways	  were	  performed	  to	  optimize	  the	  assay	  and	  chemical	  treatment	  conditions.	  The	   feasibility	  of	   testing	  hundreds	  of	  zebrafish	  per	  day	  with	  this	  assay	  allowed	  us	  to	  perform	  a	  chemical	  screen	  to	  identify	  compounds	  regulating	  engraftment.	   	   A	   chemical	   library	   of	   480	   chemicals	   of	   known	   bioactivities	   was	  screened	  using	  this	  competitive	  transplantation	  assay.	  	  After	  the	  primary	  screen	  and	  secondary	  round	  of	  confirmation,	  we	   found	  10	  compounds	  capable	  of	  significantly	  increasing	  marrow	  engraftment	  through	  blind	  scoring.	  	  In	   conclusion,	   in	  vivo	   chemical	   screening	   using	   zebrafish	   competitive	  marrow	  transplantation	   provides	   a	   successful	   example	   of	   phenotypic	   screening	   in	   whole	  adult	  vertebrates.	  The	  discovery	  of	  novel	  repopulation	  modulators	  should	  provide	  a	  better	  understanding	  of	  signaling	  events	  that	  regulate	  homing	  and	  self-­‐renewal,	  and	  may	  have	  clinical	  application	  in	  marrow	  or	  cord	  blood	  transplantation.	  	  	  	  	  	  	  	  
	   	  
Chapter	  2:	  Zebrafish	  Competitive	  Transplantation	  Model	  &	  Chemical	  Screen	   	  
	  
25
Results	  	  In	   order	   to	  develop	   a	   competitive	   transplantation	   assay	   suitable	   for	   unbiased	  screening	   experiments,	   we	   evaluated	   the	   most	   recent	   advancement	   of	  transplantation	   techniques	   in	   zebrafish	   and	   further	   optimized	   several	   conditions,	  leading	   to	   the	   development	   of	   the	   imaging-­‐based	   competitive	   marrow	  transplantation	  assay	  in	  zebrafish.	  	  
	  
Optimizing	  the	  Myeloablative	  Conditions	  Hematopoietic	   stem	   cells	   (HSC)	   reside	   in	   the	   marrow	   space	   surrounded	   by	  different	   cells	   that	   constitute	   a	   microenvironment	   called	   the	   niche.	   It	   has	   been	  postulated	   and	   indirectly	   proven	   that	   there	   are	   only	   a	   limited	   number	   of	   niches	  where	  HSCs	   can	   enter	   (Micklem	  et	   al.,	   1968).	  When	   the	   endogenous	  HSCs	   occupy	  the	   niche,	   transplanted	   HSCs	   have	   to	   compete	   with	   the	   endogenous	   cells	   for	   the	  limited	   space.	   In	   addition,	   the	   endogenous	   immune	   system	   forms	   a	   natural	  defensive	  barrier	  for	  exogenous	  cells	  to	  engraft.	  Therefore,	  to	  clear	  the	  endogenous	  niches	   and	   minimize	   the	   resistance	   from	   the	   endogenous	   immune	   system,	  myeloablative	  methods	  have	  been	  adapted	  both	  clinically	  in	  human	  patients	  and	  in	  animal	   models.	   Irradiation	   and/or	   chemotherapy	   are	   the	   most	   commonly	   used	  methods	   to	   pre-­‐condition	   marrow	   transplantation	   recipients.	   Neutralizing	  antibodies	  against	   c-­‐Kit	  have	  also	  been	  used	   to	   loosen	  up	   the	   interaction	  between	  the	   niche	   and	   the	   endogenous	   HSCs	   in	   immune-­‐deficient	  mice	   (Czechowicz	   et	   al.,	  2007).	   	   Because	   of	   the	   lack	   of	   a	   zebrafish	   c-­‐kit	   antibody	   and	   the	   potential	   high	  variability	   of	   injecting	   chemotherapy	   chemicals,	   a	   single	   dose	   of	   25Gy	   radioactive	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irradiation	   has	   been	   the	   pre-­‐dominant	  method	   for	   pre-­‐conditioning	   the	  wild-­‐type	  zebrafish	   recipients.	   	   However,	   the	   25Gy	   single	   irradiation	   is	   not	   an	   optimal	  condition,	   because	   it	   does	   not	   completely	   ablate	   the	   endogenous	   HSPCs	   and	   also	  causes	  high	  toxicity	  to	  the	  digestive	  system.	  We	  have	  also	  observed	  that	  irradiated	  recipients	  were	  often	  malnourished	  due	  to	  damage	  in	  the	  gut.	  Therefore,	  the	  effects	  of	   different	   irradiation	   regimens	   on	   the	   survival	   of	   casper	   zebrafish	   was	   tested.	  Splitting	  the	  30Gy	  irradiation	  dose	   into	  equally	  divided	  double	  doses	  separated	  by	  24	  hrs	  (hours),	  or	  40Gy	  equally	  into	  triple	  doses,	  dramatically	  increased	  the	  survival	  of	   irradiated	   zebrafish	   (Figure	   2.1A).	   	   With	   the	   improved	   survival	   rate,	   one	   can	  increase	   the	   total	   dose	   of	   irradiation,	   and	   presumably	   ablate	   the	   endogenous	  hematopoietic	   system	   more	   efficiently.	   To	   test	   if	   this	   is	   true,	   100,000	   Tg(β-­‐
actin:GFP)	  WKM	  cells	  were	   transplanted	   into	  differently	   irradiated	   recipients.	  The	  engrafted	   recipients	   were	   imaged	   with	   a	   fluorescent	   microscope,	   and	   the	   GFP	  fluorescence	  intensity	  was	  measured	  within	  the	  kidney	  region.	  Animals	  receiving	  a	  30Gy	   double-­‐split	   dose	   or	   40Gy	   triple-­‐split	   dose	   both	   had	   increased	   survival	   and	  engraftment	  by	  4	  wpt	   (week	  post	   transplant)	   (Figure	  2.1B).	   In	  order	   to	  maximize	  both	   the	   survival	   and	   the	   effectiveness	   of	   myelo-­‐ablation,	   a	   double-­‐split	   dose	   of	  30Gy	  was	  chosen	  for	  future	  experiments.	  	  	  
	   	  





Figure	  2.1	  Optimizing	  the	  Myeloablative	  Conditions	  
	  (A)	  The	  survival	  curve	  of	  casper	  after	  various	  doses	  and	  conditions	  of	  irradiation.	  IR,	  irradiation.	  Single:	  single	  dose;	  Double:	  double-­‐split	  dose;	  Triple:	  triple-­‐split	  dose.	  (B)	   The	   engraftment	   of	   100,000	   Tg(β-­‐actin:GFP)	   WKM	   cells	   in	   casper	   receiving	  various	   doses	   of	   irradiation.	   	   The	   engraftment	   was	   quantified	   by	   the	   GFP	  fluorescence	  intensity	  in	  the	  kidney	  region.	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Optimize	  the	  Injection	  Technique	  	   Traditionally,	   chemicals	  or	  cells	  are	   infused	   into	   the	  blood	  circulation	  of	  adult	  zebrafish	  via	  intra-­‐cardiac	  injection.	  Although,	  zebrafish	  have	  much	  stronger	  repair	  and	  regeneration	  capability	  after	  cardiac	  injury	  compared	  to	  human	  or	  mouse,	  this	  method	   still	   causes	   very	   high	   procedure-­‐associated	   mortality.	   R.	   M.	   White	  introduced	   the	   new	   retro-­‐orbital	   injection,	   inspired	   by	   the	   practice	   in	   mouse	  transplantation.	  Cells	  or	  chemicals	  can	  be	  injected	  into	  the	  sinus	  venous	  behind	  the	  eye	  (Figure	  2.2A,	  B).	  	  To	  test	  how	  fast	  the	  injected	  substances	  get	  into	  circulation,	  we	  injected	  Dextran-­‐conjugated	  TexasRed	   dyes	  with	   a	  molecular	  weight	   of	   70,000	   or	  3,000.	  Within	  15min	  after	  injection,	  the	  dye	  distributed	  in	  the	  circulation	  system	  of	  the	   whole	   fish,	   including	   the	   tail	   fin,	   the	   most	   distal	   tissue	   (Figure	   2.2C,	   D).	   The	  70,000	  dye	  stays	  in	  the	  vascular	  system	  with	  minimal	  diffusion	  for	  the	  first	  15mins,	  while	   the	   3,000	   dye	   can	   permeabilize	   the	   endothelial	   wall	   and	   diffuse	   into	   the	  surrounding	   tissue	   (data	   not	   shown).	   The	   kinetics	   of	   injected	   cells	   getting	   into	  circulation	  may	   differ	   from	   those	   of	   the	   chemical	   dye.	   Therefore,	  we	   injected	   red	  blood	  cells	  harvested	  from	  Tg(lcr:GFP)	  zebrafish	  into	  casper.	  GFP+	  cells	  were	  seen	  in	  the	   circulation	  within	   2	   hrs	   after	   injection	   (Figure	   2.2E).	   	   In	   order	   to	   observe	   the	  GFP+	   cells	   in	   circulation	   immediately,	   a	   relatively	   large	  number	  of	   red	  blood	   cells	  (greater	   than	   500,000)	   need	   to	   be	   injected	   due	   to	   the	   quick	   dilution	   by	   the	  endogenous	  GFP-­‐	  cells.	  	  	  




Figure	  2.2	  Retro-­‐orbital	  injection	  in	  adult	  zebrafish	  	  (A)	  Illustration	  of	  the	  location	  of	  retro-­‐orbital	  injection.	  The	  needle	  aims	  at	  the	  spot	  on	  the	  eye	  equivalent	  to	  seven	  O’clock	  on	  a	  clock.	  	  	  (B)	  Anatomy	  of	  the	  zebrafish	  eye	  region.	  The	  dashed	  box	  (top)	  represents	  the	  region	  where	   the	  needle	   (the	   black	   arrow)	   enters.	  Upon	   correct	   injection,	   the	   cells	   enter	  the	  venous	  sinus	  (bottom).	  	  (C-­‐D)	   15min	   after	   retro-­‐orbital	   injection	   with	   70,000	   Dextran-­‐TexasRed	   dye.	   The	  dye	  enters	  the	  circulation	  and	  is	  distributed	  throughout	  the	  whole	  body	  (C)	  and	  the	  tail	  fin	  (D).	  	  (E)	  2hrs	  after	  retro-­‐orbital	  injection	  with	  500,000	  Tg(lcr:GFP)	  red	  blood	  cells.	  GFP+	  cells	  circulate	  in	  the	  recipient’s	  peripheral	  blood.	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Comparison	  of	  the	  Engraftment	  Capabilities	  of	  Different	  Transgenic	  Strains	  	   Using	   casper	   as	   the	   WKM	   transplantation	   recipient	   allows	   for	   in	   vivo	   visual	  assessment	   of	   homing	   and	   engraftment.	   However,	   due	   to	   the	   variation	   among	  recipients	  and	  the	  subtle	  differences	  of	  injection	  techniques,	  it	  is	  difficult	  to	  quantify	  the	   engraftment	  with	   a	   single	  marrow	   transplantation.	   The	   solution	   is	   to	   have	   an	  internal	   control.	   We	   designed	   a	   double-­‐color	   labeled	   competitive	   transplantation	  assay,	   in	  which	  donor	  marrows	   labeled	  with	   two	  different	  colors	  are	   transplanted	  into	   the	   same	   recipient.	  While	   one	  of	   the	   two	  donor	  populations	   stays	   consistent,	  the	  other	  donor	  population	  can	  be	  chemically	  or	  genetically	  manipulated.	  This	  way,	  the	   effect	   of	   the	   chemical	   or	   genetic	   changes	   on	   marrow	   engraftment	   can	   be	  standardized	  based	  on	  the	  engraftment	  of	  unmanipulated	  marrow	  population.	  	  In	   order	   to	   develop	   such	   a	   competitive	   transplantation	   assay,	   two	   transgenic	  zebrafish	  strains	  labeled	  with	  different	  fluorescence	  proteins	  are	  needed	  as	  donors,	  such	  as	  GFP	  and	  DsRed.	  Ideally,	  to	  make	  the	  quantification	  of	  engraftment	  from	  the	  two	  donors	  comparable,	  the	  promoters	  driving	  GFP	  and	  DsRed	  expression	  should	  be	  the	   same.	   For	   example,	   Tg(lyz:GFP)	   and	   Tg(lyz:DsRed)	   both	   label	   macrophages	  (Figure	  2.3)	  (Hall	  et	  al.,	  2007),	  while	  Tg(gata1:GFP)	  and	  Tg(gata1:DsRed)	  both	  label	  erythroid	  progenitors	  and	  some	  mature	  red	  blood	  cells	   in	  adult	  zebrafish	  (Long	  et	  al.,	   1997).	   These	   transgenic	   lines	   only	   label	   a	   very	   specific	   subset	   of	   blood	   cells.	  Therefore,	  they	  are	  not	  appropriate	  for	  evaluating	  the	  engraftment	  capability	  of	  the	  WKM	   population,	   although	   they	   are	   well	   suited	   for	   studying	   specific	  progenitor/precursor	  populations.	  	  	  




Figure	  2.3	  Transgenic	  zebrafish	  labeling	  myeloid	  cells	  	  (A)	  and	  (B)	  WKM	  FACS	  analysis	  of	  Tg(lyz:GFP)	  and	  Tg(lyz:DsRed)	  (C)	   Fluorescence	   microscopy	   of	   kidney	   of	   casper	   following	   competitive	   WKM	  transplantation	  of	  100,000	  Tg(lyz:GFP)	  and	  100,000	  Tg(lyz:DsRed),	  2wpt.	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The	   most	   widely	   used	   ubiquitous	   transgenic	   zebrafish	   is	   Tg(β-­‐actin:GFP)	  (Traver	  et	  al.,	  2003b).	  GFP	   is	  driven	  by	  the	  zebrafish	  ubiquitous	  promoter	  β-­‐actin,	  and	   labels	   the	  majority	   of	   the	  white	   blood	   cell	   and	   progenitor	   populations	   in	   the	  kidney	   marrow	   (Figure	   2.4A).	   Due	   to	   the	   lack	   of	   a	   Tg(β-­‐actin:DsRed)	   line,	   a	  commercially	   available	   transgenic	   zebrafish,	   Red	   Glofish®	   was	   used	   as	   the	   red	  donor.	  Red	  Glofish®	   is	  a	  double	   transgenic	   fish	  with	  β-­‐actin:DsRed2	  and	  mlc:DsRed	  (Blake,	   2010).	   There	   are	   a	   series	   of	   Glofish®	   expressing	   different	   fluorescence	  proteins	  under	   the	  control	  of	   the	   same	  promoters,	   including	  a	  green	   line	  zsGreen.	  The	  majority	   of	   the	   kidney	  marrow	   cells	   in	   both	   the	   Red	   and	   Green	   Glofish®	   are	  labeled	  with	   fluorescent	   proteins	   (Figure	   2.4B).	   The	   Red	   Glofish®	  WKM	  was	   also	  able	   to	   engraft	   recipient	   fish	   (figure	  2.4C);	   however,	  when	   the	   zsGreen	  WKM	  was	  transplanted	  at	  various	  cell	  doses	  or	  with	  different	  injection	  methods,	  the	  recipients	  were	  never	  showed	  any	  GFP+	  cells	  (data	  not	  shown).	  We	  speculated	  that	  this	  could	  be	   due	   to	   silencing	   of	   the	   transgene,	   which	   is	   associated	   with	  multiple	   copies	   of	  	  short	  transgenes	  in	  	  tandem	  and	  might	  also	  reflect	  the	  position	  effect	  of	  the	  specific	  transgene	   insertion	   location	   (Garrick	   et	   al.,	   1998).	   However,	   we	   never	   officially	  tested	  the	  hypothesis.	  Eventually,	  the	  Tg(β-­‐actin:GFP)	  and	  Red	  Glofish®	  were	  chosen	  as	  the	  donors	  for	  the	  competitive	  transplantation	  assay.	  	  	  	  	  	  	   	  





Figure	  2.4	  FACS	  analysis	  of	  ubiquitous	  transgenic	  zebrafish	  strains	  
	  Dashed	   black	   line	   represents	   the	   negative	   control.	   The	   blood	   lineages	   are	   gated	  based	  on	  the	  forward	  scatter	  and	  side	  scatter	  of	  the	  whole	  kidney	  marrow	  (Traver	  et	  al.,	  2003).	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A	   Zebrafish	   Marrow	   Competitive	   Transplantation	   Assay	   Allows	   Direct	  
Visualization	  and	  Quantification	  of	  Engraftment	  in	  vivo	  With	   the	   optimized	   conditions,	   we	   standardized	   the	   zebrafish	   competitive	  marrow	  transplantation	  assay.	  Whole	  kidney	  marrow	  (WKM)	  cells	  were	  harvested	  from	   two	   transgenic	   donors,	  Tg(β-­‐actin:GFP)	   and	   RedGlo®	   fish	   (Figure	   2.5A).	   The	  two	  marrow	  populations	  were	  co-­‐injected	  retro-­‐orbitally	  into	  sublethally	  irradiated	  
casper	  zebrafish.	  Donor-­‐derived	   fluorescent	   cells	   can	   be	   directly	   visualized	  with	   a	  fluorescent	   stereoscope	   (Figure	   2.5B).	   The	   average	   GFP	   or	   DsRed2	   fluorescence	  intensities	  were	  measured	  within	   the	   same	   region	  using	   ImageJ.	  After	   subtracting	  the	  background	   fluorescence	   intensity,	   the	   relative	   engraftment	  was	   calculated	  by	  G/R=(Gkidney-­‐Gbackground)/(Rkidney-­‐Rbackground).	   Taking	   this	   non-­‐invasive	   live	   imaging	  approach,	   the	   same	  recipients	   can	  be	   repeatedly	   imaged	  over	   time	   to	  monitor	   the	  engraftment	  kinetics,	  even	  up	  to	  3	  months.	  Engraftment	  was	  evident	  in	  the	  recipient	  kidney	   as	   early	   as	   2	   weeks	   post	   transplant	   (wpt).	   By	   4	   wpt,	   with	   further	  proliferation	  and	  differentiation,	  donor-­‐derived	  mature	  hematopoietic	   cells	   can	  be	  observed	   in	   recipients’	   circulation	   as	   well	   as	   in	   epidermis	   as	   tissue	   residential	  macrophages.	  At	  8	  wpt,	  donor-­‐derived	  lymphoid	  cells	  also	  repopulate	  the	  recipient	  immune	   system.	   In	   these	   transplants,	   the	   long-­‐term	   survival	   of	   recipients	   is	  compromised	   due	   to	   multiple	   reasons,	   including	   immune	   rejection,	   which	   can	  greatly	  benefit	   from	  MHC	  matching	  (de	  Jong	  et	  al.,	  2011).	   	  This	  perspective	  will	  be	  discussed	   in	  more	  details	   in	  Chapter	  4.	   In	  all	   the	   later	  experiments,	  we	  have	  been	  assessing	   engraftment	   4	   wpt,	   mainly	   examining	   the	   progenitor	   repopulation	  capability.	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Figure	  2.5	  Zebrafish	  whole	  kidney	  marrow	  (WKM)	  competitive	  
transplantation	  assay	  	  (A)	  Schematic	  of	  zebrafish	  WKM	  competitive	  transplantation	  in	  adult	  zebrafish.	  wpt,	  week	  post	  transplant.	  (B)	  Representative	   images	  of	   recipients	   co-­‐engrafted	  with	  GFP	  and	  DsRed2	  donor	  marrows.	  Gkid,	  kidney	  GFP	  intensity;	  Rkid,	  kidney	  DsRed2	  intensity.	  (C)	  The	  linear	  correlation	  of	  the	  relative	  engraftment	  results	  from	  FACS	  analysis	  and	  imaging	  analysis.	  (D)	  Limiting	  dilution	  competitive	  transplant	  in	  zebrafish.	  A	  total	  number	  of	  100,000	  donor	  cells	  were	  transplanted.	  *	  Student's	  t	  test	  p	  values	  <	  0.05.	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To	  evaluate	  the	  accuracy	  of	  the	  imaging-­‐based	  analysis	  of	  marrow	  engraftment,	  recipients	   were	   dissected	   after	   imaging,	   and	   their	   WKM	   were	   subjected	   to	   FACS	  (fluorescence-­‐activated	  cell	  sorting).	  The	  ratio	  between	  the	  percentages	  of	  GFP+	  and	  DsRed2+	   cells	   was	   compared	   to	   the	   G/R	   ratio	   of	   the	   same	   recipient	   based	   on	  imaging.	   The	   two	   results	   were	   linearly	   correlated	   (R2=0.9595),	   validating	   the	  quantitative	  success	  of	  this	  imaging-­‐based	  approach	  (Figure	  2.5C).	  	  In	  order	  to	  apply	  this	   novel	   competitive	   transplantation	   system	   to	   the	   study	   of	   HSPC	   engraftment	  process,	  the	  sensitivity	  of	  the	  assay	  was	  assessed.	  The	  donor	  marrow	  cells	  at	  green-­‐to-­‐red	   ratios	   of	   1:3,	   1:2,	   and	   1:1	   were	   transplanted	   with	   a	   total	   number	   of	  transplanted	  cells	  at	  200,000.	  An	  increase	  of	  average	  G/R	  fluorescence	  intensity	  was	  observed	   accompanying	   the	   increasing	   donor	   green-­‐to-­‐red	   ratio	   (Figure	   2.5D).	  Within	  the	  donor	  cell	  dose	  and	  ratio	  range	  assayed	  above,	  the	  zebrafish	  competitive	  marrow	   transplantation	   system	   can	   detect	   the	   change	   of	   relative	   engraftment	  capability	  in	  the	  donor	  cell	  populations.	  	  	  
Adult	   Zebrafish	   Competitive	   Marrow	   Transplantation	   Can	   Detect	   Chemical	  
Effects	  on	  Marrow	  Engraftment	  To	   test	   if	   the	   zebrafish	   competitive	   transplantation	   system	   is	   suitable	   for	  chemical	  screening,	  green	  marrow	  cells	  were	  treated	  ex	  vivo	  with	  chemicals	  known	  to	   enhance	   HSPC	   engraftment.	   dmPGE2	   (16,	   16-­‐dimethyl-­‐prostaglandin	   E2)	   is	   a	  stabilized	  derivative	  of	  PGE2,	  which	  binds	  to	  the	  E	  prostanoid	  (EP)	  receptor	  (North	  et	  al.,	  2007).	  BIO	  activates	  the	  Wnt	  pathway	  by	  inhibiting	  GSK-­‐3β	   (Goessling	  et	  al,,	  2009).	  The	  chemicals	  were	  incubated	  with	  the	  green	  marrow	  cells	  for	  4	  hrs	  at	  room	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temperature	   and	  washed	   off.	   The	   green	  marrow	   cells	  were	  mixed	  with	   untreated	  red	  marrow	  and	  transplanted	  together	  (20,000	  GFP	  WKM	  vs.	  80,000	  DsRed2	  WKM).	  Similar	  to	  the	  observation	  in	  mice,	  dmPGE2	  and	  BIO	  both	  enhanced	  zebrafish	  WKM	  engraftment	  capability	  at	  4	  wpt	  (Figure	  2.6).	  Next,	  the	  colors	  of	  competitor	  and	  test	  donors	   were	   switched,	   and	   the	   increase	   of	   engraftment	   efficiency	   by	   dmPGE2	  treatment	  of	  the	  test	  donor	  was	  still	  evident	  (data	  not	  shown).	  	  Additional	   chemicals	   targeting	   other	  well-­‐conserved	   signaling	   pathways	  were	  also	   tested	   using	   this	   assay	   in	   order	   to	   assess	   the	   throughput	   of	   the	   assay.	   These	  chemicals	  also	  showed	  various	  effects	  on	  engraftment,	  although	  the	  definitive	  roles	  of	   the	   chemicals	   need	   to	   be	   further	   confirmed	   (data	   not	   shown).	   In	   conclusion,	  direct	   visualization	   of	   competitive	   marrow	   repopulation	   greatly	   facilitates	   the	  developmental,	   physiological	   or	   pathological	   study	   of	   HSCs	   and	   progenitors	   by	  providing	   a	  novel	   platform	   for	   the	   assay	  of	   specific	   genes	  or	   chemicals	   that	   could	  alter	  homing,	  engraftment	  or	  self-­‐renewal.	  
	  
Figure	  2.6	  Use	  of	  the	  zebrafish	  competitive	  transplantation	  assay	  to	  evaluate	  
chemical	  effects	  on	  marrow	  engraftment.	  	  	  GFP+	  marrow	  cells	  were	  treated	  in	  vitro	  at	  room	  temperature	  for	  4	  hrs	  with	  DMSO,	  10µM	  dmPGE2,	  or	  0.5µM	  BIO.	  **	  Student’s	  t	  test	  p	  values<0.005.	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A	  Chemical	  Screen	  Identified	  Novel	  Regulators	  of	  HSPC	  Engraftment	  Although	  competitive	  transplantation	  in	  the	  mouse	  has	  been	  the	  gold	  standard	  for	   studying	  HSCs,	   it	   has	  been	  mostly	  used	   to	   test	   a	   single	  hypothesis	   such	  as	   the	  relative	  contribution	  of	  mutant	  to	  normal	  HSCs.	  Because	  of	  the	  high	  cost	  and	  labor	  intensity,	  an	  unbiased	  chemical	  screen	  has	  not	  been	  done	  to	  categorize	  pathways	  in	  relation	   to	   transplant	   engraftment.	   Using	   this	   novel	   competitive	   WKM	  transplantation	  assay	  in	  zebrafish,	  we	  can	  handle	  hundreds	  of	  animals	  per	  day	  with	  dramatically	   reduced	   cost.	   Therefore,	   we	   performed	   the	   first	   marrow-­‐transplantation-­‐based	   chemical	   screen	   with	   the	   Biomol	   ICCB	   Known	   Bioactive	  Library,	  which	  covers	  480	  diverse	  compounds	  with	  known	  bioactivities	  (Figure	  2.7).	  	  
	  
Figure	  2.7	  Schematic	  of	  the	  chemical	  screen	  based	  on	  adult	  zebrafish	  
competitive	  transplantation	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Table	  2.1	  Hits	  from	  Adult	  Zebrafish	  WKM	  Competitive	  Transplantation-­‐Based	  
Chemical	  Screen	  	  
	  









5	   Bioactive	  lipids/	  PKC	  activator	  



















CHC000064	   AM-­‐580	   5	   Nuclear	  receptor	  ligands/	  Retinoid	  RAR	  agonist	  
CHC000146	   TTNPB	   5	   Nuclear	  receptor	  ligands/	  Retinoid	  RAR	  agonist	  





5	   Bioactive	  lipids/	  MDR	  ATPase	  activator	  




CHC000135	   Prostaglandin	  E2	  (PGE2)	  
5	  
Bioactive	  lipids/	  
Prostaglandin	  EP	  receptor	  
agonist	  
CHC000259	   Ro	  20-­‐1724	   5	   phosphodiesterase	  (PDE4)	  inhibitor	  
	   	  












Figure	  2.8	  Chemical	  screen	  hits	  enhance	  short-­‐term	  kidney	  marrow	  
engraftment	  in	  adult	  zebrafish.	  (referring	  to	  Table	  2.1	  for	  the	  acronyms)	  	  	  	  
Some	  Hits	  Have	  Effects	  on	  Embryonic	  Hematopoiesis	  In	  order	  to	  explore	  their	  other	  potential	  roles	  on	  HSPCs,	  the	  hit	  chemicals	  were	  also	   tested	   for	   effects	   on	   embryonic	   hematopoiesis.	   In	   the	   zebrafish	   embryo,	  hematopoiesis	   happens	   in	   two	   waves,	   primitive	   and	   definitive,	   similar	   to	  mammalian	   hematopoiesis	   (Davidson	   and	   Zon,	   2004).	   The	   primitive	   wave	   only	  transiently	   generates	   embryonic	   erythrocytes	   and	   myeloid	   cells,	   while	   definitive	  HSPCs	   emerge	   from	   the	   hemogenic	   endothelium	   of	   the	   AGM	   (aorta-­‐gonad-­‐mesonephros	   region)	   and	   last	   the	  whole	   life	   (Bertrand	   et	   al.,	   2010;	   Boisset	   et	   al.,	  2010;	  Davidson	  and	  Zon,	  2004;	  Kissa	   and	  Herbomel,	   2010;	  Orkin	   and	  Zon,	  2008).	  The	   definitive	   HSPCs	   enter	   circulation,	   then	   travel	   to	   and	   engraft	   in	   the	   caudal	  hematopoietic	  tissue	  (CHT),	  a	  secondary	  hematopoietic	  site	  equivalent	  to	  the	  mouse	  fetal	   liver	   (Murayama	   et	   al.,	   2006;	   Orkin	   and	   Zon,	   2008).	   Because	  we	  were	  more	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interested	   in	   the	   HSPCs	   that	   last	   the	   lifetime	   of	   the	   fish,	   we	   focused	   on	   the	   time	  window	  after	  primitive	  hematopoiesis	  and	  during	  the	  specification	  and	  trafficking	  of	  the	  definitive	  HSPCs.	  Various	  drug	  doses	  were	  tested.	  We	  found	  some	  of	  the	  screen	  hits,	  such	  as	  the	  two	  farnesyl	  analogs,	  FTA	  and	  FCME,	  could	  increase	  the	  definitive	  HSPC	  markers,	  runx1/c-­‐myb	  in	  the	  AGM,	  while	  the	  RAR	  agonist,	  AM-­‐580,	  decreased	  the	  expression	  of	  these	  markers	  (Figure	  2.9).	  	  Interestingly,	  we	  found	  one	  chemical,	  11.12-­‐EET,	   can	   increase	   both	   the	   HSPC	   marker	   expression	   in	   the	   AGM	   and	   the	  trafficking	  of	  definitive	  HSPCs	  from	  AGM	  to	  CHT	  (Figure	  2.9).	  	  	  	  	  	  	  	  	  
	   	  



































Figure	  2.9	  Effects	  of	  screen	  hits	  on	  embryonic	  definitive	  hematopoietic	  stem	  
and	  progenitor	  cells	  	  Embryos	  were	  treated	  with	  chemicals	  during	  the	  time	  window	  indicated	  above	  the	  figures.	   HSC	   markers	   were	   examined	   in	   the	   AGM	   (aorta-­‐gonad-­‐mesonephros)	   at	  36hpf	  (left	  column)	  and	  CHT	  (caudal	  hematopoietic	  tissue)	  at	  72	  hpf	  (right	  column).	  Blue	  arrows	  indicate	  decrease,	  and	  red	  arrows	  indicate	  increase.	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Developing	   Transgenic	   Zebrafish	   Lines	   with	   More	   Ubiquitous	   Labeling	   of	  
Blood	  Cells	  Several	   zebrafish	   transgenic	   lines	   have	   been	   previously	   described	   to	   have	  ubiquitous	   expression	   patterns,	   including	   the	   zebrafish	   h2afx,	   tbp,	   β-­‐actin	  control	  elements	  (Kwan	  et	  al.,	  2007;	  Burket	  et	  al.,	  2008;	  Gillette-­‐Ferguson	  et	  al.,	  2003),	  and	  the	  Xenopus	   laevis-­‐derived	   elongation	   factor	  1a	  promoter	   (XlEef1a1)	   (Johnson	   and	  Krieg,	   1994).	   However,	   the	   expression	   of	   fluorescence	   proteins	   driven	   by	   these	  transgenes	   is	   not	   truly	   ubiquitous	   in	   the	   adult	   zebrafish	   blood	   compartment.	   For	  example,	   the	  Tg(β-­‐actin:GFP)	   have	   the	  majority	   of	   their	   white	   blood	   cells	   labeled	  with	  GFP,	  but	  not	  their	  red	  blood	  cells	  (Figure	  2.4).	  Recently,	  Christian	  Mosimann	  et	  al	  in	  our	  lab	  BLAST-­‐searched	  using	  the	  human	  Ubiquitin	  peptide	  ORF	  as	  a	  query	  and	  identified	   the	   predicted	   zebrafish	   gene	   locus	   zgc:172187	   on	   linkage	   group	   5,	  referred	  to	  here	  as	  zebrafish	  ubiquitin	  B	  (ubi).	  The	  zebrafish	  ubi	  gene	  features	  a	  71	  bp	   non-­‐coding	   first	   exon,	   a	   2	   kb	   spanning	   intron,	   followed	   by	   a	   second	   exon	  encoding	   a	   multimeric	   (8	   repeats)	   Ubiquitin	   peptide	   precursor,	   a	   gene	   structure	  homologous	  to	  ubi	  loci	  in	  other	  species.	  Using	  PCR,	  we	  cloned	  a	  3.5kb	  sequence	  from	  BAC	  CH211-­‐202A12	   immediately	  upstream	  of	   the	  ATG	  start	   codon	  at	   the	  5’	   end	  of	  exon	   2	   that	   is	   analogous	   to	   the	   previously	   reported	   Drosophila	   and	   human	   ubi	  control	  region	  fragments	  (Lee	  et	  al.,	  1988;	  Schaefer	  et	  al.,	  2001;	  Schorpp	  et	  al.,	  1996)	  and	  includes	  the	  putative	  intron/exon	  splice	  junctions.	  Stable	  transgenic	  lines	  were	  constructed	  using	  this	  piece	  of	  regulatory	  element	  driving	  the	  expression	  of	  GFP	  or	  mCherry,	  annotated	  as	  Tg(ubi:GFP)	  and	  Tg(ubi:mCherry)	  (Mosimann	  et	  al.,	  2011).	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ubi	  Expresses	  in	  All	  Blood	  Cell	  Types	  	  We	  sought	  to	  analyze	  ubi	  expression	  in	  the	  hematopoietic	  system	  and	  profiled	  the	   blood	   expression	   of	   adult	   ubi:EGFP	   and	   ubi:mCherry	   heterozygous	   transgenic	  zebrafish	  using	  flow	  cytometric	  analysis	  of	  dissected	  WKM	  (Traver	  et	  al.,	  2003),	  the	  major	   hematopoietic	   tissue	   in	   adult	   zebrafish.	   The	   analyzed	   ubi:EGFP	   and	  
ubi:mCherry	  transgenic	  lines	  showed	  robust	  fluorophore	  expression	  in	  all	  resolvable	  blood	   cell	   gates	   (Figure	  2.10)	   and	   in	   the	   vast	  majority	   of	   cells	   in	   these	   respective	  populations,	   including	   erythroid,	   myeloid,	   and	   lymphoid	   lineages,	   plus	   precursor	  cell	   population.	   This	   is	   in	   stark	   contrast	   to	   β-­‐actin	   promoter-­‐driven	   EGFP	  transgenics,	   which	   overall	   show	   weaker	   expression	   in	   hematopoietic	   lineages,	  particularly	  in	  erythrocytes,	  which	  barely	  express	  β-­‐actin:EGFP	  (Figure	  2.4).	  	  	  	  	  	  	  	   	  




Figure	  2.10	  ubi-­‐driven	  transgenes	  express	  in	  all	  blood	  cell	  lineages.	  	  Representative	   flow	  cytometry	  analysis	  of	  Tg(–3.5ubi-­‐EGFP)	   (A-­‐C)	  and	  Tg(–3.5ubi-­‐
mCherry)	  (D-­‐F)	  adult	  whole	  kidney	  marrow	  (WKM).	  	  (A)	  (D)	  Separation	  of	  blood	  cell	  populations	  by	  forward	  and	  side	  scatter.	  	  (B)	  (E)	  The	  majority	  of	  all	  WKM	  express	  EGFP	  or	  mCherry.	  (C)	  (F)	  The	  individual	  subpopulations	  express	  EGFP	  or	  mCherry.	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This	   broad	   hematopoietic	   expression	   should	   therefore	   allow	   assessment	   of	  multilineage	   engraftment	   in	   transplantation	   experiments	   using	   ubi:EGFP	   or	  
ubi:mCherry.	  To	   test	   this	  application,	  we	   isolated	  WKM	  from	  either	  ubi:mCherry	  or	  
ubi:EGFP	   heterozygous	   adults,	   and	   performed	   retro-­‐orbital	   WKM	   transplantation	  into	  irradiated	  roy–/–;	  nacre–/–	  (casper)	  (White	  et	  al.,	  2008)	  transparent	  recipients	  to	  allow	   for	   easy	   visualization.	   Three	   weeks	   post-­‐transplantation,	   the	   transparent	  
casper	  recipients	  showed	  strong	  localized	  fluorescence	  marking	  the	  kidney	  territory	  (Figure	  2.11E,	  2.11E).	  Flow	  cytometry	  analysis	  of	  WKM	  from	  these	  casper	  recipients	  revealed	   chimeric	   contribution	   of	   fluorophore-­‐expressing	  donor	   cells	   to	   all	   light-­‐scatter	  resolvable	  blood	  cell	  populations,	  as	  described	  above	  (Figure	  2.11,	  2.12).	  We	  have	   successfully	   monitored	   ubi:EGFP	   and	   ubi:mCherry	  WKM-­‐transplanted	   casper	  recipients	  with	   long-­‐term	   transplants	   over	   3	   months	   post	   transplant,	   as	   well	   as	  performed	   transplantation	   with	   mixed	   ubi:EGPF	   and	   ubi:mCherry	   populations	   in	  competitive	   transplants,	   without	   detecting	   any	   diminishing	   fluorophore	   intensity	  (Figure	   2.13).	   ubi-­‐driven	   transgenic	   reporters	   are	   therefore	   suitable	   reagents	   for	  hematopoietic	   transplantation	  experiments,	  and	  their	  true	  multilineage	  expression	  offers	  a	  clear	  advantage	  over	  previously	  used	  transgene	  reporters.	  	  
	   	  






Figure	  2.11	  Whole	  kidney	  marrow	  transplantation	  using	  ubi:EGFP.	  	  	  Cells	  isolated	  from	  Tg(–3.5ubi-­‐EGFP)	  adult	  WKM	  were	  transplanted	  via	  retro-­‐orbital	  injection	  into	  irradiated	  casper	  recipient	  adults	  and	  read-­‐out	  3	  wpt	  for	  EGFP	  blood	  chimerism	  by	  flow	  cytometry	  (A-­‐D)	  and	  fluorescence	  microscopy	  (E).	  	  (A)	  Separation	  of	  the	  recipient’s	  blood	  cell	  populations	  by	  forward	  and	  side	  scatter.	  	  (B)	  Overall	  and	  (C)	  different	  lineage	  engrafted	  with	  EGFP+	  donor-­‐derived	  cells.	  (D)	  The	  distribution	  of	  donor-­‐derived	  GFP+	  cells	  in	  different	  blood	  lineages.	  (E)	  Live	  imaging	  of	  the	  recipient	  engrafted	  with	  GFP+	  donor-­‐derived	  marrow.	  	  	  	  





Figure	  2.12	  Whole	  kidney	  marrow	  transplantation	  using	  ubi:mCherry.	  	  	  Cells	  isolated	  from	  Tg(–3.5ubi-­‐mCherry)	  adult	  WKM	  were	  transplanted	  via	  retro-­‐orbital	  injection	  into	  irradiated	  casper	  recipient	  adults	  and	  read-­‐out	  3	  weeks	  post	  transplant	  (wpt)	  for	  mCherry	  blood	  chimerism	  by	  flow	  cytometry	  (A-­‐D)	  and	  fluorescence	  microscopy	  (E).	  	  (A)	  Separation	  of	  the	  recipient’s	  blood	  cell	  populations	  by	  forward	  and	  side	  scatter.	  	  (B)	  Overall	  and	  (C)	  different	  lineage	  engrafted	  with	  mCherry+	  donor-­‐derived	  cells.	  (D)	  The	  distribution	  of	  donor-­‐derived	  mCherry+	  cells	  in	  different	  blood	  lineages.	  (E)	  Live	  imaging	  of	  the	  recipient	  engrafted	  with	  mCherry+	  donor-­‐derived	  marrow.	  	  
	   	  




	  	  	  
Figure	  2.13	  Competitive	  transplantation	  with	  ubi	  transgenic	  zebrafish	  	  
Tg(ubi:EGFP)	  and	  Tg(ubi:mCherry)	  donor	  marrows	  were	  transplanted	  at	  either	  a	  G:R	  ratio	  of	  1:2	  (33,000:66,000)	  (A)	  or	  1:1	  (50,000:50,000),	  and	  recipients	  were	  imaged	  at	   4	  wpt.	   At	   the	   ratio	   of	   1:2,	   all	   the	   recipients	  were	   only	   engrafted	  with	  mCherry	  donor-­‐derived	   cells.	   At	   the	   ratio	   of	   1:1,	   half	   of	   the	   recipients	  were	   engrafted	  with	  both	  EGFP+	  and	  mCherry+	  cells.	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Discussion	  In	   summary,	   we	   evaluated	   multiple	   factors	   to	   produce	   an	   optimal	  transplantation	   model.	   These	   factors	   included	   donor	   zebrafish	   strains,	  myeloablation	   conditions,	   donor	   cell	   ratios,	   injection	   techniques,	   readout	   time-­‐points	   and	   quantification	   method.	   Eventually,	   we	   were	   able	   to	   develop	   a	   live	  imaging-­‐based	   adult	   zebrafish	   marrow	   competitive	   transplantation	   assay.	   This	  assay	  allows	   fast	  quantification	  of	  marrow	  engraftment	  capability.	  The	  system	  can	  be	   used	   to	   evaluate	   the	   effect	   of	   genetic	   mutations	   or	   transgene	   effects	   on	   adult	  HSPCs.	  We	  demonstrated	  that	  dmPGE2	  and/or	  GSK-­‐3β	   inhibitor	  treatment	  of	  GFP+	  marrows	  for	  4	  hrs	  could	  dramatically	  increase	  the	  marrow	  repopulation	  capability	  in	   zebrafish.	   Using	   this	   assay,	   the	   first	   chemical	   screen	   in	   adult	   vertebrates	   was	  performed	   in	   vivo.	   This	   approach	   defined	   critical	   pathways	   regulating	   HSPC	  engraftment	   in	  vertebrates,	   represented	  by	  10	  chemicals.	  These	  hits	   include	  PGE2,	  which	  is	  the	  positive	  control	  of	  the	  screen.	  The	  other	  hits	  target	  novel	  pathways	  that	  have	   not	   been	   linked	   to	   HSPC	   engraftment.	   Some	   compounds	   also	   increased	   HSC	  formation	  in	  zebrafish	  embryos,	  indicating	  that	  some	  pathways	  might	  be	  common	  to	  different	  developmental	  stages.	  	  	  	  
The	  Variability	  of	  Marrow	  Transplantation	  and	  Engraftment	  Due	   to	   the	   complexity	   of	   whole-­‐organism	   level	   physiology	   and	   the	   biological	  processes	   involved	   in	   engraftment,	   transplantation	   has	   always	   been	   a	   relatively	  variable	   experimental	   approach,	   even	  within	   the	   genetically	   homogeneous	  mouse	  population.	   Zebrafish	   have	   a	   more	   diverse	   genetic	   background	   than	   mice.	   After	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multiple-­‐generations	   of	   inbreeding	   to	   create	   more	   homogenous	   zebrafish	  populations,	   fertility	   rates	   decline,	   presenting	   one	   of	   the	   greatest	   challenges	   of	  zebrafish	   husbandry	   (Monson	   and	   Sadler,	   2010).	   Although	   homozygous	   diploid	  clonal	   zebrafish	   strains	   can	   be	   created	   by	   embryo	   manipulation	   at	   early	   stages,	  whether	   they	   will	   have	   the	   same	   inbreeding	   and	   fertility	   issues	   still	   needs	   to	   be	  tested	   over	   time	   (Mizgirev	   and	   Revskoy,	   2010).	   Therefore,	   all	   adult	   zebrafish	  transplantation	   performed	   to	   date	   has	   been	   on	   a	   genetically	   non-­‐homogenous	  population.	  This	  genetic	  heterogeneity	  may	  be	  a	  major	  cause	  of	  the	   large	  standard	  deviation	   of	   the	   engraftment	   level	   within	   each	   experimental	   group.	   On	   the	   other	  hand,	   this	  might	  more	  accurately	  reflect	   the	  reality	  of	   transplantation	  engraftment	  in	   the	   human	   population,	   more	   so	   in	   fact	   than	   the	   clonal	   mouse	   model,	   since	  patients	   undergoing	   marrow	   or	   HSC	   transplantation	   have	   very	   diverse	   genetic	  backgrounds.	   In	  addition,	   the	   low	  cost	  of	  zebrafish	  husbandry	  allows	  the	  sampling	  of	  a	  large	  number	  of	  animals	  for	  more	  rigorous	  statistical	  analysis.	  	  	  Another	  major	   cause	   of	   the	   engraftment	   variability	   comes	   from	   the	   injection	  technique	   itself.	   Due	   to	   the	   small	   size	   of	   zebrafish,	   only	   3-­‐5ul	   of	   liquid	   can	   be	  injected	  through	  retro-­‐orbital	  or	  intra-­‐cardiac	  injection.	  The	  total	  blood	  volume	  of	  a	  single	  adult	  zebrafish	  is	  between	  20-­‐50ul	  by	  estimation,	  depending	  on	  the	  size	  of	  the	  fish.	   Therefore,	   this	   introduces	   a	   huge	   technical	   challenge	   to	   efficiently	   and	  consistently	  deliver	  the	  full	  volume	  into	  the	  animal.	  We	  hope	  with	  the	  experimental	  design	  of	  competitive	  transplantation,	  one	  donor	  can	  serve	  as	  an	  internal/technical	  control	   for	   the	   injection.	   From	   our	   experience,	   this	   enables	   us	   to	   quantify	   the	  relative	  engraftment	  capability	  changes	  with	  a	  relatively	  small	  number	  of	  recipients,	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otherwise	   almost	   impossible	   to	   achieve	   with	   single	   marrow	   transplantation.	  However,	   the	   consistency	   of	   this	   competitive	   transplantation	   assay	   can	   certainly	  benefit	  from	  the	  development	  of	  better	  injection	  technique	  in	  the	  future.	  A	   third	   factor	   that	   can	   introduce	  major	   variability	   is	   the	   heterogeneity	   of	   the	  donor	   population.	   Similar	   to	   the	   recipients,	   the	   donors	   are	   not	   clonal	   either.	   The	  heterogeneity	   of	   fluorescence	   strength	   among	   siblings	   from	   the	   same	   stable	  transgenic	   parent	   pair	   has	   been	   known	   for	   years	   (Akitake	   et	   al.,	   2011).	   This	  phenomenon	   has	   also	   been	   observed	   in	   other	   model	   organisms	   too,	   which	   is	  different	  from	  the	  position	  effect	  (Dobie	  et	  al.,	  1996).	  In	  order	  to	  have	  enough	  cells	  for	   200	   recipients,	   we	   pooled	   kidney	   marrows	   from	   multiple	   sibling	   donors	  together,	  which	  might	   also	   help	   to	   normalize	   the	   fluorescence	   intensity	   level.	   But	  the	   variability	   from	   experiment	   to	   experiment	   is	   still	   not	  marginal.	   Therefore	  we	  always	  normalize	  G/R	  relative	  to	  the	  DMSO	  control	  of	  each	  experiment	  (making	  the	  average	  G/R	  of	  DMSO	  equal	  to	  1)	  before	  combining	  the	  data	  from	  any	  independent	  experiments.	  	  	  
Retinoic	  Acid	  Receptor	  Agonists	  Retinoic	  acids	  have	  long	  been	  known	  to	  play	  a	  role	  in	  hematopoiesis.	  	  They	  bind	  to	  a	  family	  of	  nuclear	  hormone	  receptors,	  called	  retinoic	  acid	  receptor	  (RAR),	  which	  then	  form	  functional	  heterodimer	  with	  retinoic	  X	  receptor	  (RXR)	  (Means	  and	  Gudas,	  1995).	   Among	   the	   seven	   RAR	   agonists	   in	   the	   chemical	   screen	   library	   only	   two	  structurally	  highly	  related	  compounds,	  AM-­‐580	  and	  TTNPB	  were	  scored	  positive	  in	  the	  screen.	  These	  two	  compounds	  have	  distinctive	  chemical	  moieties	  from	  the	  other	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agonists,	   which	   include	   all-­‐trans	   retinoic	   acid	   (ATRA)	   used	   for	   treating	   acute	  promyelocytic	   leukemia	   (Figure	   2.14)	   (Degos	   and	   Wang,	   2001).	   This	   structure	  difference	  might	  lead	  to	  the	  different	  agonistic	  effects	  on	  RAR	  or	  specific	  binding	  to	  other	   unknown	   targets.	   However,	   false	   negative	   results	   are	   quite	   common	   in	   a	  screening	   project,	   partially	   due	   to	   the	   subjective	   choice	   of	   a	   single	   concentration	  tested	   in	   the	   screen.	   Further	   tests	  with	   appropriate	  dose	   titration	   across	  multiple	  structurally	   different	   RAR	   agonists	   are	   necessary	   before	   making	   any	   definitive	  conclusion.	  	  	  
	  	  
Figure	  2.14	  Chemical	  structures	  of	  different	  retinoic	  acid	  receptor	  agonists.	  	  
	  The	   hits	   from	   the	   screen,	   AM-­‐580	   and	   TTNPB,	   share	   similar	   structure	  characteristics,	  while	  the	  rest	  closely	  resemble	  ATRA	  (all-­‐trans	  retinoic	  acid),	  which	  were	  not	  scored	  as	  positive	  in	  the	  screen.	  
	  
Farnesylation-­‐Related	  Chemicals	  S-­‐farnesyl-­‐L-­‐cysteine	   methyl	   ester	   (FCME)	   was	   annotated	   in	   the	   chemical	  library	  as	  an	  MDR	  ATPase	  activator,	  and	   farnesylthioacetic	  acid	   (FTA)	   is	  a	  protein	  carboxymethylation	  inhibitor.	  However,	  the	  chemical	  structures	  of	  both	  compounds	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greatly	   resemble	   farnesyl	   cysteine,	   the	   intermediate	   product	   for	   protein	  farnesylation	   modification	   (Figure	   2.15A).	   Farnesylation	   is	   a	   type	   of	   post-­‐translational	  modification	  in	  which	  a	  farnesyl	  group	  is	  attached	  to	  the	  CAXX	  tail	  at	  the	  C-­‐terminus	  of	   a	   given	  protein.	  Three	  enzymes	  are	   required	   for	   this	   sequential	  modification	   reaction:	   	   farnesyl	   transferase	   (FTase)	   which	   attaches	   the	   farnesyl	  diphosphate	  to	  the	  cysteine	  at	  the	  C-­‐terminus,	  CAAX	  protease	  (RCE1)	  which	  cleaves	  the	   –AAX	   off	   the	   C-­‐terminus,	   and	   the	   CAAX	   methyltransferase	   (ICMT)	   which	  attaches	   a	   methyl	   group	   (-­‐CH3)	   to	   the	   bare	   C-­‐terminus	   (Figure	   2.15)	   (Zhang	   and	  Casey,	   1996).	   A	   parallel	   modification	   with	   geranylgeranyl	   group	   employs	   similar	  principles,	  and	  shares	  the	  same	  enzymes	  of	  RCE1	  and	  ICMT.	  Together,	  these	  types	  of	  modification	   are	   called	   prenylation.	   FTA	   blocks	   the	   third	   step	   of	   C-­‐terminal	  carboxylation	  by	  inhibiting	  ICMT.	  Based	  on	  the	  structural	  similarity	  between	  FCME	  and	  FTA,	  we	  hypothesize	   that	  FCME	  might	   also	   inhibit	   ICMT.	   In	   addition,	  we	  only	  observed	   the	   positive	   effect	   of	   farnesyl	   analogs,	   but	   not	   geranylgeranyl	   analogs	  (data	  not	  shown).	  	  Prenylation	   changes	   the	   membrane	   affinity	   of	   the	   protein,	   and	   therefore	  modifies	   its	   intracellular	   localization.	  Many	  proteins	  are	  regulated	  by	   this	  process,	  such	   as	   the	   RAS	   and	   Rho	   small	   GTPase	   family,	   some	   phosphatases	   and	   kinases,	  nuclear	   lamins,	   and	   centromeric	  proteins	  CENP-­‐E&-­‐F.	  Most	   of	   the	  proteins	  have	   a	  preference	   for	   either	   farnesylation	   or	   geranylgeranylation,	   although	   not	   exclusive	  (Winter-­‐Vann	   and	   Casey,	   2005).	   The	   importance	   of	   this	   process	   has	   been	  exemplified	  by	  knockout	  mice.	  Rce1-­‐null	  mice	  die	  between	  E15.5	  and	  first	  week	  of	  life	  (Kim	  et	  al.,	  1999).	  Icmt-­‐null	  mice	  have	  severe	  anemia	  and	  liver	  defects,	  and	  die	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at	   E11.5	   (Bergo	   et	   al.,	   2001).	   Conditional	   knockout	   of	   Rce1	   in	   the	   blood	  compartment	  of	  the	  Kras2-­‐driven	  MPD	  (myeloproliferative	  disorder)	  mouse	  model	  (Rce1fl/flKras2LSL/+Mx1-­‐Cre)	  causes	  accelerated	  MPD,	  while	  knocking	  out	  Icmt	   in	  the	  same	  mice	   (Icmtfl/flKras2LSL/+Mx1-­‐Cre)	   ameliorates	  MPD	   	   (Wahlstrom	   et	   al.,	   2008).	  	  The	   effects	   of	   knocking	   out	   Rce1	   or	   Icmt	   on	   MPD	   development	   might	   reflect	  different	   means	   of	   modulation	   of	   Ras	   protein	   activity,	   but	   it	   clearly	   shows	   the	  importance	   of	   prenylation	   in	   regulating	   hematopoiesis.	   Marrow	   engraftment	  requires	  small	  GTPases,	  such	  as	  Rho	  and	  Rac,	  whose	   localization	  and	  activities	  are	  also	   regulated	   by	   prenylation.	   Therefore,	   further	   examination	   of	   the	   role	   of	   this	  pathway	  in	  the	  context	  of	  HSPC	  engraftment	  might	  generate	  interesting	  insights	  into	  how	  engraftment	  is	  regulated	  through	  lipid	  modification.	  	  	  
	  
Discussion	  Summary	  	   In	   summary,	   despite	   some	   of	   the	   caveats	   associated	   with	   the	   zebrafish	  competitive	  marrow	  transplantation,	  it	  is	  still	  a	  very	  powerful	  assay	  for	  determining	  short-­‐term	  engraftment.	  More	   importantly,	   it	   is	  amenable	   for	  performing	  chemical	  or	  genetic	  screening	  for	  HSPC	  engraftment,	  therefore	  making	  it	  a	  useful	  platform	  to	  tackle	   the	   question	   in	   vivo.	   The	   screen	   hits	   need	   further	   optimization	   with	   dose	  titration	  and	  validation	  by	  bone	  marrow	  transplantation	  experiments	   in	  mice.	  The	  interesting	  categories	  of	  hits	  indicate	  some	  intriguing	  biological	  mechanisms	  behind	  HSPC	  engraftment.	  	  	  	   	  




Figure	  2.15	  Protein	  prenylation	  pathway	  and	  chemical	  inhibitors	  	  (A)	   Prenylation	   pathway:	   the	   substrates	   farnesyl	   diphosphate	   or	   geranylgeranyl	  diphosphate	   are	   synthesized	   from	  HMG-­‐CoA,	  which	   is	   part	   of	   the	   sterol	   synthesis	  pathway.	  The	  two	  substrates	  are	  attached	  to	  proteins	  with	  C-­‐terminal	  CAAX	  tail	  by	  farnesyl	   transferase	   (FTase)	   or	   geranygeranyl	   transferase	   (GGTase).	   The	   prenyl-­‐CAAX	   intermediate	   products	   are	   processed	   by	   the	   enzyme,	   RCE1	   (CAAX	   prenyl	  protease)	  to	  lose	  the	  AAX	  amino	  acids.	  The	  final	  step	  is	  catalyzed	  by	  ICMT	  (protein-­‐S-­‐isoprenylcysteine	  O-­‐methyltransferase)	  which	  attaches	  a	  methyl	  group	  to	  the	  bare	  C-­‐terminus.	  FTA	  is	  a	  known	  ICMT	  inhibitor.	  The	  target	  of	  FCME	  is	  unclear.	  	  (B)	  Chemical	   structures	  of	  FCME	  and	  FTA.	  The	  methyl	  ester	  group	   in	  FCME	   is	  not	  stable	  in	  water,	  which	  can	  be	  quickly	  degraded	  to	  lose	  the	  methyl	  group.	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Material	  and	  Methods	  
	  
Zebrafish	  strains	  Zebrafish	  were	  maintained	   in	   accordance	  with	  Animal	  Research	  Guidelines	   at	  Children's	  Hospital	  Boston.	  The	  following	  transgenic	  or	  mutant	  zebrafish	  lines	  were	  used	  in	  the	  experiments:	  GreenGlo®	  and	  RedGlo®	  zebrafish	  were	  purchased	  from	  5D	  Tropical	   and	   authorized	   for	   research	   use	   (Blake,	   2010).	   zsGreen	   or	   DsRed2	   are	  overexpressed	  under	  the	  mlc	  (myosin	  light	  chain)	  and	  β-­‐actin	  dual	  promoters.	  Tg(β-­‐
actin:GFP),	   Tg(lyz:GFP),	   Tg(lyz:DsRed),	   Tg(ubi:EGFP)	   and	   Tg(ubi:mCherry),	   and	  
casper	  lines	  were	  previously	  described	  (Kikuchi	  et	  al.,	  2011;	  White	  et	  al.,	  2008).	  	  
Adult	  Kidney	  Marrow	  Competitive	  Transplantation	  Briefly,	   GFP+	  marrow	   cells	   are	   competed	   against	   DsRed2+	  marrow	   cells.	   The	  donor	   animals	   have	   ubiquitous	   GFP	   based	   on	   β-­‐actin-­‐driven	   expression	   and	   a	  ubiquitous	  DsRed2	  based	  on	  a	  commercially	  available	  GloFish.	  The	  two	  marrows	  are	  mixed	  at	  a	  certain	  ratio	  and	  co-­‐injected	  into	  casper	  recipients.	  We	  used	  the	  ratio	  of	   average	   GFP	   intensity	   over	   average	   DsRed2	   intensity	   within	   the	   same	   kidney	  region	  as	  the	  measurement	  of	  relative	  engraftment	  efficiency	  (G/R).	  The	  higher	  the	  ratio,	  the	  more	  competitive	  the	  green	  cells	  are.	  	  Adult	   zebrafish	   donors	   are	   anaesthetized	  with	   0.2%	   tricaine	   before	   blood	   and	  kidney	   collection.	   Peripheral	   blood	   is	   obtained	   from	   adult	   casper	   by	   cardiac	  puncture	   with	   micropipette	   tips	   coated	   with	   heparin	   and	   collected	   into	   0.9XPBS	  containing	   5%	   FCS.	   About	   3-­‐5	  million	   red	   blood	   cells	   can	   be	   harvested	   from	   one	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donor.	  To	  dissect	  whole	  kidney	  marrow	  (WKM),	  a	  ventral	  midline	  incision	  is	  made	  on	   the	  donor	   fish.	  Whole	  kidney	   is	  dissected	  out	  and	  placed	   into	   ice-­‐cold	  0.9XPBS	  containing	  5%	  FCS.	  Single-­‐cell	  suspensions	  are	  generated	  by	  aspiration	  followed	  by	  filtration	   through	   a	   40-­‐μm	   nylon	   mesh	   filter	   into	   a	   50ml	   conical	   tube.	   The	   flow-­‐though	  part	  is	  diluted	  with	  a	  final	  volume	  of	  25ml	  and	  centrifuged	  at	  1,500rpm	  for	  8	  minutes.	  The	  supernatant	   is	  discarded	  and	  the	  pellet	  cells	  are	  resuspended	   in	  1ml	  0.9XPBS	   containing	   5%	   FCS.	   The	   number	   of	   cells	   alive	   is	   counted	   with	   a	  hemacytometer.	   On	   average,	   500,000-­‐700,000	   cells	   can	   be	   harvested	   per	   donor.	  Finally,	  the	  peripheral	  blood	  and	  kidney	  marrow	  cells	  are	  centrifuged	  at	  1,500rpm	  for	  8	  minutes,	   resuspended	   in	  0.9XPBS	   containing	  5%	  FCS	  and	  mixed	  at	   a	   certain	  ratio	  and	  concentration.	  Ten-­‐	  to	  fourteen-­‐week	  old	  casper	  recipients	  are	  sublethally	  irradiated	  with	  30Gy	  γ-­‐irradiation,	  split	  by	  two	  doses,	  15Gy	  each	  at	  both	  2d	  and	  1d	  before	   transplantation.	   	   Recipients	   are	   anesthetized	   in	   tricaine.	   4ul	   of	   the	   cell	  suspension	  mixture	  above	   is	   injected	   into	   the	  circulation	   retro-­‐orbitally	   through	  a	  Hamilton	  syringe	  (26s	  gauge,	  10ml	  volume).	  Usually	  50,000-­‐200,000	  marrow	  cells	  plus	   100,000-­‐200,000	   peripheral	   blood	   cells	   are	   able	   to	   rescue	   the	   recipient.	  Recipients	   are	   kept	   in	   still	   fish	   water	   supplemented	   with	   anti-­‐fungal	   reagents	   to	  reduce	   infection	   for	   one	   week	   with	   minimal	   feeding,	   and	   then	   placed	   into	   the	  communal	  system	  with	  circulating	  water	  and	  a	  reduced	  amount	  of	  food.	  	  
Imaging-­‐Based	  Quantification	  of	  Engraftment	  in	  Adult	  Zebrafish	  Transplanted	  recipients	  can	  be	  anesthetized	  in	  tricaine	  and	  visualized	  over	  time	  on	  a	  Zeiss	  Discovery	  V8	  stereomicroscope	  with	  a	  1.2X	  PlanApo	  lens	  and	  GFP/DsRed	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filters.	   Images	   are	   captured	  using	  AxioVision	   software	   and	   for	   each	   recipient,	   two	  images	  are	  taken	  with	  GFP	  or	  DsRed	  filter	  respectively.	  The	  images	  are	  all	  saved	  in	  .tif	   format	   and	   analyzed	   using	   ImageJ	   software.	   The	   kidney	   region	   is	   manually	  selected	  for	  every	  fish	  and	  the	  average	  fluorescence	  intensities	  per	  pixel	  of	  both	  GFP	  and	   DsRed	   are	   measured	   within	   the	   same	   region	   (Gkid	   and	   Rkid).	   Background	   for	  each	  image	  is	  measured	  in	  a	  region	  outside	  the	  fish	  (Gbkg	  and	  Rbkg),	  and	  subtracted	  from	   the	   correlated	   kidney	   fluorescence	   intensity.	   The	   relative	   engraftment	   level	  was	   calculated	   as	   G/R=	   (Gkid	   -­‐	   Gbkg	   )	   /	   (Rkid	   -­‐	   Rbkg).	   For	   the	   chemical	   screen,	   the	  average	  G/R	  in	  the	  DMSO	  group	  was	  normalized	  to	  1,	  and	  all	  the	  other	  groups	  were	  normalized	  according	  to	  DMSO.	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Attributions	  I	  designed	  and	  performed	  the	  chemical	  screen	  leading	  to	  the	  discovery	  of	  EETs	  as	  novel	   regulators	  of	  HSPC	  engraftment.	   I	  performed	  all	   the	  mouse	  bone	  marrow	  and	  HSPC	  transplantation	  experiments,	  peripheral	  blood	  analysis	  and	  bone	  marrow	  stem	   and	   progenitor	   cell	   analysis,	  with	   technical	   advice	   from	  T.	   V.	   Bowman,	   G.	   C.	  Heffner	   and	   S.	   McKinney-­‐Freeman.	   I	   designed	   and	   performed	   the	   chemical	  suppressor	   screening,	   the	   morpholino	   experiments	   in	   zebrafish	   embryos,	   the	  western	  blotting	  and	  qRT-­‐PCR	  experiments	  in	  human	  cell	  lines,	  with	  some	  technical	  assistance	   from	   E.	   K.	   Pugach	   and	   E.	   B.	   Riley.	   I	   designed	   and	   performed	   the	   time-­‐lapse	   confocal	   imaging	   analysis	   with	   the	   imaging	   technical	   assistance	   from	   O.	   J.	  Tamplin.	   C.	   R.	   Lee,	   M.	   L.	   Edin	   from	   D.	   C.	   Zeldin’s	   laboratory	   and	   D.	   Panigrahy	  provided	  the	  Tg(Tie2:CYP2C8)	  transgenic	  mice.	  I	  analyzed	  all	  the	  data	  above.	  	  I	  designed	  and	  prepared	  mRNA	   for	   the	  microarray	  and	  RNA-­‐seq	  experiments.	  The	  microarray	  was	  performed	  by	  the	  Molecular	  Genetics	  Core	  Facility	  at	  Children's	  Hospital	   Boston,	   supported	   by	   NIH-­‐P50-­‐NS40828	   and	   NIH-­‐P30-­‐HD18655.	   The	  microarray	  raw	  data	  was	  processed	  and	  analyzed	  by	  A.	  Dibiase.	  The	  RNA-­‐seq	  was	  sequenced	  by	  the	  Whitehead	  Institute,	  and	  analyzed	  by	  R.	  M.	  White.	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Introduction	  	  	  In	   Chapter	   2,	   I	   described	   the	   zebrafish	   whole	   kidney	   marrow	   (WKM)	  competitive	  transplantation	  assay	  and	  the	  chemical	  screen	  based	  on	  this	  assay.	  The	  screen	   led	   to	   the	   discovery	   of	   multiple	   novel	   chemicals	   that	   can	   modulate	   the	  hematopoietic	  stem	  and	  progenitor	  cell	  (HSPC)	  engraftment	  capability	  in	  zebrafish.	  This	   includes	  a	  group	  of	   lipids,	   epoxyeicosatrienoic	  acids	   (EETs)	   that	   can	  enhance	  marrow	   transplantation	  efficiency.	  EETs	   are	  biosynthesized	   from	  arachidonic	   acid	  by	   cytochrome	   P450	   enzymes,	   especially	   members	   of	   the	   2C	   and	   2J	   families	   in	  mammals	  (Figure	  3.1A)	  (Panigrahy	  et	  al.,	  2011b;	  Pfister	  et	  al.,	  2010).	  EETs	  have	  very	  short	  half-­‐life	   in	  vivo,	  and	  are	  quickly	  degraded	  by	  soluble	  epoxide	  hydrolase	   into	  dihydroxyeicosatrienoic	  acids	  (DHETs),	  which	  have	  much	  less	  potent	  bioactivities	  in	  general.	   EETs	   regulate	   various	   physiological	   and	   pathological	   processes,	   such	   as	  vascular	  tone,	  inflammation,	  angiogenesis,	  and	  tumor	  growth/metastasis	  (Michaelis	  et	  al.,	  2005;	  Panigrahy	  et	  al.,	  2011b;	  Pfister	  et	  al.,	  2010).	  	  Each	  step	  leading	  to	  engraftment	  involves	  a	  response	  to	  diverse	  external	  signals	  in	  the	  niche,	  dramatic	  cellular	  changes,	  and	  cell-­‐cell	  interactions	  (Laird	  et	  al.,	  2008).	  Signaling	  by	  stromal-­‐derived	  factor	  1	  (SDF-­‐1)	  and	  stem	  cell	  factor	  (SCF)	  guides	  HSCs	  that	   express	   the	   receptors,	   CXCR4	  and	   c-­‐KIT	   respectively,	   to	  home	   to	   the	  marrow	  (Lapidot	   et	   al.,	   2005).	   Prostaglandin	  E2	   (PGE2)	   enhances	   the	   homing	   efficiency,	   as	  well	  as	  the	  number	  of	  HSCs	  (Goessling	  et	  al.,	  2009;	  Hoggatt	  et	  al.,	  2009;	  North	  et	  al.,	  2007).	   Gαs	   signaling,	   which	   can	   be	   activated	   by	   PGE2,	   is	   required	   for	   marrow	  engraftment	  (Adams	  et	  al,	  2009).	   	  Integrins	  and	  other	  adhesion	  molecules	  mediate	  the	   HSC-­‐endothelial	   interaction	   essential	   for	   entering	   the	   marrow	   (Mazo	   et	   al.,	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1998;	   Papayannopoulou	   et	   al.,	   1995).	   Small	   GTPases,	   such	   as	   Rac	   and	   Cdc42,	   are	  required	   to	   orchestrate	   cell	   movement	   for	   efficient	   homing,	   retention	   and	  localization	  (Cancelas	  et	  al.,	  2005;	  Gu	  et	  al.,	  2003;	  Williams	  et	  al.,	  2008;	  Yang	  et	  al.,	  2001).	   Once	   HSCs	   enter	   the	   bone	  marrow	   niche,	   extrinsic	   signaling	   from	   various	  niche	  cells,	  such	  as	  vascular	  and	  mesenchymal	  cells,	  influence	  HSC	  cell	  fate	  decisions	  to	   maintain	   quiescence,	   proliferate	   or	   differentiate;	   reciprocally,	   HSCs	   might	   also	  participate	  in	  niche	  formation	  (Mercier	  et	  al.,	  2011).	  	  Here,	   we	   show	   pulse	   treatment	   with	   EETs	   can	   enhance	   whole	   marrow	  engraftment	   both	   in	   zebrafish	   and	   mice.	   Genetic	   analysis	   in	   zebrafish	   embryos	  demonstrated	  that	  EET	  acts	  through	  a	  Gα12/13-­‐mediated	  receptor,	  which	  activates	  PI3K	  and	  induces	  transcription	  factors	  of	  the	  AP-­‐1	  family.	  This	  PI3K/AP-­‐1	  pathway	  directly	   induced	   the	   transcription	   of	   HSC	   marker,	   runx1,	   in	   embryos.	   The	  autonomous	   activation	   of	   PI3K	   in	   HSPCs	   by	   EET	   promoted	   HSPC	   migration	   and	  interactions	  with	  niche	  cells.	  Our	  studies	  define	  a	  role	  for	  EETs	  in	  the	  development	  of	  blood	  stem	  cells	  during	  embryogenesis,	  and	  in	  engraftment	  in	  adult	  vertebrates.	  This	   discovery	   may	   have	   clinical	   application	   in	   marrow	   or	   cord	   blood	  transplantation.	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Results	  	  	  
	  
EETs	  Promote	  Marrow	  Engraftment	  in	  Zebrafish	  From	  the	  chemical	  screening	  described	  in	  Chapter	  2,	  we	  identified	  10	  chemicals	  that	   were	   able	   to	   enhance	   marrow	   engraftment	   capabilities.	   Among	   them	   are	  epoxyeicosatrienoic	  acids	  (EET),	  eicosanoids	  derived	  from	  arachidonic	  acid	  through	  the	  cytochrome	  P450	  epoxygenase	  pathway,	  especially	  2C	  and	  2J	  in	  humans	  (Figure	  3.1A)	   (Panigrahy	   et	   al.,	   2011b;	   Pfister	   et	   al.,	   2010).	   Four	   isomers	   of	   EETs	   exist	   in	  vivo:	  5,6-­‐EET,	  8,9-­‐EET,	  11,12-­‐EET	  and	  14,15-­‐EET.	  	  	  
	  
Figure	  3.1.	  EETs	  enhance	  marrow	  engraftment	  capabilities	  in	  zebrafish.	  	  (A)	  EET	  metabolic	  pathway	  
(B)	  Chemical	  treatment	  enhanced	  engraftment	  in	  zebrafish.	  GFP+	  marrow	  cells	  were	  treated	   in	  vitro	  with	  DMSO,	  10µM	  dmPGE2,	  0.5µM	  BIO,	  0.5µM	  11,12-­‐EET	  or	  0.5µM	  14,15-­‐EET	  for	  4	  hrs.	  **	  Student’s	  t	  test	  p	  values<0.005.	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Both	   (±)11,12-­‐EET	   and	   (±)14,15-­‐EET	   increased	   the	   marrow	   engraftment	   in	  zebrafish	   at	   0.5	   µM	   concentration	   (Figure	   3.1B).	   In	   this	   chapter,	   the	   follow-­‐up	  studies	   on	   understanding	   the	   signaling	   and	   molecular	   mechanism	   of	   EETs	   are	  reported.	  
	  
EETs	  Promote	  Adult	  HSPC	  Engraftment	  in	  Mammals	  To	   test	   if	   the	   effects	   of	   EETs	   are	   conserved	   in	   mammals,	   we	   performed	  competitive	   whole	   bone	   marrow	   (WBM)	   transplantation	   in	   mice.	   20,000	   CD45.1	  WBM	   cells	  were	   treated	  with	   11,12-­‐EET	   or	  DMSO	   for	   4hrs,	   at	   room	   temperature.	  After	   washing	   off	   the	   chemicals,	   the	   treated	   marrow	   cells	   were	   competitively	  transplanted	  with	  200,000	  non-­‐treated	  CD45.2	  WBM.	  Consistent	  with	  results	   from	  zebrafish,	   11,12-­‐EET	   also	   enhanced	   short-­‐term	   donor-­‐derived	  WBC	   (white	   blood	  cell)	  chimerism	  by	  4	  wpt	  in	  mice.	  The	  effect	  was	  particularly	  prominent	  in	  myeloid	  cells,	  the	  earliest	  indicator	  of	  engraftment	  (Figure	  3.2A).	  EET-­‐treated	  WBM	  yielded	  enhanced	  repopulation,	  relative	  to	  control,	  for	  at	  least	  24	  weeks,	  as	  indicated	  by	  the	  increased	   number	   of	   recipients	  with	   long-­‐term	  multi-­‐lineage	   engraftment	   (Figure	  3.2B).	   Enhanced	   short-­‐term	   and	   long-­‐term	   engraftment	   suggest	   that	   EET	   may	  impact	   both	   LT-­‐HSC	   and	   progenitor	   cells,	   perhaps	   by	   establishing	   a	   competitive	  advantage	  at	  the	  very	  early	  stage	  of	  engraftment.	  	  To	   genetically	  modify	   the	   concentration	  of	   EETs,	  we	  utilized	  Tg(Tie2:CYP2C8)	  mice,	   which	   overexpresses	   one	   of	   the	   human	   cytochrome	   P450	   epoxygenases,	  
CYP2C8,	  under	  the	  regulation	  of	  mouse	  Tie2	  promoter	  (Lee	  et	  al.,	  2010;	  Panigrahy	  et	  al.,	  2011a)	  (Figure	  3.1A).	  Tie2	  is	  expressed	  by	  endothelial	  cells	  and	  HSPCs	  (Arai	  et	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al.,	  2004).	  These	  transgenic	  mice	  produce	  higher	  level	  of	  EETs	  than	  their	  wild	  type	  siblings	   (Lee	   et	   al.,	   2010;	   Panigrahy	   et	   al.,	   2011a).	   At	   steady-­‐state	   conditions,	  
Tg(Tie2:CYP2C8)	  mice	  have	  normal	  peripheral	  blood	  cell	   counts	   (Figure	  3.3A)	  and	  numbers	   of	   HSPCs	   in	   the	   bone	   marrow	   (Figure	   3.3B).	   We	   performed	   a	   limiting	  dilution	   competitive	   transplant	   to	   further	   challenge	   the	   HSPCs	   (Figure	   3.3C),	   and	  found	  that	  Tg(Tie2:CYP2C8)	  donor	  marrow	  cells	  had	  a	  4-­‐fold	  increase	  of	   long-­‐term	  competitive	   repopulating	   units	   (Figure	   3.3D,	   Table	   3.1).	   The	   difference	   between	  transplantation	   and	   homeostatic	   hematopoiesis	   indicates	   the	   biological	   aspect	  regulated	  by	  EET	  is	  specifically	  involved	  in	  HSPC	  engraftment.	  	  	  
	  
Figure	  3.2.	  EET	  treatment	  enhances	  marrow	  engraftment	  capabilities	  in	  
mammals.	  
	  Mouse	  whole	   bone	  marrow	   (WBM)	   competitive	   transplant:	   DMSO	   or	   2µM	   11,12-­‐EET	   treated	   20,000	   CD45.1	   bone	   marrow	   cells	   were	   transplanted	   together	   with	  200,000	   untreated	   CD45.2	   bone	  marrow	   cells.	  WBC,	  white	   blood	   cell;	  M,	  myeloid	  cells.	   B,	   B	   cells;	   T,	   T	   cells.	   *	   Student's	   t	   test	   p	   values	  <	   0.05,	   **	   student’s	   t	   test	   p	  values<0.005.	  	  (A)	  EET	  enhanced	  short-­‐term	  engraftment	  at	  4wpt.	  	  	  (B)	  EET	  enhanced	  long-­‐term	  multilineage	  engraftment	  at	  24wpt.	  	  	  	  






Figure	  3.3.	  Tg(Tie2:CYP2C8)	  mice	  have	  normal	  hematopoiesis	  at	  homeostasis	  
but	  competitive	  advantage	  in	  transplantation.	  	  (A)	   Complete	   blood	   count	   (CBC)	   of	   the	   Tg(Tie2:CYP2C8)	   mice	   (n=4).	   WBC,	   white	  blood	  cell;	  NE,	  neutrophil	  granulocytes;	  LY,	  lymphocytes;	  MO,	  monocytes;	  RBC,	  red	  blood	  cells;	  Hb,	  hemoglobin;	  HCT,	  hematocrit;	  PLT,	  platelets.	  	  (B)	   Bone	  marrow	   analysis	   of	   the	  Tg(Tie2:CYP2C8)	   mice	   (n=3).	   LT-­‐HSC,	   long-­‐term	  HSC	   (Lin-­‐	   c-­‐Kit+Sca-­‐1+CD150+CD48-­‐);	   ST-­‐HSC,	   short-­‐term	   HSC	   (Lin-­‐	   c-­‐Kit+Sca-­‐1+CD150+CD48+);	  MPP,	  multipotent	   progenitor	   (Lin-­‐	   c-­‐Kit+Sca-­‐1+CD150-­‐CD48+);	  LSK:	  Lin-­‐Sca-­‐1+c-­‐Kit+;	  GMP:	  granulocyte-­‐macrophage	  progenitor	  (Lin-­‐	  c-­‐Kit+Sca-­‐1-­‐CD34+FcγRhigh);	   CMP:	   common	   myeloid	   progenitor	   (Lin-­‐	   c-­‐Kit+Sca-­‐1-­‐CD34+FcgRmid);	  MEP:	  megakaryocyte-­‐erythroid	  progenitor	  (Lin-­‐	  c-­‐Kit+Sca-­‐1-­‐CD34-­‐FcgRlow).	  	  	  (C-­‐D)	   Limiting	   dilution	   competitive	   transplant	   with	   Tg(Tie2:CYP2C8).	   30,000	   or	  60,000	  wild	  type	  or	  transgenic	  CD45.2	  whole	  bone	  marrow	  cells	  were	  transplanted	  with	   300,000	   CD45.1	   wild	   type	   marrow	   cells,	   into	   CD45.1/2	   recipients.	   The	  frequency	  of	  long-­‐term	  competitive	  repopulating	  unit	  (CRU)	  was	  calculated	  by	  ELDA	  (Hu	  and	  Smyth,	  2009).	  	  	   	  




Table	  3.1.	  	  Tg(Tie2:CYP2C8)	  Limiting	  Dilution	  Competitive	  
Transplantation_14wpt	  
	  	   Peripheral	  Blood	  CD45.2+CD45.1-­‐	  Chimerism	  	   Total	   Myeloid	   B	  Cells	   T	  Cells	  WT_30k_001	   0.023	   0	   0	   0.12	  WT_30k_003	   1.76	   0.27	   3.36	   1.41	  WT_30k_004	   0.048	   0.033	   0.096	   0	  
WT_30k_005	   6.46	   18.7	   1.91	   2.87	  WT_30k_006	   2.29	   1.43	   3.82	   0.25	  WT_30k_007	   0.38	   0.12	   0.32	   0	  2C8_30k_001	   0.012	   0.048	   0	   0	  2C8_30k_002	   0.21	   0.036	   0.036	   0	  
2C8_30k_003	   2.37	   1.4	   1.28	   5.7	  2C8_30k_004	   0.19	   0.19	   0.029	   0.21	  
2C8_30k_005	   50.9	   14.2	   75.1	   66.7	  2C8_30k_006	   0.11	   0.039	   0.17	   0.1	  
2C8_30k_007	   11.2	   12	   14.2	   5.49	  WT_60k_001	   0.77	   0.4	   1.05	   0.98	  WT_60k_002	   0.069	   0.072	   0	   0.035	  WT_60k_003	   0.52	   1.1	   0.57	   0	  
WT_60k_005	   5.14	   2.27	   4.42	   9.49	  WT_60k_006	   0.11	   0.082	   0.069	   0.048	  
WT_60k_007	   11.3	   9.97	   9.21	   18.2	  
2C8_60k_001	   2.87	   2.13	   1.39	   7.49	  
2C8_60k_002	   3.36	   2.23	   1.93	   8.8	  
2C8_60k_003	   23.7	   19.8	   30.8	   18.2	  
2C8_60k_004	   11.4	   4.16	   13	   18.6	  2C8_60k_005	   0.73	   0.3	   1.18	   0.14	  
2C8_60k_006	   1.94	   1.09	   1.01	   5.01	  
2C8_60k_007	   11.6	   4.23	   12.7	   17.1	  	  2C8:	  Tie2:CYP2C8	  transgenic	  mice;	  WT:	  Wild	  type	  mice	  Mice	   with	   >1%	   chimerism	   in	   all	   three	   lineages	   (myeloid,	   B	   and	   T	   cells)	   were	  considered	  as	  engraftment	  (as	  shaded	  in	  grey).	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EETs	   Induce	   runx1	   Transcription	   and	   HSPC	   Engraftment	   During	   Zebrafish	  
Embryo	  Development	  	  To	   understand	   the	   molecular	   mechanism	   of	   EET	   regulation	   of	   HSPC	  engraftment,	  EET	  effects	  on	  HSPCs	  during	  embryo	  development	  were	  studied.	  In	  the	  zebrafish	   embryo,	   HSCs	   emerge	   from	   the	   hemogenic	   endothelium	   of	   the	   AGM	  (aorta-­‐gonad-­‐mesonephros	   region),	   similar	   to	   mammals	   (Bertrand	   et	   al.,	   2010;	  Boisset	  et	  al.,	  2010;	  Davidson	  and	  Zon,	  2004;	  Kissa	  and	  Herbomel,	  2010;	  Orkin	  and	  Zon,	   2008).	   The	   HSPCs	   enter	   circulation,	   then	   travel	   to	   and	   engraft	   in	   the	   caudal	  hematopoietic	  tissue	  (CHT),	  a	  secondary	  hematopoietic	  site	  equivalent	  to	  the	  mouse	  fetal	   liver	   (Figure	   3.4A)	   (Murayama	   et	   al.,	   2006;	   Orkin	   and	   Zon,	   2008).	   The	  trafficking	  of	  HSPCs	  in	  embryos	  shares	  some	  similar	  signaling	  pathways	  employed	  by	   adult	   HSCs	   during	   homing	   and	   engraftment,	   such	   as	   SCF/C-­‐KIT	   and	   SDF-­‐1/CXCR4	  (Laird	  et	  at,	  2008).	  	  Various	  doses	  of	  11,12-­‐EET	  and	  different	  treatment	  time	  windows	  were	  studied	  during	  HSPC	  development	  in	  zebrafish	  embryos.	  	  Treatment	  of	  embryos	  with	  11,12-­‐EET	   during	   24-­‐36	   hpf	   dramatically	   increased	   the	   embryonic	   HSPC	  marker,	   runx1	  (Figure	  3.4B)	   (Kalev-­‐Zylinska	   et	   al.,	   2002;	   Soza-­‐Ried	   et	   al.,	   2010).	   To	   examine	   the	  later	   effect	   of	   runx1	   upregulation	   in	   AGM,	   the	   HSPC	   behavior	   during	   CHT	  colonization	   was	   studied.	   EET	   was	   washed	   off	   at	   48	   hpf	   and	   the	   embryos	   were	  allowed	  to	  develop	  for	  another	  24	  hrs,	  during	  which	  time	  HSPCs	  from	  AGM	  would	  migrate	  to	  and	  engraft	  in	  the	  CHT.	  The	  number	  of	  HSPCs	  in	  CHT	  was	  quantified	  by	  using	   a	   transgenic	   zebrafish	   expressing	   mCherry	   under	   the	   mouse	   Runx1+23	  enhancer	  that	  specifically	  labels	  definitive	  HSPCs	  (Bee	  et	  al.,	  2009;	  Nottingham	  et	  al.,	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Figure	  3.4.	  EETs	  induce	  runx1	  expression	  and	  enhance	  HSPC	  engraftment	  in	  
zebrafish	  embryos	  	  (A)	  Schematic	  of	  HSPC	  development	  and	  chemical	  treatment	  in	  zebrafish	  embryos.	  hpf,	   hour	   post	   fertilization;	   AGM,	   aorta-­‐gonad-­‐mesonephros;	   CHT,	   caudal	  hematopoietic	  tissue.	  	  (B)	  EET	  increased	  runx1	  expression	  in	  the	  AGM.	  	  (C-­‐D)	  EET	  enhanced	  the	  number	  of	  HSPCs	  engrafted	  in	  the	  CHT.	  Using	  a	  transgenic	  zebrafish	   expressing	  mCherry	   under	   the	  mouse	  Runx1+23	   enhancer	   to	   specifically	  label	  definitive	  HSPCs.	  mCherry+	  cell	  number	  was	  quantified	  with	  ImageJ.	  *	  Student's	  t	  test	  p	  values	  <	  0.05.	  	  (E)	  EET	  increased	  HSPC	  marker	  cmyb	  in	  the	  CHT	  at	  72hpf.	  	  (F)	  EET	  induced	  ectopic	  runx1	  in	  the	  non-­‐hematopoietic	  cells	  in	  the	  tail.	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Immediate	   Induction	   of	   AP-­‐1	   Transcription	   Factors	   Is	   Required	   for	   EET-­‐
Induced	  runx1	  Expression	  Although	   runx1	   has	   been	   well	   accepted	   as	   a	   HSC	   marker	   in	   embryos,	   the	  mechanism	   by	   which	   runx1	   transcription	   is	   induced	   during	   development	   is	   not	  completely	   understood.	   To	   study	   how	   EETs	   induced	   runx1	   expression,	   we	  performed	  microarray	   analysis	   on	  EET-­‐treated	  36	  hpf	   embryos.	   Surprisingly,	   only	  68	  transcripts	  were	  up	  or	  down-­‐regulated	  by	  EET	  treatment,	   including	  a	  subset	  of	  genes	  upregulated	  in	  zebrafish	  tail	  fin	  regeneration,	  such	  as	  fn1	  and	  mvp,	  and	  genes	  essential	  for	  cholesterol	  metabolism,	  such	  as	  hmgcs1	  and	  cyp51a	  (Table	  3.2	  and	  3.3)	  (Yoshinari	  et	  al.,	  2009).	  Most	  of	   the	  up-­‐regulated	  genes	  were	  confirmed	  by	  whole-­‐mount	   in	  situ	  hybridization.	  A	  group	  of	   transcription	  factors	  belonging	  to	  the	  AP-­‐1	  (Activation	   Protein	   1)	   family,	   such	   as	   fosl2	   and	   junb,	   were	   both	   induced	   by	   EET	  treatment	  and	  fin	  regeneration	  (Figure	  3.5A).	  	  	  	   AP-­‐1	   transcripts	   can	   be	   rapidly	   induced	   by	   many	   stimuli	   (Jochum	   et	   al.,	  2001).	  Fixing	  embryos	  at	  different	  time-­‐points	  upon	  EET	  treatment	  showed	  a	  robust	  induction	  of	  AP-­‐1	  within	  1	  hr	  (25	  hpf)	  and	  runx1	  after	  4	  hrs	  (28	  hpf)	  (Figure	  3.5B,	  C).	  To	  examine	  if	  AP-­‐1	  was	  an	  immediate	  early	  gene	  induced	  by	  EET,	  cycloheximide	  was	   used	   to	   block	   translation.	   Runx1	   transcription	   was	   completely	   blocked	   by	  cycloheximide	   at	   28	   hpf	   (Figure	   3.5D),	   but	   not	   AP-­‐1	   expression	   at	   25	   hpf	   (Figure	  3.5E).	   EET-­‐induced	   signaling	   transduction	   directly	   activated	   AP-­‐1	   transcription,	  while	  runx1	   upregulation	   is	  dependent	  on	   the	  de	  novo	   protein	   synthesis	  of	  one	  or	  more	  upstream	  regulators.	  	  
	  
	  






Table	  3.2	  Microarray	  Analysis	  of	  11,12-­‐EET-­‐treated	  36	  hpf	  Zebrafish	  Embryos	  
List	  of	  Genes	  with	  Increased	  Expression	  	  
probe	   mean.fc	   q	   gene	  Dr.14719.1.A1_at	   4.359432	   0	   ARF1	  Dr.24471.1.A1_at	   2.896713	   0.079602	   PALLADIN	  Dr.19888.1.S1_at	   2.52457	   0	   VED	  DrAffx.2.81.A1_at	   2.114362	   0.015873	   CYP51A1	  Dr.12110.1.S1_at	   2.097974	   0	   SC4MOL	  Dr.4938.1.S1_at	   1.998925	   0.015873	   FADS2	  Dr.22219.1.S1_at	   1.997586	   0.079602	   ACTN2	  Dr.16634.1.A1_at	   1.749673	   0.015873	   AK128797	  Dr.20131.2.A1_at	   1.516192	   0	   CLU	  Dr.13651.1.A1_at	   1.47763	   0.028986	   FBP1	  Dr.16392.1.A1_at	   1.413491	   0	   C6	  Dr.11572.1.A1_at	   1.30334	   0.015873	   WDR34	  Dr.2051.1.S1_at	   1.158936	   0	   HMGCS1	  Dr.25093.1.A1_s_at	   1.157838	   0.037736	   TAR3	  Dr.24233.1.S1_at	   1.148094	   0	   FN1	  Dr.9617.1.A1_at	   1.094222	   0	   SOCS3	  Dr.23811.1.A1_at	   1.072796	   0.079602	   MOGAT1	  Dr.10130.2.A1_at	   0.971631	   0	   FOSL2	  Dr.967.1.S1_at	   0.967481	   0	   MMP9	  Dr.9642.1.A1_at	   0.844911	   0.015873	   ASPN	  Dr.19560.1.S1_at	   0.781171	   0.028986	   INSIG1	  Dr.22334.1.S1_at	   0.747641	   0	   MS4A4A	  /	  ms4a17a.11	  Dr.19560.1.S2_at	   0.720476	   0.015873	   INSIG1	  Dr.2487.1.S1_at	   0.710377	   0.037736	   UPB1	  Dr.10326.1.S1_at	   0.704015	   0.079602	   JUNB	  Dr.1089.1.S1_at	   0.701168	   0.015873	   THBS3	  Dr.25191.1.S1_at	   0.635516	   0.015873	   IDH1	  Dr.737.1.A1_at	   0.543973	   0.037736	   JUNB	  Dr.26534.1.A1_at	   0.502621	   0.079602	   INSIG1	  Dr.7010.1.S1_at	   0.475427	   0.074713	   ELOVL7	  Dr.24562.1.S1_a_at	   0.387242	   0.066667	   MVP	  	  	   	  








Table	  3.3	  Microarray	  Analysis	  of	  11,12-­‐EET-­‐treated	  36	  hpf	  Zebrafish	  Embryos	  
List	  of	  Genes	  with	  Decreased	  Expression	  	  
probe	   mean.fc	   q	   gene	  Dr.20008.1.S1_at	   -­‐0.234813	   0.074713	   SLC25A5	  AFFX-­‐Dr-­‐acta1-­‐5_at	   -­‐0.290608	   0.037736	   ACTA1	  Dr.6826.1.S1_at	   -­‐0.381291	   0.083333	   COL1A1b	  Dr.20272.1.A1_at	   -­‐0.395476	   0.034722	   SNRP70	  Dr.5531.3.S1_at	   -­‐0.405781	   0.015873	   KRT15	  Dr.12425.1.S1_at	   -­‐0.415358	   0.034722	   KRT17	  Dr.1377.1.A1_at	   -­‐0.440683	   0.015873	   COL1A2	  Dr.24292.5.S1_at	   -­‐0.467295	   0	   KRT15	  Dr.15266.1.A1_at	   -­‐0.51983	   0.015873	   CHRNG	  Dr.24487.1.A1_at	   -­‐0.526189	   0.079602	   KRT8	  Dr.3484.1.S1_at	   -­‐0.529253	   0.074713	   sap30bp	  Dr.5439.2.S1_at	   -­‐0.566989	   0.079602	   NSFL1C	  Dr.2539.1.A1_at	   -­‐0.577588	   0.015873	   wu:fy25c05	  Dr.24399.1.A1_at	   -­‐0.579821	   0	   ARGLU1B	  Dr.4681.1.A1_at	   -­‐0.61717	   0	   TTN	  Dr.23502.1.A1_at	   -­‐0.781435	   0	   APOE	  Dr.14514.1.S1_a_at	   -­‐0.999159	   0	   RPL13	  Dr.18173.1.A1_at	   -­‐1.131191	   0.015873	   MPP2	  Dr.17747.1.S1_at	   -­‐1.366207	   0.015873	   SCEL	  Dr.9478.4.S1_at	   -­‐3.077714	   0.079602	   MPX	  Dr.12749.1.A1_at	   -­‐3.319542	   0.023256	   RHCG	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Figure	  3.5.	  EET	  induces	  AP-­‐1	  transcription,	  but	  not	  runx1	  transcription,	  
independent	  of	  translation.	  	  All	  treatments	  started	  at	  24	  hpf	  with	  5uM	  11,12-­‐EET.	  	  (A)	  EET	  induced	  AP-­‐1	  family	  transcription	  factors,	  represented	  by	  fosl2	  and	  junb.	  	  (B)	  EET	  quickly	  induced	  AP-­‐1	  within	  1hr	  of	  treatment.	  	  (C)	  Runx1	  was	  induced	  by	  EET	  after	  4hr	  of	  treatment.	  	  (D)	   AP-­‐1	   induction	   was	   not	   dependent	   on	   de	   novo	   protein	   synthesis.	   Wild	   type	  embryos	  were	   incubated	  with	   300µM	  cycloheximide,	   a	   translation	  blocker,	   for	   30	  min	  before	  the	  addition	  of	  EET.	  	  (E)	  Runx1	   transcription	   required	   de	  novo	   protein	   synthesis.	   Same	   treatment	  with	  cycloheximide	  as	  (C)	  blocked	  runx1	  transcription.	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To	   evaluate	   the	   function	   of	   AP-­‐1	   during	   AGM	   HSC	   induction,	   AP-­‐1	   members	  were	  individually	  knocked	  down	  with	  anti-­‐sense	  morpholinos	  in	  zebrafish	  embryos.	  	  
fosl2	  at	  a	  high	  dose	  completely	  inhibited	  EET-­‐induced	  upregulation	  of	  runx1	  in	  both	  AGM	   and	   tail,	   without	   affecting	   basal-­‐level	   runx1	  expression	   (Figure	   3.6).	   Double	  knockdown	   of	   fosl2	   and	   cfos,	   at	   a	   much	   lower	   dose,	   synergistically	   blocked	   both	  EET-­‐induced	  and	  basal-­‐level	  runx1	  transcription,	  showing	  the	  Fos	  family	  is	  required	  for	   both	   endogenous	   and	   induced	   runx1	   transcription	   (Figure	   3.6).	   Fos	  members	  form	   heterodimers	   with	   Jun	   family	   for	   transcriptional	   regulation	   (Jochum	   et	   al.,	  2001).	  Different	  Jun	  members	  were	  studied	  by	  morpholino	  knockdown.	  The	  results	  showed	   the	   specific	   requirement	   for	   junb,	   but	   not	   c-­‐jun,	   to	   induce	   runx1	  transcription	  both	   in	   the	  AGM	  and	   tail	   (Figure	  3.6).	  At	  a	   slightly	  higher	  dose,	   Junb	  morphants	   had	   circulation	   defects.	   	   The	   lower	   doses	   of	   junb	   morpholino	  demonstrated	  specific	  decreased	  runx1	  expression	  independent	  of	  circulation.	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Figure	  3.6.	  AP-­‐1	  transcription	  factors	  are	  required	  for	  runx1	  upregulation.	  	  	  AP-­‐1	   was	   required	   for	   runx1	   transcription.	   8ng	   morpholino	   (MO)	   targeting	   fosl2	  ATG	   site	   did	   not	   decrease	   basal	   level	   of	   runx1	   (DMSO),	   but	   blocked	   EET-­‐induced	  
runx1	   transcription	   (EET).	   Double	  morpholinos	   against	   both	   fosl2	   and	   cfos	   at	   low	  doses	   (2ng	   each)	   synergistically	   decreased	   both	   the	   basal-­‐level	   and	   EET-­‐induced	  
runx1.	  Morpholino	  against	  junb	  (2ng)	  also	  completely	  inhibited	  runx1	  transcription.	  Wild-­‐type	  zebrafish	  embryos	  were	   injected	  with	  c-­‐jun	  morpholino	  at	  4ng/embryo,	  the	   highest	   concentration	   tolerated	  by	   the	   embryos.	  Knocking	  down	   c-­‐jun	   did	   not	  affect	  EET-­‐induced	  runx1	  expression.	  	  	  	  




Figure	  3.7.	  AP-­‐1	  binding	  sites	  on	  RUNX1	  DNA	  in	  human	  K562	  cells	  	  (A)	   ChIP-­‐Seq,	   RNA-­‐Seq,	   DHS	   (DNase	   I	   Hypersensitivity)	   mapping,	   and	   28-­‐way	  conservation	   analysis	   for	   human	   RUNX1	   locus	   were	   retrieved	   and	   analyzed	   on	  Encode.	  Two	  representatives	  of	  the	  AP-­‐1	  family	  member,	  C-­‐FOS	  and	  C-­‐JUN,	  showed	  multiple	   identical	  peaks,	   including	  the	  two	  alternative	  promoters	  (P1	  and	  P2),	  and	  the	  enhancer	  region	  within	  the	  first	  intron	  (e1,	  e2,	  e3	  and	  e4).	  	  (B)	  Zoom-­‐in	  images	  of	  the	  AP-­‐1	  binding	  sites	  on	  RUNX1.	  AP-­‐1	  binding	  on	  e2,	  e4,	  and	  P2	  correlates	  with	  transcription	  activation	  mark	  H3K27ac	  (Creyghton	  et	  al.,	  2010),	  and	   open	   chromatin	   structure	   by	   DHS.	   The	   binding	   on	   e4	   and	   P2	   are	   highly	  evolutionarily	  conserved.	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These	  observations	  on	  Jun	  family	  member	  knockdown	  are	  consistent	  with	  the	  mouse	   mutant	   phenotype.	   Junb-­‐deficient	   embryos	   died	   in	   utero	   due	   to	   vascular	  defects	   (Jochum	   et	   al.,	   2001).	   Knockout	   of	   c-­‐Jun	   did	   not	   cause	   any	   abnormality	  intrinsic	   to	   the	   hematopoietic	   or	   endothelial	   compartment	   (Eferl	   et	   al.,	   1999).	   In	  addition,	   myeloid-­‐specific	   deficiency	   of	   Junb	   caused	   myeloproliferative	   disorder,	  supporting	  the	  important	  role	  of	  Junb	  in	  hematopoietic	  cells	  (Passegue	  et	  al.,	  2001).	  	  The	   genetic	   studies	   above	   demonstrated	   that	   AP-­‐1	   is	   upstream	   of	   runx1.	   To	  evaluate	   if	   AP-­‐1	   directly	   binds	   to	   runx1	   transcriptional	   regulatory	   elements,	   we	  further	  examined	  ChIP-­‐Seq	  data	  from	  the	  ENCODE	  Consortium	  database	  (Birney	  et	  al.,	  2007).	  The	  transcription	  of	  RUNX1	  utilizes	  two	  promoters,	  spaced	  by	  a	  >100kb	  enhancer	   region	   (Bee	   et	   al.,	   2009;	   Challen	   and	   Goodell,	   2010).	   ChIP-­‐Seq	   in	   K562	  human	   leukemia	  cells	   showed	  strong	  binding	  sites	  of	  AP-­‐1	   family	  members	  at	   the	  evolutionarily	   conserved	   regions	  of	  RUNX1	   promoters,	   especially	  P2,	   as	  well	   as	   at	  the	  enhancer	  sites	   in	  the	  first	   intron	  (Figure	  3.7).	  Different	  AP-­‐1	  members	  had	  the	  same	   binding	   sites	   on	   the	  RUNX1	   regulatory	   region.	   This	   suggests	   that	   AP-­‐1	   is	   a	  direct	  regulator	  of	  RUNX1.	  	  	  
EETs	  Signal	  Through	  a	  Gα12/13-­‐Mediated	  Receptor	  	  Despite	  the	  dramatic	  biological	  effects	  of	  EETs,	  efforts	  to	  identify	  and	  clone	  the	  EET	   receptor	   have	   been	   unsuccessful.	   	   Several	   recent	   studies	   indicated	   that	   EETs	  bind	   to	   a	   receptor	   on	   the	   extracellular	  membrane	   (Chen	   et	   al.,	   2007;	   Yang	   et	   al.,	  2008).	  Using	  UV-­‐activated	   cross-­‐linking	  between	   radioactively	   labeled	  EET	   analog	  and	   cells,	   an	  unknown	  47	  kDa	   cell	  membrane	  protein	  was	   shown	   to	  directly	  bind	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EETs	   (Chen	   et	   al.,	   2011).	   The	   estimated	   size	   of	   the	   receptor	   is	   within	   the	   typical	  range	  of	  G	  protein-­‐couple	  receptors	  (GPCR).	  Due	  to	  the	  similarity	  between	  EETs	  and	  other	   eicosanoids,	   the	  majority	   of	  which	   target	   GPCRs,	  we	   hypothesize	   that	   EETs	  might	  also	  bind	  one	  or	  multiple	  GPCR(s).	  All	  GPCRs	  are	  coupled	  to	  at	  least	  one	  type	  of	   the	   G-­‐trimeric	   proteins	   composed	   of	  α-­‐,	  β-­‐,	   γ-­‐	   subunits,	   required	   for	   activating	  diverse	  secondary	  signaling	  messengers.	  	  Even	  though	  more	  than	  1000	  GPCRs	  have	  been	   annotated	   in	   the	   human	   genome,	   there	   are	   a	   fairly	   small	   number	   of	  Gα subunits:	   Gαs,	   Gαi,	   Gαq,	   Gα12/13	   (Lappano	   and	   Maggiolini,	   2011).	   Different	  methods	  were	  used	  to	  block	  Gα	  proteins	  in	  zebrafish	  embryos:	  chemical	  inhibitors	  for	   Gαs	   (adenylate	   cyclase	   inhibitor	   SQ22536,	   PKA	   inhibitor	   H89),	   injecting	  pertussis	   toxin	   mRNA	   to	   block	   Gαi	   (Slusarski	   et	   al.,	   1997),	   and	   morpholino	  knockdown	   of	   individual	   Gαq	   (gna11,	   gna14,	   gna15/16	   and	   gnaq)	   and	   Gα12/13	  (gna12,	   gna13a,	   gna13b).	   Blocking	   Gαs	   or	   Gαi	   did	   not	   affect	   EET-­‐induced	   runx1	  expression	   (Figure	   3.8A,B);	   however,	   knocking	   down	   the	   zebrafish	   orthologs	   of	  human	  GNA13,	  gna13a	   and	  gna13b	   together,	   or	  gna12	   alone	  partially	   blocked	   the	  EET	   effects	   (Figure	   3.8C,D).	   Considering	   the	   potential	   redundancy	   of	   Gα12	   and	  Gα13,	   we	   did	   triple	   knockdown	   of	   gna12,	   gna13a	   and	   gna13b.	   The	   triple	  morpholinos	  completely	  blocked	  EET-­‐induced	  expression	  of	  runx1,	  fosl2	  and	  genes	  involved	   in	   cholesterol	   metabolism,	   such	   as	   hmgcs1	   (Figure	   3.8E).	   This	   strongly	  supports	  that	  EETs	  act	  through	  a	  receptor	  mediated	  by	  Gα12/13.	  	  	  
	   	  















Figure	  3.8	  EETs	  signal	  through	  a	  Gα12/13-­‐mediated	  receptor.	  	  (A)	  Inhibiting	  Gas	  downstream	  signaling	  with	  adenylate	  cyclase	  inhibitor	  SQ22536	  (50uM)	  did	  not	  block	  EET-­‐induced	  runx1	  expression.	  	  (B)	  Representative	  images	  of	  knocking	  down	  gna13a/b	  or	  gna12	  alone.	  Only	  partial	  inhibition	  was	  observed.	  	  (C)	   Quantification	   of	   the	   effects	   of	   inhibiting	   Gαs	   or	   Gαi	   on	   runx1	   expression.	  Embryos	  were	  categorized	   into	   two	  groups	  with	  either	  normal	  or	   increased	  runx1	  expression	   level.	   The	   bar	   graph	   represented	   the	   percentage	   of	   embryos	   in	   each	  group.	   PtxA,	   pertussis	   toxin	   A,	   3pg,	   inhibiting	   GαI;	   H89,	   5µM,	   PKA	   inhibitor;	  SQ22536,	  50µM.	  	  (D)	  Synergistic	  effects	  of	  knocking	  down	  gna12/13	  on	  runx1	  expression	  in	  zebrafish	  embryos.	   Morpholinos	   against	   gna13a/b	   (1ng	   each)	   or	   gna12	   (2ng)	   partially	  blocked	   runx1	   expression.	   Triple	  morpholinos	   against	   gna12,	   gna13a	   and	   gna13b	  (0.67ng	   each)	   completely	   blocked	   runx1.	   Embryos	   were	   categorized	   into	   three	  groups	  with	  either	  decreased,	  normal	  or	  increased	  runx1	  expression	  level.	  The	  bar	  graph	  represented	  the	  percentage	  of	  embryos	  in	  each	  group.	  (E)	  Gna12/13a/13b	  is	  required	  for	  EET-­‐induced	  multiple	  gene	  expression	  (see	  also	  Figure	  S5).	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Activation	  of	  PI3K	  Is	  Required	  for	  EET-­‐Induced	  AP-­‐1	  and	  runx1	  Expression	  Many	   different	   signaling	   pathways	   have	   been	   proposed	   to	   be	   downstream	   of	  EETs,	   in	   a	   cell-­‐	   and	   tissue-­‐type	   dependent	  manner	   (Michaelis	   and	   Fleming,	   2006;	  Panigrahy	  et	  al.,	  2011b;	  Yang	  et	  al.,	  2007).	  In	  search	  for	  the	  pathway(s)	  responsible	  for	   the	   EET	   effects	   on	   HSPC	   engraftment,	   we	   performed	   a	   chemical	   suppressor	  screen	  in	  zebrafish	  embryos.	  Upon	  EET	  treatment,	  upregulation	  of	  AP-­‐1	  and	  runx1	  are	   the	   earliest	  markers	   relevant	   to	   HSPCs.	   Using	   these	  markers,	   we	   examined	   if	  small	  molecules	  could	  inhibit	  the	  response	  to	  EETs.	  	  We	   incubated	   23.5	   hpf	   embryos	   for	   30	   min	   with	   chemicals	   targeting	   the	  pathways	  previously	  reported	  to	  be	  downstream	  of	  EETs.	  11,12-­‐EET	  was	  added	  at	  24	  hpf	  (Figure	  3.9A).	  Multiple	  PI3K	  inhibitors	  (LY294002,	  Wortmannin,	  and	  PI-­‐103)	  completely	  suppressed	  EET-­‐induced	  runx1	  expression,	  both	  in	  the	  AGM	  and	  the	  tail	  (Figure	   3.9B).	   In	   contrast,	   MEK1/2	   inhibitor	   (U0126)	   had	   no	   effect	   on	   runx1	  expression	  (Figure	  3.9B).	  fosl2	  and	  junb	  expression	  were	  also	  blocked	  by	  LY294002,	  but	  not	  by	  U0126	  (Figure	  3.9C).	  LY294002	  had	  a	  negligible	  effect	  on	  hmgcs1,	  while	  U0216	  completely	  blocked	  hmgcs1	   (Figure	  3.9D).	  The	  mutually	  exclusive	  effects	  of	  inhibiting	   PI3K	   and	   MAPK	   pathway	   provide	   an	   example	   where	   single	   ligand	  stimulation	  activates	  genetically	  separable	  signaling	  pathways.	  	  	  
	   	  





































Figure	  3.9.	  EET-­‐induced	  PI3K	  activation	  leads	  to	  AP-­‐1/runx1	  expression	  	  	  (A)	  Schematic	  of	  chemical	  suppressor	  screen	  to	  identify	  EET	  downstream	  signaling	  pathways.	  ISH,	  in	  situ	  hybridization.	  	  (B)	  PI3K	  inhibitors,	  LY294002	  (10µM)	  and	  Wortmannin	  (2µM)	  completely	  blocked	  EET-­‐induced	   induction	   of	   runx1	   in	   both	   AGM	   and	   tail,	   while	   MEK1/2	   inhibitor	  U0126	  (30µM)	  had	  no	  effect	  on	  runx1	  expression.	  (C)	  Inhibiting	  PI3K	  ,	  not	  MEK1/2,	  completely	  blocked	  EET-­‐induced	  AP-­‐1	  expression.	  	  (D)	   Inhibiting	   MEK1/2,	   not	   PI3K,	   completely	   blocked	   EET-­‐induced	   cholesterol	  metabolism	  gene	  expression.	  	  







Figure	  3.10	  EETs	  induce	  PI3K	  activation	  and	  AP-­‐1	  transcription	  cell-­‐
autonomously.	  	  (A)	  EET	  activated	  PI3K	  autonomously	   in	  human	  mobilized	  CD34+	  HSPCs.	  Western	  blotting	  for	  phosphorylated	  AKT	  as	  an	  indicator	  of	  PI3K	  activation.	  	  	  (B)	   EET	   induced	   the	   transcription	   of	   multiple	   AP-­‐1	   factors	   in	   human	   peripheral	  blood	  mobilized	  CD34+	  HSPCs.	  Inhibition	  of	  PI3K	  with	  10µM	  LY294002	  reduced	  the	  magnitude	  of	  EET-­‐induced	  AP-­‐1	  expression.	  	  	  (C)	  EET	  activated	  PI3K	  and	  MAPK	  pathways	  in	  a	  cell-­‐autonomous	  fashion	  in	  human	  leukemia	  cell	  line	  U937.	  (D)	  EET	  activated	  PI3K	  and	  MAPK	  pathways	  in	  a	  cell-­‐autonomous	  fashion	  in	  human	  immortalized	  endothelial	  cell	  line	  EAhy.	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Activation	  of	  PI3K	  in	  HSPCs	  Is	  Required	  for	  the	  Enhancement	  of	  Engraftment	  	  To	  test	  if	  the	  activation	  of	  these	  signaling	  pathways	  is	  autonomous	  to	  HSPCs,	  we	  performed	   western	   blot	   analysis	   on	   EET-­‐treated	   human	   mobilized	   CD34+	   HSPCs	  isolated	  from	  peripheral	  blood.	  EET	  quickly	  induced	  phosphorylation	  of	  AKT,	  as	  an	  indicator	  of	  PI3K	  activation	  (Figure	  3.10A).	  qRT-­‐PCR	  also	  confirmed	  that	  EET	  could	  induce	   multiple	   AP-­‐1	   members,	   especially	   the	   FOS	   family,	   in	   a	   PI3K-­‐dependent	  manner	   (Figure	   3.10B).	   Similarly,	   PI3K	   activation	   and	   ERK	   phosphorylation	  were	  also	   observed	   in	   human	   leukemia	   U937	   and	   immortalized	   endothelial	   EAhy	   cell	  lines	  treated	  with	  EET	  (Figure	  3.10C,	  D).	  	  We	   tested	   if	   PI3K	   activation	   is	   responsible	   for	   enhanced	   transplantation	  engraftment.	  Mouse	  WBM	  was	  pre-­‐incubated	  with	  LY294002	  for	  30	  min	  before	  the	  addition	  of	  11,12-­‐EET.	  We	   found	  LY294002	  blocked	  EET-­‐induced	  enhancement	  of	  long-­‐term	   multi-­‐lineage	   engraftment	   in	   mice	   (Figure	   3.11).	   The	   cell-­‐autonomous	  activation	  of	  PI3K	  is	  completely	  required	  for	  enhancing	  HSPC	  engraftment.	  	  To	  directly	  observe	  how	  EETs	  regulate	  HSPC	  behavior	  during	  engraftment,	  we	  studied	   HSPC	   engraftment	   during	   zebrafish	   embryo	   development.	   The	   process	   of	  HSPCs	  from	  AGM	  traveling	  to	  and	  engrafting	  CHT	  is	  comparable	  to	  the	  murine	  HSC	  trafficking	  from	  AGM	  to	  fetal	  liver	  (Murayama	  et	  al.,	  2006).	  	  We	  used	  the	  transgenic	  zebrafish	   described	   before	   (Runx1+23:EGFP,	   instead	   of	   Runx1+23:mCherry)	   to	  specifically	   label	   HSPCs	   (Tamplin	   et	   al,	   unpublished	   data).	   Endothelial	   cells	   were	  marked	  with	  kdrl:DsRed.	  The	  double	  transgenic	  embryos	  were	  treated	  with	  DMSO,	  11,12-­‐EET	   or	   LY294002	   between	   24-­‐48	   hpf.	   Chemicals	   were	   washed	   off	   and	   the	  embryos	  were	  imaged	  by	  time-­‐lapse	  confocal	  between	  54-­‐64	  hpf.	  At	  the	  beginning	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of	   imaging,	  which	  is	  54	  hpf,	  HSPCs	  have	  already	  started	  migrating	  out	  of	  AGM	  and	  engrafting	  CHT.	  DMSO	  or	  EET-­‐treated	  embryos	  had	  similar	  numbers	  of	  HSPCs	  that	  had	   already	   arrived	   at	   the	  CHT	   at	   this	   timepoint	   (Figure	   3.12A),	  while	   LY-­‐treated	  embryos	  had	  fewer	  engrafted	  cells	  (Figure	  3.13A).	  Over	  the	  next	  10	  hrs,	  the	  number	  of	   HSPCs	   in	   DMSO	   or	   LY-­‐treated	   embryos	   was	   relatively	   unchanged,	   while	   a	  significant	  accumulation	  of	  HSPCs	  was	  seen	  in	  EET-­‐treated	  embryos	  (Figure	  3.12A).	  Individual	  HSPCs	  were	   traced	   over	   time	   to	   observe	   their	   behavior.	   The	  migration	  routes	   of	   single	   cells	   were	   tracked	   using	   ImageJ	   (Figure	   3.12B).	   We	   found	   EET	  dramatically	  enhanced	  HSPC	  migration.	  On	  average,	  HSPCs	  in	  EET-­‐treated	  embryos	  migrated	  longer	  distance	  at	  a	  higher	  speed	  than	  in	  DMSO-­‐treated	  embryos	  (Figure	  3.12C,	  D).	  	  
	  
Figure	  3.11	  EETs	  enhance	  mouse	  engraftment	  in	  a	  PI3K-­‐dependent	  manner.	  	  
	  20,000	  CD45.1+	  WBM	  cells	  were	  pre-­‐incubated	  with	  DMSO	  or	  10µM	  LY294002	  for	  30	  min,	  before	  2µM	  11,12-­‐EET	  was	  added	  and	  incubated	  for	  4	  hrs.	  *	  Student's	  t	  test	  p	  values	  <	  0.05;	  n.s.,	  not	  significant.	  	  




Figure	  3.12	  EETs	  enhance	  engraftment	  by	  modulating	  HSPC	  migration.	  (A)	  Time-­‐lapse	  confocal	  imaging	  of	  HSPCs	  engrafting	  zebrafish	  embryo	  caudal	  CHT	  between	   54-­‐64hpf.	   HSPCs:	   Runx1+23:GFP;	   endothelial	   cells:	   kdrl:DsRed.	   Embryos	  were	  treated	  between	  24-­‐48hpf.	  White	  arrowheads	  point	  to	  HSPCs.	  	  (B)	  Tracking	  individual	  HSPC	  migration	  with	  ImageJ	  and	  MTrackJ.	  	  (C-­‐D)	  Quantification	  of	   average	  HSPC	   travel	  distance	   (C)	  and	  migration	   speed	   (D).	  ***	  Student’s	  t	  test	  p	  values<0.0005.	  






	   	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Figure	  3.13.	  PI3K	  activation	  regulates	  HSPC	  migration	  and	  interaction	  with	  
endothelial	  niche	  cells.	  	  	  (A)	  Time-­‐lapse	  confocal	  imaging	  of	  HSPCs	  engrafting	  zebrafish	  embryo	  caudal	  CHT	  between	   54-­‐64hpf.	   HSPCs:	   Runx1+23:GFP;	   endothelial	   cells:	   kdrl:DsRed.	   Embryos	  were	   treated	   between	   24-­‐48hpf.	   White	   arrowheads	   point	   to	   HSPCs.	   For	   DMSO-­‐treated	  control,	  see	  Figure	  3.12A.	  	  (B)(C)	  Timelapse	   imaging	   the	   individual	  HSPC	  behavior	  during	   the	  engraftment	  of	  CHT	  in	  zebrafish	  embryos	  treated	  with	  DMSO	  (B)	  or	  LY294002	  (C).	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Despite	   the	   increased	  migration,	   HSPCs	   in	   the	   EET	   group	  maintained	   a	   close	  contact	  with	   endothelial	   cells	   and	   did	   not	   show	   any	   higher	   tendency	   to	   leave	   the	  CHT.	   In	   EET-­‐treated	   embryos,	   there	   were	   more	   productive	   interactions	   between	  endothelial	   cells	   and	   HSPCs	   to	   form	   new	   niches,	   meaning	   more	   accumulated	  engraftment	   events.	   In	   contrast,	   in	   LY-­‐treated	   embryos,	   the	   circulation	   was	  relatively	   normal	   and	  GFP+	   HSPCs	   still	   travelled	   through	   CHT.	   	   The	  HSPCs	   rarely	  made	   successful	   contact	   with	   endothelial	   cells,	   which	   led	   to	   failed	   engraftment	  (Figure	  3.13C).	  EETs	  enhance	  engraftment	  by	   combined	  effects	  of	   enhanced	  HSPC	  migration	  and	  improved	  interactions	  with	  the	  niche	  in	  a	  PI3K-­‐dependent	  manner.	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Discussion	  The	   zebrafish	   whole	   kidney	   marrow	   (WKM)	   transplantation-­‐based	   chemical	  screening	   identified	   new	   chemicals/pathways	   regulating	   marrow	   engraftment,	  including	   a	   novel	   group	   of	   chemicals,	   epoxyeicosatrienoic	   acids	   (EETs).	   EETs	  enhanced	   marrow	   engraftment	   after	   transplantation	   in	   zebrafish	   and	   promoted	  both	   short-­‐	   and	   long-­‐term	   engraftment	   in	   mice	   in	   a	   PI3K-­‐depdent	   manner.	   The	  source	  of	  EETs	  in	  the	  marrow	  could	  involve	  endothelial	  cell	  expression,	  as	  has	  been	  previously	   shown	   (Pfister	   et	   al,	   2010).	   	   A	   gene	   expression	   study	   reported	  mouse	  
Cyp2j6,	  a	  cytochrome	  P450	  epoxygenase,	  is	  one	  of	  the	  93	  genes	  enriched	  in	  normal	  HSCs,	   in	   comparison	   to	  mobilized	  HSCs,	   leukemic	   HSCs	   and	   normal	  MPPs	   (multi-­‐potent	  progenitors)	  (Forsberg	  et	  al.,	  2010).	  Our	  studies	  establish	  a	  role	  of	  EETs	   in	  regulating	  HSPC	  migration	  and	  interaction	  with	  niche	  cells.	  	  
EETs	  Alter	  the	  Cellular	  Behavior	  of	  HSPCs	  During	  Engraftment	  By	  directly	  tracking	  the	  behavior	  of	  individual	  HSPC	  engrafting	  CHT,	  we	  found	  EETs	   dramatically	   enhanced	   HSPC	   migration	   and	   modulate	   adhesion	   properties	  (Figure	  3.12).	  After	  crossing	  the	  endothelial	  barrier,	  instead	  of	  staying	  locally	  where	  they	  extravasated,	  a	  higher	  percentage	  of	  HSPCs	   in	  EET-­‐treated	  embryos	  migrated	  away	  from	  the	  initial	  niche	  and	  then	  initiated	  new	  niche	  formation.	  The	  empty	  niche	  was	  then	  available	  for	  HSPC	  engraftment.	  This	  suggests	  that	  there	  is	  specific	  signal	  exchange	  between	  the	  migrating	  HSPC	  and	  endothelial	  cells	  in	  the	  niche,	  involving	  a	  fine	   balance	   between	   migration	   and	   adhesion.	   Pre-­‐treatment	   of	   marrow	   cells	   or	  whole	   zebrafish	   embryos	   with	   EETs	  might	   modulate	   the	   migratory	   and	   adhesive	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properties	  of	  HSPCs	  in	  a	  PI3K-­‐dependent	  manner.	  PI3K	  and	  one	  of	  its	  downstream	  effectors,	   AKT,	   are	   required	   for	   migration	   and	   adhesion	   of	   many	   cell	   types.	   Two	  recent	   studies	   indicated	   a	   negative	   role	   of	   AKT	   in	   regulating	   HSC	   homing	   and	  engraftment	   (Buitenhuis	   et	   al.,	   2010;	   Kharas	   et	   al.,	   2010).	   In	   our	   studies,	   when	  hematopoietic	  or	  endothelial	  cells	  were	  pre-­‐treated	  with	  EETs,	  PI3K	  activation	  only	  lead	  to	  a	  transient	  phosphorylation	  of	  AKT	  (Figure	  3.10).	  This	  is	  distinct	  from	  over-­‐expressing	  a	  constitutively	  active	  form	  of	  AKT	  (Buitenhuis	  et	  al.,	  2010;	  Kharas	  et	  al.,	  2010).	   In	   contrast	   to	   24	   hr	   inhibition	   of	   AKT	   in	   those	   studies,	  we	   did	   not	   see	   an	  increase	  of	  engraftment	  with	  short-­‐term	  incubation	  with	  PI3K	  inhibitor,	  LY294002	  (Figure	  3.11).	  This	  could	  be	  due	  to	  the	  different	  inhibitors	  used	  and	  the	  duration	  of	  inhibition,	   thereby	   differentially	   affecting	   the	   fine	   balance	   between	  migration	   and	  adhesion.	  	  	  One	   caveat	   with	   the	   experiments	   in	   embryos	   is	   that	   the	   whole	   embryo	   is	  immersed	   in	   EETs.	   Establishing	   cell-­‐autonomous	   effects	   can	   be	   difficult.	   In	   the	  mouse	   transgenic	   experiments,	   the	   Tg(Tie2:CYP2C8)	   mouse	   donor	   marrows	   can	  secrete	   higher	   level	   of	   EETs.	   HSPCs	   and	   niche	   cells	   might	   each	   receive	   high	   EET	  signals.	   It	   has	   been	   reported	   that	   constitutive	   Akt	   activation	   in	   endothelial	   cells	  caused	  HSPC	  expansion	  (Kobayashi	  et	  al.,	  2010).	  Nevertheless,	   the	   transplantation	  experiments	  with	   transient	   EET	   exposure	   demonstrate	   a	   cell	   autonomous	   role	   of	  EETs	  on	  blood	  cells.	  	  
Regulation	  of	  runx1	  Transcription	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In	   the	  process	  of	  pursuing	   the	  molecular	  mechanism	  of	  EET	  effects,	  we	   found	  EET-­‐induced	   PI3K	   activation	   also	   led	   to	   increased	   transcription	   of	   the	   stem	   cell	  marker,	  runx1,	  in	  zebrafish	  embryos.	  As	  a	  HSC	  marker	  in	  embryo	  development,	  the	  transcription	   of	  Runx1	   requires	   hematopoietic	  master	   regulators,	   such	   as	   Scl	   and	  Gata2	   (Nottingham	   et	   al.,	   2007).	   	  Meanwhile,	  Runx1	   is	   also	   expressed	   in	  multiple	  non-­‐hematopoietic	   progenitor	   cells,	   such	   as	   hair	   follicle	   stem	   cells	   and	   cardiac	  muscle	  progenitors	  (Hoi	  et	  al.,	  2010;	  Kubin	  et	  al.,	  2011;	  Osorio	  et	  al.,	  2008;	  Osorio	  et	  al.,	  2011).	  The	  transcriptional	  regulation	  of	  Runx1	   in	  these	  non-­‐hematopoietic	  cells	  has	  not	  been	  well	  understood.	  EETs	  induced	  runx1	  in	  both	  hematopoietic	  and	  non-­‐hematopoietic	   progenitor	   cells	   in	   zebrafish	   embryos,	   arguing	   for	   a	   general	  transcriptional	  regulatory	  mechanism	  of	  runx1.	  Consistent	  with	  the	  hypothesis,	  the	  requirement	  of	  AP-­‐1	  for	  runx1	  induction	  was	  genetically	  established	  (Figure	  3.6).	  In	  agreement	  with	  our	  finding,	  another	  group	  independently	  discovered	  FOSL2/RUNX1	  are	   part	   of	   the	   transcriptional	   module	   for	   mesenchymal	   transformation	   of	  glioblastoma	  through	  bioinformatics	  analysis	  (Carro	  et	  al.,	  2010).	  The	  ChIP-­‐Seq	  data	  showed	  binding	  of	  AP-­‐1	  to	  both	  promoter	  and	  multiple	  enhancer	  regions	  of	  RUNX1	  in	   human	   K562	   cells	   (Figure	   3.7).	   The	   binding	   sites	   in	   the	   promoter	   regions,	  especially	  P2,	  are	  evolutionarily	  conserved	  and	  co-­‐bound	  by	  RNA	  POLII	  (Figure	  3.7).	  RNA-­‐Seq	   data	   showed	   the	   short	   transcript	   initiated	   from	   the	   P2	   promoter	   is	   the	  dominant	  isoform	  in	  K562	  cells,	  which	  is	  different	  from	  what	  has	  been	  reported	  in	  human	  HSCs	  (Challen	  and	  Goodell,	  2010).	  The	  AP-­‐1-­‐bound	  regions	  were	  also	  labeled	  with	  active	  marks,	   such	  as	  H3K4me	  and	  H3K27ac	   (Figure	  3.7).	  This	   supports	   that	  AP-­‐1	  could	  activate	  runx1	  transcription	  directly.	  A	  suggestion	  of	  co-­‐operation	  with	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hematopoietic	   master	   regulators	   was	   found	   based	   on	   conserved	   sites	   in	   the	   first	  intron	  region,	  where	  AP-­‐1	  colocalizes	  with	  GATA1/2	  (e1,	  e4	  in	  Figure	  3.7).	  This	  co-­‐operation	   has	   also	   been	   indicated	   in	   human	   umbilical	   vein	   endothelial	   cells	  (Linnemann	   et	   al.,	   2011).	   Some	   AP-­‐1-­‐bound	   regions	   were	   also	   found	   devoid	   of	  GATA1/2	   (e2,	   e3	   in	   Figure	   3.7).	   The	   versatile	   binding	   capabilities	   enable	   AP-­‐1	   to	  regulate	  RUNX1	   expression	   in	   different	   cell	   types,	   in	   collaboration	  with	   cell	   type-­‐specific	  master	  transcription	  factors.	  	  EETs	  also	  induce	  AP-­‐1	  in	  HSPCs	  in	  vitro.	  It	  is	  possible	  that	  AP-­‐1	  is	  also	  required	  for	  engraftment,	  although	  we	  did	  not	  formally	  test	  this	  hypothesis.	  In	  contrast	  to	  AP-­‐1,	  the	  increase	  of	  runx1	  transcription	  was	  only	  observed	  in	  embryos.	  	  This	  suggests	  that	  AP-­‐1	  is	  not	  sufficient	  to	  induce	  runx1	  expression	  by	  itself,	  and	  runx1	  induction	  in	   the	   adult	  marrow	   is	   not	   required	   for	   engraftment.	   	   In	   support	   of	   this,	  Mx-­‐Cre-­‐mediated	   Runx1	   inactivation	   in	   adult	   murine	   HSCs	   does	   not	   affect	   stem	   cell	  maintenance	   (Ichikawa	   et	   al.,	   2004).	   The	   enhanced	   engraftment	   by	   EETs	   is	   likely	  through	  other	  pathways	  downstream	  of	  PI3K	  activation.	  	  
Direct	  target	  of	  EETs	  Despite	   the	  potent	  biological	  effects,	   the	  receptor(s)	   for	  EETs	  are	  unknown.	   It	  has	   long	   been	   proposed	   that	   EETs	   bind	   to	   a	   GPCR	   (G-­‐protein	   coupled	   receptor)	  (Chen	   et	   al.,	   2011;	   Node	   et	   al.,	   2001;	   Yang	   et	   al.,	   2008).	   	   For	   the	   first	   time	   we	  provided	  genetic	  evidence	  showing	  Gα12/13	  is	  required	  for	  EET	  effects,	  supporting	  the	   GPCR	   hypothesis.	   The	   12/13	   family	   Gα	   subunits	   have	   been	   shown	   to	   play	   an	  important	   role	   in	   regulating	   cell	   migration	   during	   embryonic	   vasculogenesis	   and	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cancer	   invasion	   (Kelly	   et	   al.,	   2006;	   Offermanns	   et	   al.,	   1997).	   In	   addition	   to	   our	  finding	  that	  EETs	  modulate	  HSPC	  migration	  behavior	  (Figure	  3.12),	  it	  has	  also	  been	  reported	  that	  EETs	  promote	  angiogenesis	  and	  cancer	  cell	  motility	  (Jiang	  et	  al.,	  2007;	  Michaelis	  et	  al.,	  2005;	  Nithipatikom	  et	  al.,	  2010;	  Panigrahy	  et	  al.,	  2011a).	  The	  similar	  cellular	   aspects	   regulated	   by	   Gα12/13	   and	   EETs	   further	   indicate	   that	   signaling	  through	  the	  EET	  receptor	  is	  mediated	  by	  Gα12/13,	  although	  other	  Ga	  subunits	  may	  be	  used	  also.	  	  The	   effects	   of	   EET	   on	   HSPCs	   may	   be	   therapeutically	   useful.	   During	   marrow	  transplant,	   HSPC	   chimerism	   over	   time	   is	   critical,	   and	   the	   time	   to	   adequate	  neutrophil	  engraftment	  is	  an	  important	  milestone	  for	  treatment	  success.	  EET	  seems	  to	  also	  have	  a	  prominent	  effect	  on	  progenitor	  engraftment,	  as	  shown	  by	   increased	  chimerism	  early	  after	  transplantation.	  Previously	  it	  was	  found	  dmPGE2,	  or	  dmPGE2	  in	   combination	  with	  Wnt	   activator	   (BIO),	   increased	   the	   engraftment	   rate	   in	   bone	  marrow	   competitive	   transplantation	   at	   a	   limited	   donor	   cell	   dose	   (Goessling	   et	   al.,	  2009;	   North	   et	   al.,	   2007).	   Both	   PGE2	   and	   EETs	   are	   arachidonic	   acid-­‐derived	  eicosanoids.	  These	  small	   lipids	  are	   locally	  derived	  near	  wounds,	  and	  may	  facilitate	  progenitor	   recruitment,	   engraftment,	   and	   proliferation.	   	   Despite	   their	   common	  origin,	  the	  underlying	  molecular	  mechanism	  and	  cell	  biology	  are	  different.	  dmPGE2	  modulates	  both	  homing	  and	  HSPC	  numbers	  via	  cAMP	  pathway,	  while	  EETs	  have	  a	  more	   dramatic	   effect	   on	   cell	   migration	   and	   adhesion	   through	   PI3K	   activation.	  Because	  of	  the	  different	  and	  complimentary	  effects	  of	  dmPGE2	  and	  EETs,	  treatment	  of	  HSPCs	  with	   both	   PGE2	   and	   EETs	  might	   lead	   to	   faster	   and	   safer	   engraftment	   in	  patients.	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Material	  and	  Methods	  
	  
Zebrafish	  strains	  and	  husbandry	  Zebrafish	  were	  maintained	   in	   accordance	  with	  Animal	  Research	  Guidelines	   at	  Children's	   Hospital	   Boston.	   The	   following	   transgenic	   zebrafish	   were	   used	   in	   the	  study:	   RedGlo®	   zebrafish,	   Tg(β-­‐actin:GFP),	   casper,	   Tg(kdrl:DsRed2),	  Tg(Runx1+23:mCherry)	   and	   Tg(Runx1+23:GFP).	   RedGlo®	   zebrafish	   was	   purchased	  from	   5D	   Tropical	   and	   authorized	   for	   research	   use	   (Blake,	   2010).	   DsRed2	   is	  overexpressed	   under	   the	  mlc	   (myosin	   light	   chain)	   and	   β-­‐actin	   promoters.	   Tg(β-­‐
actin:GFP),	  casper	  and	  Tg(kdrl:DsRed2)	   lines	  were	  previously	  described	  (Kikuchi	  et	  al.,	   2011;	  White	   et	   al.,	   2008).	  Tg(Runx1+23:mCherry)	   and	  Tg(Runx1+23:GFP)	  were	  constructed	   and	   provided	   by	   Owen	   J.	   Tamplin	   (unpublished	   data).	   The	   +23	  enhancer	  region	  of	  mouse	  Runx1	  was	  used	  to	  drive	  HSPC-­‐specific	  expression	  (Bee	  et	  al.,	  2009).	  
	  
Zebrafish	  embryo	  morpholino	  and	  mRNA	  injection	  Morpholinos	   were	   obtained	   from	   Gene	   Tools,	   LLC.	   Morpholinos	   and	   mRNA	  were	   injected	   into	   one	   to	   two	   cell-­‐stage	   embryos.	   See	   Table	   3.4	   for	   morpholino	  sequences.	  All	  of	  the	  morpholinos	  used	  in	  the	  study	  target	  the	  translation	  initiation	  site	  (ATG).	  All	  of	  the	  morpholinos	  were	  tested	  at	  2,	  4,	  and	  6	  ng	  to	  decide	  the	  effective	  dosage.	  	  There	   are	   5	   types	   of	   Gα	   subunits	   and	   16	   functional	   gna	   loci	   in	   human.	   In	  zebrafish,	   they	   are	  Gαs	   (gnas,	   gnal),	   Gαi	   (gnai1,	   gnai2,	   gnai2l,	   gnai3,	   gnaia,	   gnat1,	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gnat2,	   gnao1a,	   gnao1b,	   gnaz),	   Gαq/11	   (gnaq,	   gna11,	   gna14,	   gna14a),	   Gα12/13	  
(gna12,	   gna12l,	   gna13a,	   gna13b),	   and	   Gαv	   (gnav).	   To	   block	   different	   types	   of	   Gα	  subunits	   individually	   in	   zebrafish	   embryos,	   different	   approaches	   were	   used.	   To	  inhibit	  Gαi	  in	  general,	  PtxA	  (Pertussis	  toxin	  A)	  mRNA	  was	  in	  vitro	  transcribed	  with	  SP6	   and	   injected	   into	   1-­‐cell	   stage	   zebrafish	   embryo	   at	   3	   pg/embryo	   with	  morphological	  defects	  but	  no	  general	  toxicity	  (Addgene,	  Plasmid	  16678)	  (Slusarski	  et	   al.,	   1997).	   To	   inhibit	   Gαq	   and	   Gα12/13,	  morpholinos	  were	   designed	   to	   inhibit	  each	  one	  (Table	  3.4).	  	  	  
Table	  3.4	  Zebrafish	  Morpholino	  Sequences	  
Gene	   Ref	  Seq	   MO	  sequence	  (5’à3’)	   Reference	  
junb	   NM_213556	   CGGTTGCTCCATTTTTGTTGACATG	   (Meder	  et	  al.,	  2010)	  
fosl2	   NM_001082998	   ATGTCCCGGTGTAATCCTGGTACAT	   Gene	  Tools	  
c-­‐jun	   NM_199987	   TTCCATCTTGGTAGACATAGAAGGC	   Gene	  Tools	  
c-­‐fos	   NM_205569	   CGGCGTTAAGGCTGGTAAACATCAT	   Gene	  Tools	  
gna12	   NM_001013277	   CGCACCACGCCAGCCATCCTGTCCA	   (Lin	  et	  al.,	  2005)	  
gna13a	   NM_001012243	   AAATCCGCCATCTTTGTAGTAGCGA	   (Lin	  et	  al.,	  2005)	  
gna13b	   NM_001013263	   AGGAAATACGCCATCTTTGTGCAAC	   (Lin	  et	  al.,	  2005)	  
gna15/16	   NM_001003626	  	   TGTAGCACCATCTCCAGCAGCCCAT	   Gene	  Tools	  
gnaq	   NM_001144799	  	   CATGATTCTCCCTGTCACTTCACAA	   Gene	  Tools	  
gna11	   NM_001007773	  	   AGGCCATCATCGACTCTAAAGTCAT	   Gene	  Tools	  
gna14	   NM_001003753	  	   CGCCTGATAAACAGCACTCCTCCAT	   Gene	  Tools	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Screen	  and	  chemical	  treatment	  	  Adult	   zebrafish	   transplantation-­‐based	   chemical	   screen	   was	   done	   at	   the	   hESC	  core	   at	   Children’s	   Hospital	   Boston.	   The	   ICCB	   Known	   Bioactive	   Library	   was	  purchased	   from	  BIOMOL	   (Enzo	   Life	   Sciences).	  WKM	   (Whole	   kidney	  marrow)	  was	  incubated	  in	  0.9xDPBS	  plus	  5%	  heat-­‐inactivated	  FBS	  for	  4	  hrs	  at	  room	  temperature,	  at	  a	  density	  of	  1000	  cells/µl.	  Chemicals	  were	  diluted	  at	  a	  1:200	  ratio.	  All	  the	  embryo	  treatment	  with	  11,12-­‐EET	   started	   at	   24	  hpf.	   The	   suppressors	  were	   added	  30	  min	  prior	  to	  EET.	  0.5µM	  11,12-­‐EET	  and	  14,15-­‐EET	  were	  used	  for	  zebrafish	  whole	  kidney	  marrow	   treatment;	   2 µM	   11,12-­‐EET	   for	   mouse	   bone	   marrow	   treatment;	   5 µM	  11,12-­‐EET	  for	  zebrafish	  embryo	  treatment.	  	  Chemicals	   used	   for	   the	   secondary	   round	   of	   screening	   for	   confirmation	   were	  from	   a	   different	   aliquot	   of	   the	   library,	   independent	   of	   the	   primary	   screen	   plate.	  11,12-­‐EET	   (Cayman	   Chemical,	   Cat.	   #	   50511)	   was	   resuspended	   in	   DMSO	   with	  original	   organic	   solvent	   evaporated.	   The	   following	   chemicals	   were	   used	   for	  zebrafish	   marrow	   treatment:	   dmPGE2	   (Cayman,	   #14750),	   10 µM;	   BIO	   (EMD),	  0.5 µM.	  For	  the	  chemical	  suppressor	  screen,	  zebrafish	  embryos	  were	  incubated	  with	  inhibitors	   at	   three	   different	   concentrations.	   The	   highest	   effective	   concentration	  without	  causing	  general	  toxicity	  is	  listed	  below.	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Table	  3.5	  	  Chemicals	  for	  Suppressor	  Screen	  in	  Zebrafish	  Embryos	  
Chemical	  Name	   Source	   Highest	  Concentration	   Pathway	  SB	  203580	   Tocris	   100 µM	   p38	  PD98059	   Calbiochem	   50 µM	   MEK1	  U0126	   Tocris	   30 µM	   MEK1/2	  GW5074	   Tocris	   50 µM	   C-­‐RAF	  LY294002	   Sigma	   10 µM	   PI3K	  wortmannin	   Sigma	   1	  µM	   PI3K	  AKT	  PI-­‐103	   Cayman	   10 µM	   PI3K	  rapamycin	   Enzo	  Life	  Sciences	   50 µM	   mTOR	  H89	   Sigma	   5 µM	   PKA	  SQ22536	   Sigma	   100 µM	   Adenylate	  Cyclase	  GW9662	   Cayman	  Chemicals	   5 µM	   PPARg	  antagonist	  BADGE	   Tocris	   10 µM	   PPARg	  antagonist	  PP2	   Sigma	   10	  µM	   SRC	  Tyrphostin	  AG1478	   Sigma	   30	  µM	   EGFR	  GM6001	   Enzo	  Life	  Sciences	   25 µM	   MMP	  SU	  5402	   Tocris	   30 µM	   FGF/VEGF	  Indomethacin	   Sigma	   20 µM	   COX	  L-­‐NAME	   Sigma	   10 µM	   NOS	  SU1498	   EMD	   50 µM	   VEGF	  NSC	  23766	   Tocris	   50 µM	   RAC	  SP600125	   Tocris	   40 µM	   JNK	  
	  
	  
Adult	  zebrafish	  WKM	  competitive	  transplantation	  Adult	   zebrafish	   kidney	   marrow	   was	   dissected,	   processed	   into	   single-­‐cell	  suspension	  and	  injected	  retro-­‐orbitally.	  Recipients	  at	  4	  wpt	  (week	  post	  transplant)	  were	   anesthetized	   with	   0.2%	   Tricaine	   in	   fish	   water	   and	   imaged	   using	   a	   Zeiss	  Discovery	   V8	   fluorescence	   stereomicroscope	   with	   GFP/RFP	   filters.	   Images	   were	  analyzed	  with	  ImageJ.	  For	  detailed	  description,	  see	  Chapter	  2.	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Imaging	  acquisition	  and	  quantification	  in	  zebrafish	  embryos	  For	   live	   imaging	  of	  embryos,	  zebrafish	  embryos	  were	  embedded	  in	  agarose	  as	  described	   before	   (Bertrand	   et	   al.,	   2010).	   Single-­‐frame	   image	   or	   time-­‐lapse	  Movie	  was	   taken	   on	   a	   spinning	   disk	   confocal	   microscope	   with	   an	   incubation	   chamber.	  Images	  were	   taken	   every	  2	  minutes.	   Images	  were	  processed	   and	  quantified	  using	  Fluorender	  and	  ImageJ.	  To	  track	  the	  cell	  migration	  routes,	  MTrackJ	  plugin	  was	  used	  together	  with	  ImageJ	  (Meijering	  et	  al.,	  2009).	  The	  number	  of	  pixels	  along	  the	  track	  measures	  the	  total	  travel	  distance.	  The	  average	  migration	  speed	  is	  calculated	  by	  the	  ratio	  between	  total	  travel	  distance	  and	  travel	  time.	  	  
Mouse	  bone	  marrow	  transplantation	  and	  chimerism	  analysis	  All	   mice	   were	   maintained	   according	   to	   IACUC	   approved	   protocols	   in	   accordance	  with	  Children's	  Hospital	  Boston	  animal	  research	  guidelines.	  9-­‐week-­‐old	  CD45.1	  and	  CD45.2	   (C57/BL6)	   mice	   were	   purchased	   from	   Jackson	   laboratories.	   14-­‐week-­‐old	  Tg(Tie2:CYP2C8)	  mice	  in	  the	  CD45.2	  (C57/BL6)	  background	  and	  wild	  type	  siblings	  were	  provided	  by	  C.	  R.	  Lee	  and	  	  D.	  C.	  Zeldin	  (Lee	  et	  al.,	  2010).	  All	  recipients	  received	  an	   11Gy	   split	   dose	   of	   γ-­‐irradiation	   prior	   to	   transplantation.	   For	   the	   chemical	  treatment,	   20,000	  CD45.1	  WBM	  cells	  were	   treated	   at	   room	   temperature	   for	  4	  hrs	  with	  2 µM	  11,12-­‐EET	  and/or	  10µM	  LY294002.	   Chemicals	  were	  washed	  off	   before	  cells	  were	   retro-­‐orbitally	   injected	  with	  200,000	   fresh	  CD45.1/2	  mouse	  WBM	  cells	  into	   CD45.2	   recipients.	   Each	   treatment	   condition	   included	   8-­‐10	   recipients	   per	  experiment	  with	  2	  biological	  repeats.	  In	  the	  limiting	  dilution	  competitive	  transplant,	  30,000	  or	  60,000	  CD45.2	  wild	  type	  or	  transgenic	  WBM	  were	  injected	  with	  300,000	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CD45.1	  WBM	   into	   CD45.1/2	   recipients	   (n=7).	   Peripheral	   blood	   was	   stained	   with	  lineage-­‐specific	   antibodies	   and	   analyzed	   every	   four	   weeks	   on	   LSRII	   (BD	  Biosciences)	  to	  assess	  engraftment.	  The	  following	  antibodies	  were	  used:	  Gr1	  (RB6-­‐8C5),	   Mac1	   (M1/70),	   B220	   (RA3-­‐B2),	   CD3	   (145-­‐2C11),	   and	   Ter119	   from	  eBioscience;	  CD45.1	  and	  CD45.2	  from	  BD	  Biosciences.	  Animals	  with	  1%	  chimerism	  in	  myeloid,	  T,	  and	  B	  cell	  lineages	  were	  considered	  to	  have	  multilineage	  engraftment.	  	  	  
Mouse	  bone	  marrow	  analysis	  	  FACS	   analysis	   was	   performed	   on	   the	   mouse	   whole	   bone	   marrow	   with	   the	  following	  antibody	  staining:	  Sca-­‐1(E13-­‐161.7),	  CD48	  (HM48-­‐1),	  FcgR	   (2.4G2),	  CD4	  (GK1.5),	   CD8	   (53-­‐6.7),	   and	   Ter119	   from	   BD	   Biosciences;	   c-­‐Kit	   (2B8),	   and	   CD34	  (RAM34)	  from	  eBioscience;	  CD150	  (TC15-­‐12F12.2)	  from	  Biolegend;	  Mac1,	  Gr1	  and	  B220	  from	  Invitrogen;	  Goat-­‐anti-­‐Rat	  IgG	  PE-­‐TexRed	  from	  SouthernBiotech.	  	  
	  
Mouse	  peripheral	  blood	  CBC	  and	  chimerism	  analysis	  
	   Tg(Tie2:CYP2C8)	   or	   wild-­‐type	   sibling	   mice	   were	   bled.	   Complete	   blood	   count	  (CBC)	  was	  performed	  on	  HEMAVET	  HV950	  (Drew	  Scientific,	  Inc).	  	  
	  
Cell	  culture	  	  	   U937	  (ATCC,	  CRL-­‐1593.2)	  was	  cultured	  in	  RPMI	  media	  supplemented	  with	  10%	  FBS,	  100	  U/mL	  penicillin	  and	  100µg/mL	  streptomycin.	  EA.hy926	  (ATCC,	  CRL-­‐2922)	  supplemented	  with	  10%	  FBS	  and	  1xHAT	   supplement	   (Gibco).	   Cells	  were	   split	   2-­‐3	  times	  per	  week.	  Before	  chemical	  treatment,	  cells	  were	  serum	  starved	  for	  12-­‐16	  hrs.	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Human	   CD34+	   cells,	   isolated	   from	   the	   peripheral	   blood	   of	   granulocyte	   colony-­‐stimulating	  factor	  mobilized	  healthy	  volunteers,	  were	  obtained	  from	  the	  Yale	  Center	  of	  Excellence	  in	  Molecular	  Hematology.	  The	  frozen	  cells	  were	  thawed	  and	  expanded	  in	   StemSpan	   medium	   (Stem	   Cell	   Technologies	   Inc.)	   with	   1×	   CC100	   cytokine	   mix	  (Stem	  Cell	  Technologies	  Inc.),	  200	  U/mL	  penicillin	  and	  200µg/mL	  streptomycin	  for	  6	  days.	  Cells	  were	  stained	  and	  analyzed	  for	  CD34,	  CD38	  and	  CD133	  surface	  marker	  expression	   before	   use.	   For	   the	   in	   vitro	   stimulation,	   expanded	   CD34+	   cells	   were	  starved	  with	   StemSpan	  medium	  without	   cytokines	   for	   1	   hr,	   and	   the	   treated	  with	  2 µM	  11,12-­‐EET.	  PI3K	  inhibitor,	  LY294002,	  was	  added	  30	  min	  before	  EET.	  	  
	  
Western	  blotting	  	   Cell	  lysates	  were	  prepared	  with	  1x	  RIPA	  buffer	  (Thermo	  Scientific)	  and	  applied	  for	  western	  with	  the	  following	  antibodies	  from	  Cell	  Signaling	  Technology:	  phospho-­‐Akt	   (S437)	   (D9E),	   pan	   Akt	   (C67E7),	   phospho-­‐p44/42	   MAPK	   (Erk1/2)	  (Thr202/Tyr204)	  (D13.14.4E),	  phospho-­‐MEK1/2	  (Ser217/221)	  (41G9);	  and	  β-­‐Actin	  (Invitrogen).	  
	  
qRT-­‐PCR	  Total	  RNA	  was	  extracted	  with	  Trizol/Chloroform.	  cDNA	  was	  made	  with	  reverse	  transcription	   (SuperScript	   III	   Reverse	   Transcriptase	   Kit,	   Invitrogen).	   qPCR	   was	  performed	  on	  BioRad	  C1000	  Real-­‐Time	  Machine	  (384-­‐well).	  Primers	  were	  designed	  by	  qPrimerDepot	  (http://primerdepot.nci.nih.gov/)	  and	  verified.	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Table	  3.6	  Primers	  for	  qPCR	  with	  Human	  Cells	  
GENE	   REF	  SEQ	   FORWARD	  (5'-­‐-­‐>3')	   REVERSE	  (5'-­‐-­‐>3')	  
GAPDH	   NM_002046	   AAGGTGAAGGTCGGAGTCAA	   AATGAAGGGGTCATTGATGG	  
JUNB	   NM_002229	   GAACAGCCCTTCTACCACGA	   AGGCTCGGTTTCAGGAGTTT	  
FOSL2	   NM_005253	   TTATCCCGGGAACTTTGACA	   TGAGCCAGGCATATCTACCC	  
FOS	   NM_005252	   CTACCACTCACCCGCAGACT	   GTGGGAATGAAGTTGGCACT	  
FOSB	   NM_006732	   ACCCTCTGCCGAGTCTCAAT	   GAAGGAACCGGGCATTTC	  
JUN	   NM_002228	   GAGGGGGTTACAAACTGCAA	   TCTCACAAACCTCCCTCCTG	  	  
Genome-­‐wide	  expression	  analysis	  	   Total	  RNA	  was	  extracted	  from	  36hpf	  zebrafish	  embryos	  treated	  with	  DMSO	  or	  5uM	   11,12-­‐EET	   between	   24-­‐36hpf,	   with	   3	   biological	   replicates	   each.	   Microarray	  hybridization	   was	   performed	   with	   the	   Affymetrix	   GeneChip	   Zebrafish	   Genome	  Array.	  Hybridized	  microarray	  was	  background-­‐corrected,	  normalized	  and	  multiple-­‐tested	   using	   Goldenspike	   (http://www2.ccr.buffalo.edu/halfon/spike/)	   in	  R/Bioconductor	  (Choe	  et	  al,	  2005).	  Genes	  with	  q<0.1	  by	  SNR	  test	  were	  considered	  differentially	  expressed.	  	  	  
Statistics	  	  The	   correlation	   between	   image-­‐	   and	   FACS-­‐based	   analysis	   was	   simulated	   by	  linear	  regression.	  Limiting	  dilution	  competitive	  transplantation	  data	  were	  analyzed	  ELDA	  (Hu	  and	  Smyth,	  2009).	  The	  rest	  of	  the	  statistics	  were	  done	  with	  student	  t-­‐test.	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Concluding	  Discussion	  In	   the	   work	   described	   in	   this	   thesis,	   we	   developed	   a	   competitive	   marrow	  transplantation	   assay	   in	   adult	   zebrafish,	   which	   allows	   quick	   visualization	   and	  quantification	  of	  marrow	  engraftment	  capabilities	  in	  vivo.	  Using	  this	  assay,	  the	  first	  transplantation-­‐based	   chemical	   screen	   was	   performed	   with	   a	   known-­‐bioactive	  chemical	  library.	  The	  screen	  led	  to	  the	  discovery	  of	  ten	  chemicals	  involved	  in	  several	  novel	  pathways	   that	  can	  enhance	  marrow	  engraftment.	  One	  example	   is	  a	  group	  of	  arachidonic	   acid-­‐derived	   lipids,	   epoxyeicosatrienoic	   acids	   (EETs).	   EETs	   can	   also	  promote	  both	  short-­‐term	  and	  long-­‐term	  marrow	  engraftment	  in	  mice.	  Using	  genetic	  knockdown	  and	  chemical	  suppressor	  screening	  in	  zebrafish	  embryos,	  we	  found	  that	  EET	  acts	  through	  a	  Gα12/13-­‐mediated	  receptor,	  which	  activates	  PI3K	  and	  induces	  transcription	   factors	  of	   the	  AP-­‐1	   family.	  This	  PI3K/AP-­‐1	  pathway	  directly	   induced	  the	  transcription	  of	  HSC	  marker,	  runx1,	  in	  embryos.	  The	  activation	  of	  PI3K	  by	  EET	  is	  required	   for	   promoting	   HSPC	   migration	   and	   interactions	   with	   niche	   cells,	   and	  therefore	   engraftment.	   In	   addition	   to	   the	   blood	   phenotype,	   EET	   also	   caused	   cell	  morphological	   and	   gene	   expression	   changes	   in	   the	   tail	   bud	   of	   zebrafish	   embryos.	  	  The	   signaling	   and	   transcription	   regulatory	   network	   indicate	   these	   changes	   share	  some	  similarities	  with	  epithelial	  mesenchymal	  transition	  (EMT).	  These	  findings	  may	  help	   explain	   the	   previously	   reported	   observation	   that	   EETs	   can	   promote	   tumor	  metastasis	  and	  angiogenesis.	  	  Our	   studies	   define	   a	   role	   for	   EETs	   in	   the	   engraftment	   of	   HSCs	   in	   adult	  vertebrates,	  and	  HSC	  development	  during	  embryogenesis.	  The	  chemical	  screen	  also	  identified	   additional	   pathways	   important	   for	   regulating	   HSC	   engraftment.	   These	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discoveries	  may	  have	  clinical	  application	  in	  marrow	  or	  cord	  blood	  transplantation,	  may	   help	   elucidate	   basic	   regulatory	   mechanisms	   of	   stem	   cell	   engraftment,	   and	  encourage	  the	  use	  of	  chemical	  screening	  approaches	  to	  study	  complicated	  biological	  processes.	  	  	  	  
Engraftment	  Rejection	  and	  Zebrafish	  Immunology	  	  The	  immune	  system	  protects	  organisms	  from	  foreign,	  “non-­‐self”	  insults	  such	  as	  bacteria,	   parasites,	   and	   viruses;	   therefore,	   it	   also	   creates	   a	   barrier	   for	   allogeneic	  transplantation.	   In	   human	   patients,	   a	   myeloablative	   regimen	   is	   taken	   before	  allogeneic	   transplantation,	   and	   immune	   suppressants	   are	   given	   to	   the	   patients	   to	  reduce	  the	  likelihood	  of	  acute	  rejection.	  	  Adult	   zebrafish	   have	   both	   innate	   and	   adaptive	   immune	   systems,	   and	   as	   in	  human	  and	  mice,	   the	  adaptive	   immune	  system	  is	  the	  biggest	  barrier	   for	  allogeneic	  transplantation	   of	   stem	   cells	   and	   tumors	   (Lieschke	   and	   Trede,	   2009).	   	   We	   have	  taken	  a	  similar	  approach	  of	  γ-­‐irradiation,	  as	   in	  humans,	  to	  suppress	  the	  recipient’s	  immune	  system	  before	  transplantation.	  With	  our	  current	  irradiation	  regimen,	  when	  high	  doses	  of	   irradiation	   are	  used	   to	   completely	   eradicate	   the	   recipient’s	   immune	  system,	   the	   general	   toxicity	   in	   the	   digestive	   system	   causes	   rapid	   death	   of	   the	  recipients,	  which	  cannot	  be	  rescued	  by	  hematopoietic	   transplantation.	  The	  overall	  survival	  of	  the	  recipients	  is	  greatly	  compromised.	  Sublethal	  irradiation	  regimen	  was	  used	  to	  partially	  ablate	  the	  immune	  system.	  Consequently,	  recipients	  recover	  their	  endogenous	   immune	   competency	   by	   about	   4	   weeks	   post-­‐irradiation	   causing	   the	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long-­‐term	   engraftment	   levels	   to	   become	   extremely	   variable,	   especially	   in	   the	  recipients	  with	  relatively	  low	  chimerism	  during	  the	  short-­‐term	  engraftment	  period.	  	  	  The	   incomplete	   ablation	   of	   the	   endogenous	   immune	   system	   creates	   a	   second	  barrier	   for	   optimal	   long-­‐term	   engraftment,	   which	   is	   the	   mismatched	   immune	  systems	  between	  the	  donor	  and	  recipient.	  The	  molecular	  cues	  used	  by	  immune	  cells	  to	  distinguish	  ‘self’	  from	  ‘non-­‐self’	  are	  based	  on	  the	  MHC	  (major	  histocompatibility	  complex)	  molecules.	  MHC	  is	  a	  family	  of	  proteins	  presented	  at	  the	  cell	  membrane	  of	  virtually	  all	  somatic	  cells	  as	  recognition	  tag	  for	  innate	  and	  adaptive	  immune	  system	  cells,	   especially	   T	   cells	   and	   natural	   killer	   (NK)	   cells.	   In	   human	   bone	   marrow	  transplantation,	  the	  donor	  and	  recipient’s	  MHC	  types,	  which	  are	  called	  HLA	  (human	  leukocyte	  antigen)	  in	  human,	  are	  matched	  to	  reduce	  the	  potential	  host	  rejection	  and	  graft-­‐versus-­‐host	   disease	   (Abbas	   et	   al.,	   2012).	   	   MHCs	   have	   been	   well	   studied	   in	  humans,	  and	   laboratory	  mice	  have	  become	   isogenic	  at	  MHC	   loci	  due	  to	  decades	  of	  inbreeding.	   In	   contrast,	   the	   MHC	   types	   in	   zebrafish	   have	   turned	   out	   to	   be	   very	  complicated	   and	   less	   well	   understood.	   Therefore,	   all	   of	   the	   transplantation	  described	   in	   this	   thesis	   has	   been	   performed	   without	   MHC-­‐matched	   donors	   and	  recipients.	  	  The	  lack	  of	  optimal	  myeloablative	  regimen	  and	  the	  mismatch	  of	  MHC	  between	  donors	  and	  recipients	  create	  a	  barrier	  for	  assessing	  long-­‐term	  engraftment	  in	  adult	  zebrafish.	  Additionally,	   the	  water-­‐living	  conditions	  of	   zebrafish	  make	   it	  difficult	   to	  create	  a	  near-­‐sterile	  environment	  for	  post-­‐transplantation	  care.	  Potential	  infections	  also	  compromise	  the	  survival	  of	  transplanted	  recipients.	  Due	  to	  the	  survival	  curve	  of	  fish	  treated	  in	  the	  non-­‐optimal	  conditions	  mentioned	  above,	  we	  decided	  to	  analyze	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engraftment	  levels	  at	  4	  wpt,	  before	  the	  recipients	  recover	  their	  endogenous	  immune	  systems.	   The	   early	   engraftment	   level	   is	   also	   meaningful	   as	   it	   represents	   the	  progenitor	   engraftment	   level.	   Further,	   in	   humans	   the	   early	   neutrophil	   count	   in	  patients	   undergoing	   HSC	   transplantation	   is	   a	   very	   important	   clinical	   index	   in	  predicting	  survival	  and	  long-­‐term	  engraftment.	  	  
	  
The	  Implications	  from	  the	  Transplantation-­‐Based	  Chemical	  Screen	  	   Among	   the	   480	   chemicals	   tested	   in	   the	   screen	   library,	   we	   identified	   10	  chemicals	  that	  can	  enhance	  marrow	  engraftment	  to	  different	  extents.	  The	  efficacy	  of	  the	   other	   hits,	   besides	   EETs,	   needs	   to	   be	   tested	   in	   the	   mouse	   competitive	  transplantation	  assay	  with	  careful	  dose	   titration.	  Some	  of	   the	  hits	   target	   the	  same	  pathway,	  which	   is	   reassuring.	   In	   general,	   structure	   activity	   relationship	   should	  be	  studied	   by	   testing	   chemicals	   with	   similar	   structures	   as	   the	   hits,	   or	   structurally	  different	  chemicals	  sharing	  the	  same	  target.	  This	  will	  help	  clarify	  the	  exact	  pathways	  targeted	  by	  the	  hits.	  	  	   The	  transplantation-­‐based	  chemical	  screen	   is	  quite	   low	  throughput;	   therefore,	  the	  chemical	  space	  covered	  by	  the	  screen	  is	  very	  small.	  However,	  our	  screen	  had	  a	  relatively	   high	   hit	   rate	   compared	   to	   in	   vitro	   cell	   culture-­‐based	   chemicals	   screens.	  Several	  reasons	  contribute	  to	  this:	  1)	  One	  potential	  issue	  with	  large	  diversity-­‐based	  chemical	  libraries	  is	  that	  the	  pharmacokinetics	  and	  bioavailability	  of	  the	  chemicals	  are	   unknown.	   Chemicals	   with	   poor	   bioavailability	   will	   definitively	   be	   scored	   as	  negative	  in	  the	  screen.	  	  The	  480	  chemicals	  in	  the	  library	  we	  chose	  are	  known	  to	  have	  bioactivities	  and	  most	  of	  them	  have	  identified	  targets.	  This	  increases	  the	  likelihood	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of	   the	   chemicals	   perturbing	   certain	  molecular	   pathways.	   2)	   Protein	   or	   cell-­‐based	  screens	  usually	  use	   in	  vitro	   readouts	  with	  one	  or	   two	  dimensional	  measurements.	  Our	   screen	   design	   is	   extremely	   high-­‐content.	   Chemical	   treatment	   can	   affect	  many	  different	   cellular	   aspects,	   such	   as	   proliferation,	  migration,	   adhesion,	   apoptosis	   vs.	  survival,	  which	  can	  all	  affect	   the	   final	   readout	  as	   the	  relative	   level	  of	  engraftment.	  Therefore,	  one	  single	  in	  vivo	  assay	  is	  more	  than	  the	  sum	  of	  several	  different	  in	  vitro	  assays.	  This	  also	   increases	  the	   likelihood	  of	  chemicals	  having	  an	  effect	  on	  the	  final	  readout.	   It	  will	  be	   interesting	   to	   test	  all	   the	  hits	   in	  specific	  assays	  assessing	  which	  cellular	  aspect	  they	  have	  an	  impact	  on,	  such	  as	  in	  vitro	  migration	  and	  proliferation,	  and	   in	  vivo	  homing	  assays.	  In	  conclusion,	   low-­‐throughput	  but	  high-­‐content	  screens	  like	  this	  can	  also	  yield	  interesting	  results.	  	  	  	  
The	  EET	  Receptor(s)	   	  	   Even	   though	   it	   has	  been	   almost	   two	  decades	   since	   the	  discovery	  of	  EETs,	   the	  direct	  receptor(s)	  that	  EETs	  bind	  to	  is	  still	  unknown.	  The	  literature	  on	  this	  topic	  is	  also	   quite	   controversial,	   because	   the	  majority	   of	   published	   data	   had	   only	   indirect	  evidence	   on	   the	   identity	   of	   the	   receptor.	   Until	   recently,	   the	   research	   led	   by	   Dr.	  William	  Campbell	  had	  observed	  the	  direct	  physical	  binding	  between	  a	  modified	  EET	  and	  an	  unknown	  47kDa	  cell	  membrane	  protein	  (Chen	  et	  al.,	  2011).	  The	  same	  paper	  also	   confirmed	   the	   expression	   of	   this	   putative	   receptor	   on	   the	   cell	   membrane	   in	  human	  leukemia	  U937	  cell	  line,	  and	  primary	  bovine	  endothelia	  cells,	  but	  not	  in	  the	  HEK293T	  cells.	  The	  authors	  hypothesized	  that	  this	  putative	  receptor	  is	  a	  GPCR	  (G-­‐protein	   coupled	   receptor),	   and	   overexpressed	  more	   than	  70	   orphan	  GPCRs	   in	   the	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HEK293T	  cells.	  None	  of	  these	  GPCRs	  bind	  to	  EETs.	  Although	  this	  study	  did	  not	  lead	  to	   the	   identification	   of	   the	   EET	   receptor,	   it	   generated	   very	   important	   information	  and	  encouraged	  the	  further	  pursuit	  of	  this	  mysterious	  receptor.	  	  	   We	   also	   hypothesized	   the	   hypothetical	   EET	   receptor	   is	   a	   GPCR	   based	   on	   the	  following	   facts:	  First,	   the	  majority	  of	  known	  arachidonic	  acid-­‐derived	   lipids	   target	  GPCRs.	   EETs	   share	   very	   similar	   chemical	   structures	   with	   prostaglandins	   and	  leukotrienes.	   Since	   ligand-­‐GPCR	  binding	   is	   very	  promiscuous,	   and	  usually	   a	   single	  lipid	  binds	   to	  multiple	  GPCRs	  with	  differential	  affinities,	  we	  hypothesize	   that	  even	  the	  GPCRs	  with	  known	   ligands	   cannot	  be	   excluded	   from	   the	   list	   of	   candidate	  EET	  receptors.	   In	  addition,	  using	  genetic	  knockdown	  approaches,	  we	  demonstrated	  the	  requirement	   of	   Gα12/13	   for	   EET-­‐induced	   gene	   expression	   in	   zebrafish	   embryos.	  This	  further	  supports	  the	  GPCR	  hypothesis,	  although	  it	  is	  also	  possible	  that	  Gα12/13	  is	  in	  a	  parallel	  pathway	  to	  EET-­‐induced	  signaling.	  	  	   Based	  on	   the	   information	  above,	  we	  decided	  to	  compare	   the	  GPCR	  expression	  profiles	  in	  cells	  that	  express	  the	  EET	  receptor	  on	  the	  membrane,	  with	  the	  ones	  that	  do	  not	  bind	  to	  EETs.	  Beside	  U937	  cell	  line	  which	  has	  been	  shown	  to	  be	  positive	  for	  the	  EET	  receptor,	  we	  also	  biochemically	  demonstrated	  that	  a	  human	  immortalized	  endothelial	   cell	   line,	   EAhy,	   can	   also	   respond	   to	   11,12-­‐EET	   and	   increase	   the	   pAKT	  level	  (Figure	  3.10).	  In	  contrast,	  the	  putative	  receptor	  is	  not	  present	  on	  the	  surface	  of	  HEK193T	  cells.	  We	  extracted	  poly-­‐A	  enriched	  mRNA	  from	  these	  three	  cell	  lines	  for	  RNA-­‐seq.	  We	  performed	  comparative	  transcriptome	  analysis,	  looking	  for	  the	  GPCRs	  differentially	  expressed	  in	  the	  responsive	  and	  non-­‐responsive	  cell	  lines.	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The	  data	  have	  been	  independently	  analyzed	  by	  Richard	  M.	  White	  in	  our	  lab	  and	  Dr.	   Guy	   Sauvageau’s	   lab	   at	  University	   of	  Montreal.	   To	   our	   surprise,	   each	   cell	   type	  only	  has	  about	  70-­‐80	  annotated	  GPCRs	  with	  detectable	  levels	  of	  mRNA	  expression.	  The	   tow	   analysis	   generated	   similar	   results.	   Strictly	   based	   on	   fold-­‐change	  without	  statistic	   tests,	   37	   GPCRs	   are	   enriched	   in	   either	   U937	   and/or	   EAhy	   cells.	   Upon	  application	   of	   statistical	   constraints	   to	   the	   datasets	   based	   on	   q<0.05,	   15	   GPCRs	  remain.	  With	  this	  manageable	  list,	  we	  have	  started	  loss-­‐of-­‐function	  studies.	  We	  have	  annotated	   the	   zebrafish	   orthologs	   of	   most	   of	   these	   candidates.	   Since	   11,12-­‐EET	  causes	   dramatic	   gene	   expression	   phenotypes,	   knocking	   down	   the	   fish	   orthologs	  with	  morpholinos	  in	  embryos	  may	  generate	  even	  cleaner	  results	  than	  knockdowns	  of	   the	   receptors	   in	   cell	   lines.	   In	   addition,	   the	   mRNA	   expression	   patterns	   of	   the	  candidates	   and/or	   the	   size	  of	   the	  protein	   can	  be	  used	   for	  prioritization.	  However,	  some	  GPCRs	  belong	  to	  specific	  GPCR	  families	  comprising	  multiple	  paralogues	  with	  high	  DNA	  sequence	  similarities,	  such	  as	  the	  C-­‐C	  chemokine	  receptor	  family.	  A	  one-­‐to-­‐one	   relationship	   does	   not	   exist	   when	   comparing	   the	   human	   and	   zebrafish	  genome.	  Therefore,	  in	  such	  situations,	  knocking	  down	  the	  candidate	  receptors	  in	  the	  human	  cell	   lines	  is	  a	  more	  reasonable	  approach.	  These	  different	  candidates	  can	  be	  knocked	   down	   in	   U937	   or	   EAhy	   cell	   lines	   with	   shRNA,	   and	   the	   effects	   on	   AKT-­‐phosphorylation	   upon	   EET	   treatment	   can	   be	   examined	   by	   western	   blotting	   or	  phospho-­‐flow	  cytometry.	  	  Though	  the	  aforementioned	  experiments	  are	  feasible,	  caution	  should	  be	  taken	  when	  doing	   this	   type	   of	   analysis,	   especially	  when	   interpreting	   the	   potential	   false-­‐negative	  results.	  First,	  the	  original	  biochemical	  identification	  of	  the	  47kDa	  receptor	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is	  based	  on	  the	  presence	  of	  the	  protein	  on	  the	  cell	  membrane.	  Many	  scenarios	  can	  lead	   to	   the	   absence	   of	   the	   protein	   but	   presence	   of	   the	   mRNA	   in	   the	   “non-­‐responding”	   cells.	   For	   example,	   the	   translation	   of	   the	  mRNA	   into	   proteins	   is	   only	  initiated	   upon	   certain	   stimulation;	   or	   the	   proteins	   are	  made	   but	   instead	   of	   being	  translocated	   to	   the	   membrane,	   they	   remain	   in	   the	   cytoplasm.	   In	   either	   case,	   the	  GPCR	   will	   not	   be	   considered	   a	   candidate	   because	   the	   mRNA	   is	   not	   differentially	  expressed.	  Second,	  the	  band	  of	  47kDa	  might	  not	  reflect	  the	  actual	  size	  of	  the	  protein.	  Post-­‐translational	   modification,	   such	   as	   glycosylation,	   can	   increase	   the	   perceived	  molecular	  weight	  of	   the	  modified	  protein,	  and	  proteolysis	   triggered	  by	  signals	  can	  make	   the	   actual	   protein	   smaller	   than	   the	   one	   predicted	   based	   on	   the	   genomic	  sequence.	  Third,	  as	  mentioned	  above,	  some	  GPCRs	  belong	  to	  multi-­‐member	  families,	  and	  one	  ligand	  can	  bind	  to	  multiple	  receptors	  within	  the	  same	  family.	  For	  example,	  PGE2	  (prostaglandin	  E2)	  binds	  to	  four	  known	  receptors.	  It	  is	  possible	  that	  EETs	  bind	  to	  two	  different	  receptors	  on	  two	  different	  non-­‐responder	  cell	  lines,	  which	  requires	  special	  attention	  when	  performing	  the	  differential	  expression	  analysis.	  Last	  but	  not	  the	  least,	  GPCRs	  can	  form	  homodimers,	  heterodimers	  or	  even	  oligomers,	  depending	  on	   the	   specific	   ligand	   and	   the	   presence/absence	   of	   binding	   partners	   (Kaczor	   and	  Selent,	   2011;	   Maurice	   et	   al.,	   2011).	   When	   performing	   gain-­‐of-­‐function	   analysis,	  overexpressing	  a	  single	  candidate	  receptor	  might	  not	  result	   in	  the	  optimal	  binding	  to	  EETs.	  	  Despite	   the	   caveats	   with	   this	   genetic	   approach,	   it	   provides	   a	   new	   angle	   for	  looking	  at	  this	  receptor	  puzzle.	  We	  have	  already	  started	  the	  loss-­‐of-­‐function	  study	  in	  zebrafish	   embryos,	   and	   are	   in	   preparation	   for	   similar	   experiments	   in	   human	   cell	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lines.	   In	   the	   meantime,	   this	   receptor	   is	   also	   being	   pursued	   by	   other	   labs	   using	  biochemical	   binding	   assays	   combined	   with	   updated	   mass	   spectrometry	  technologies.	  We	  are	  hoping	  to	  get	  the	  answer	  in	  the	  near	  future.	  	  	  
The	  Cell	  Autonomy	  vs.	  Non-­‐Autonomy	  Effects	  In	   the	   situation	   of	   whole	   kidney	   marrow	   or	   bone	   marrow	   transplantation,	   a	  mixed	  population	  of	  cells	  was	  exposed	  to	  EETs,	  including	  mature	  white	  blood	  cells,	  red	  blood	  cells,	  endothelial	  cells,	  mesenchymal	  cells,	  and	  other	  cell	  types.	  Knowing	  which	   cell	   population(s)	   is/are	   the	   direct	   responding	   cells	   is	   important	   for	  understanding	   how	   EETs	   enhance	   engraftment.	   Because	   the	   receptor	   of	   EETs	   is	  unknown,	   the	  direct	   target	   cells	   cannot	  be	   separated	  by	  FACS.	  Therefore,	   the	  best	  approach	   for	   identification	   of	   the	   relevant	   cell	   type	   is	   to	   sort	   out	   different	   cell	  populations	   and	   treat	   them	   separately	   with	   EETs.	   In	   mice,	   different	   phenotypic	  HSPC	  populations	  can	  be	  finely	  purified	  based	  on	  cell	  surface	  markers.	  	  We	  sorted	  Lin-­‐c-­‐Kit+Sca-­‐1+CD150+CD48-­‐CD34-­‐	  long-­‐term	  HSCs	  from	  wild	  type	  mice,	  and	  treated	  them	  with	  EETs.	  However,	  we	  did	  not	  see	  a	  significant	  increase	  in	  long-­‐term	  engraftment	  with	  sorted	  cells.	  This	  result	  can	  have	  multiple	  explanations.	  One	  seemingly	  obvious	  scenario	  is	  when	  the	  whole	  kidney/bone	  marrow	  is	  exposed	  to	   EETs,	   the	   direct	   responding	   cells	   are	   not	   the	   phenotypic	   LT-­‐HSCs.	   EETs	   are	  known	   to	   have	   effects	   on	   endothelial	   cells	   and	   some	   types	   of	   mature	   blood	   cells	  (Fleming,	  2007;	  Spector,	  2009).	  It	  is	  possible	  that	  EET	  directly	  modulate	  some	  other	  cells	   types,	  which	   can	   have	   a	   secondary	   effect	   on	  HSCs,	   for	   example,	   by	   secreting	  cytokines	  and	  grow	  factors	  upon	  EET	  stimulation.	  In	  fact,	  it	  has	  been	  reported	  that	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14,15-­‐EET	   can	   induce	   the	   production	   of	   FGF2	   (fibroblast	   growth	   factor	   2)	   in	  endothelial	  cells	  (Zhang	  et	  al.,	  2006).	   If	   this	  hypothesis	   is	   true,	   it	  suggests	   that	   the	  quality	   of	   HSCs	   may	   be	   improved	   by	   modulating	   their	   niche	   cells.	   Testing	   this	  hypothesis	  is	  not	  an	  easy	  task,	  due	  to	  the	  complexity	  of	  bone	  marrow	  components.	  One	  possible	  experiment	  is	  to	  sort	  out	  different	  niche	  cell	  types,	  such	  as	  endothelial	  or	   stromal	   cells,	   and	   incubate	   these	   cells	   with	   EET	   for	   a	   period	   of	   time.	   The	  conditioned	  media	  from	  this	  treatment	  can	  then	  be	  collected	  and	  applied	  to	  purified	  HSPCs,	  which	  can	  later	  be	  transplanted.	  This	  experimental	  design	  assumes	  whatever	  the	   intermediate	   signaling	   molecule	   is	   soluble,	   and	   the	   effect	   on	   HSPCs	   is	   not	  dependent	  on	  the	  physical	  cell-­‐cell	  interaction.	  	  Another	  less	  obvious	  explanation	  for	  why	  EET-­‐treatment	  of	  LT-­‐HSCs	  alone	  did	  not	  enhance	  the	  engraftment	  is	  EET	  might	  affect	  a	  specific	  HSC	  population	  separate	  from	   phenotypic	   LT-­‐HSCs.	   Based	   on	   previously	   published	   microarray	   data,	   the	  phenotypic	  LT-­‐HSCs	  express	  higher	  level	  of	  cytochrome	  P450	  enzymes	  than	  ST-­‐HSC	  and	  progenitors.	   It	   is	  possible	   that	   the	  phenotypic	  LT-­‐HSCs	  can	  already	  synthesize	  high-­‐level	  of	  EETs,	  and	  are	  therefore	  self-­‐sufficient.	  In	  contrast,	  treating	  phenotypic	  ST-­‐HSCs	   with	   EETs	   may	   compensate	   for	   their	   lack	   of	   the	   LT-­‐HSC	   signature,	   and	  therefore,	   make	   them	   act	   more	   LT-­‐HSC–like.	   To	   formally	   test	   this	   hypothesis,	  different	  HSPC	  populations	  need	   to	  be	  purified	   first,	   treated	  with	  EETs	  separately,	  and	  then	  transplanted.	  	  	   Both	  the	  non-­‐autonomous	  and	  the	  autonomous	  models	  can	  be	  interesting.	  Even	  more	   interesting	   is	   that	  EET	  might	  affect	  both	  stem	  cells	  and	  the	  niche.	  Both	  stem	  cells	  and	  endothelial	  cells	  are	  capable	  of	  synthesizing	  high	  levels	  of	  EETs,	  which	  may	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be	   employed	   as	   a	  means	   of	   communication	   between	   different	   cell	   populations	   to	  coordinate	  the	  responses	  to	  various	  environmental	  fluctuations.	  	  	  	  
Transplanting	  Limited	  Numbers	  of	  HSCs	  	   From	  the	  competitive	  transplantation	  experiment	  we	  noticed	  that	  the	  effect	  of	  EET	  on	  engraftment	  was	  only	   significant	  when	  a	   low	  dose	  of	  whole	  bone	  marrow	  cells	  were	   transplanted	   in	   an	   extreme	   competition	   situation.	   For	   example,	   20,000	  wild	  type	  donor	  whole	  bone	  marrow	  cells	  competing	  with	  200,000	  competitors	  can	  only	  result	  in	  long-­‐term	  multi-­‐lineage	  engraftment	  in	  about	  20%	  of	  the	  recipients.	  In	  contrast,	  200,000	  donor	  cells	  competing	  with	  200,000	  competitors	  can	  engraft	  90-­‐100%	  of	   the	   recipients.	  With	  EET	   treatment,	   there	  was	  a	  dramatic	   increase	  of	   the	  percentage	  of	  recipients	  with	  long-­‐term	  engraftment	  in	  the	  20,000	  cell	  group,	  while	  200,000	  cells	  still	  engrafted	  sufficiently,	  and	  no	  significant	  difference	  of	  the	  average	  chimerism	   among	   the	   recipients	  was	   observed.	   This	   special	   effect	   in	   the	   extreme	  competition	   situation	   has	   also	   been	   reported	   on	   other	   pathways.	   For	   example,	   in	  
vitro	   treatment	  with	  dmPGE2	  for	  2hrs	  had	  very	  similar	  effects	  as	  EET	  (North	  et	  al,	  2007).	   Another	   example	   is	   the	   immediate	   early	   response	   gene	  EGR1.	   	  Egr-­‐/-­‐	  bone	  marrow	  cell	  performed	  normally	   in	  non-­‐competitive	  transplantation,	  at	  a	  cell	  dose	  as	   low	  as	  25,000.	   In	   the	  competitive	   transplantation	  situation,	  Egr-­‐/-­‐	  bone	  marrow	  had	  a	   significant	   increase	  of	   long-­‐term	  myeloid	  engraftment	  at	   a	  25,000	  cell	  dose,	  but	  not	  100,000	  (Min	  et	  al,	  2008).	  	  	   These	  observations	   raise	   a	  mysterious	  but	   fascinating	  question:	   do	   stem	   cells	  behave	  differently	  within	   a	   large	   group	  of	   stem	   cells	   versus	   as	   a	   single	   stem	   cell?	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Within	  20,000-­‐25,000	  whole	  bone	  marrow	  cells,	  there	  are	  on	  average	  only	  1-­‐2	  LT-­‐HSCs.	  One	  hypothetical	  rationalization	  for	  this	  differential	  behavior	  of	  stem	  cells	  is	  that	   the	   number	   of	   “healthy”	   niche	   cells	   after	   irradiation	   is	   extremely	   limited.	  Therefore	   far	   fewer	   stem	   cells	   can	   engraft	   than	   what	   is	   expected,	   especially	   in	   a	  competitive	  transplantation	  situation.	  However,	  if	  this	  is	  the	  case,	  we	  would	  expect	  to	  see	   that	  EET	  or	  dmPGE2	   treated	  bone	  marrow	  cells	  have	  a	  higher	  chimerism	   in	  the	  200,000	  v.s.	  200,000	  group,	  because	  they	  will	  be	  more	  competitive	  at	  occupying	  the	  niche	  than	  the	  control	  population.	  Therefore,	  the	  niche	  hypothesis	  is	  not	  a	  likely	  explanation.	  A	  second	  hypothesis	   is	   that	  HSCs	  can	  communicate	   to	  each	  other	  and	  sense	  the	  quantity	  and	  quality	  of	  other	  stem	  cells.	  In	  the	  situation	  with	  a	  saturated	  number	  of	  HSCs,	  some	  stem	  cells	  might	  receive	  suppressive	  signals	  from	  other	  stem	  cells	   to	   enter	   quiescence.	   Therefore,	   when	   looking	   at	   the	   output	   from	   a	   large	  population	   of	   stem	   cells,	   the	   effects	   of	   EETs	   or	   PGE2	   will	   be	   masked	   by	   the	  population	  behavior.	  In	  the	  situation	  of	  limited	  number	  of	  HSCs,	  the	  same	  chemical	  effect	   can	   be	   amplified	   and	   become	   detectable.	   To	   test	   this	   pure	   theoretical	  hypothesis,	  more	  advanced	  single	  stem	  cell	  analysis	   is	  required,	  such	  as	  single	  cell	  transcriptome	  and	  proteomics	  analysis,	  single	  cell	  in	  vivo	  tracking,	  etc.	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Future	  Directions	  	  
Generate	  MHC-­‐Matched	  Donor/Recipients	  Due	   to	   the	   immune	   rejection	   discussed	   above,	   some	   alternative	   zebrafish	  systems	  have	  been	  adapted	  to	  allow	  long-­‐term	  engraftment,	  such	  as	  using	  younger	  larvae	   as	   recipients	   without	   any	   immune-­‐suppressive	   regimen.	   The	   major	  maturation	   events	   for	   immune	   competence	   occur	   between	   2-­‐4	   weeks	   post	  fertilization.	  It	  has	  been	  shown	  that	  transplanting	  adult	  kidney	  marrow	  cells	  into	  2-­‐day	   old	   gata1-­‐/-­‐	   embryos	   rescued	   the	   otherwise	   lethal	   mutant	   phenotype	   with	  continued	  contribution	  of	  donor	  marrow	  cells	  to	  the	  recipient’s	  hematopoiesis	  up	  to	  8	  months	   (Traver	   et	   al.,	   2003a).	   This	   shows	   the	   plasticity	   of	   the	   immune	   system	  during	  development.	  	  Another	   approach	   is	   to	   try	   to	   match	   the	   MHC	   types	   between	   donor	   and	  recipient	   zebrafish.	   Our	   lab	   has	   shown	   that	   the	   Type	   I	   MHC	   cluster	   on	   zebrafish	  chromosome	  19	  plays	  a	  major	  role	  on	  immune	  rejection	  (de	  Jong	  et	  al.,	  2011).	  We	  have	   genotyped	   casper	   zebrafish	   and	   found	   they	   are	   homozygous	   for	   this	  chromosome	  19	  locus	  (unpublished	  data).	  The	  next	  step	  is	  to	  breed	  the	  transgenic	  donors	   into	   casper,	   and	   select	   the	   progenies	   with	   homozygous	   MHC	   types	   on	  chromosome	  19	  matching	   casper.	   The	   genomic	  differences	  between	   zebrafish	   and	  human	   MHC	   genes	   is	   that	   in	   the	   zebrafish	   genome,	   they	   are	   distributed	   among	  multiple	   chromosomes;	   while	   in	   the	   human	   genome,	   they	   all	   cluster	   in	   a	   single	  genomic	   locus	  (Graser	  et	  al.,	  1998;	  Sambrook	  et	  al.,	  2005).	  This	  creates	  challenges	  for	  a	  perfect	  MHC	  match.	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Alternatively,	   Streisinger	   and	   co-­‐worker	   have	   created	   isogenic	   zebrafish	   lines	  by	  applying	  a	  heat-­‐shock	  procedure	  at	  the	  one	  cell	  stage.	  The	  resulting	  completely	  homozygous	   zebrafish	   strain	   is	   called	   clonal	   zebrafish	   (Streisinger	   et	   al.,	   1981).	  Within	   the	   clonal	   strain,	   all	   individuals	   have	   the	   same	   MHC	   genotype,	   therefore	  immune	   barriers	   concerns	   are	   eliminated.	   Recently	   several	   labs	   were	   able	   to	  generate	   tumor	  models	   in	   these	  clonal	   zebrafish,	  and	  showed	   that	   transplantation	  within	   the	   same	   family	   of	   clonal	   zebrafish	   can	   improve	   tumor	   transplantability	  (Mizgireuv	  and	  Revskoy,	  2006;	  Smith	  et	  al.,	  2010).	  	  To	   improve	   the	   transplantation	   efficiency	   and	   fully	   benefit	   from	   the	   imaging	  power	   provided	   by	   the	   zebrafish,	   one	   promising	   future	   direction	   is	   to	   generate	   a	  clonal	   casper	   strain	   and	   model	   transplantation	   and	   diseases	   in	   this	   strain.	   This	  requires	  remaking	  the	   fluorescence	   transgenic	  donors	   in	   the	  same	  strain,	  which	   is	  not	  a	  trivial	  task.	  However	  in	  the	  long-­‐term,	  this	  would	  be	  an	  ideal	  system	  for	  direct	  visualization	   of	   engraftment	   and	   elimination	   of	   immune	   rejection.	   However,	  cautions	  need	   to	   be	   taken	  when	   inbreeding	   these	   clonal	   strains,	   since	   it	   has	   been	  reported	  that	  highly	  inbred	  zebrafish	  strains	  have	  decreased	  fertility	  and	  epigenetic	  silencing	  of	  transgenes.	  	  	  
Identify	  bona	  fide	  HSCs	  in	  Adult	  Zebrafish	  After	  more	  than	  two	  decades	  of	  studies	  in	  mice,	  subpopulations	  of	  bone	  marrow	  cells	  can	  be	  purified	  and	  characterized	  by	  fluorescence-­‐activated	  cell	  sorting	  (FACS).	  For	   example	   long-­‐term	  HSCs	   can	  be	   highly	   enriched	  using	   a	   combination	   of	  more	  than	  eight	  surface	  proteins/antibodies	  (Kiel	  et	  al.,	  2005).	  However,	  in	  zebrafish	  this	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technique	   is	   critically	   lagging,	   due	   to	   a	   lack	   of	   antibodies	   targeting	   zebrafish	   cell	  surface	   proteins.	   Though	   the	   existence	   of	   long-­‐term	   HSCs	   in	   zebrafish	   WKM	   is	  widely	   recognized	   through	   serial	   transplantation,	   the	   bona	   fide	   zebrafish	   HSCs	  cannot	  be	  prospectively	  identified.	  I	  have	  tested	  some	  mouse	  antibodies	  (B220,	  CD4,	  CD8,	  Mac-­‐1,	   Gr1,	   c-­‐Kit	   and	   Sca-­‐1)	  with	   zebrafish	   kidney	  marrow	   cells	   in	   hopes	   of	  species	  cross-­‐reactivity.	  But	  due	  to	   the	   low	  conservation	  of	   these	  surface	  markers,	  none	   of	   the	   antibodies	   generated	   signal	   with	   zebrafish	   cells.	   	   Generating	   new	  antibodies	   against	   zebrafish	   surface	   proteins	   is	   a	   critical	   step	   towards	   fully	  embracing	  the	  potential	  of	  this	  model	  organism	  in	  stem	  cell	  research.	  	  Stem	   cells	   can	   also	   be	   marked	   using	   transgenic	   techniques	   to	   express	  fluorescent	   proteins	   under	   the	   control	   of	   stem	   cell-­‐specific	   promoters.	   With	   the	  highly	   efficient	   transgenic	   techniques	   in	   zebrafish	   and	   fast	   expanding	   toolbox	   of	  fluorescent	  proteins,	   the	   generation	  of	  multi-­‐color	   transgenic	   zebrafish	   employing	  the	  combination	  of	  multiple	  stem	  cell	  markers	  is	  a	  feasible	  approach	  to	  increase	  the	  purity	  of	  stem	  cells.	  In	  addition,	  multi-­‐color	  transgenic	  zebrafish	  would	  facilitate	  the	  live	   tracking	   and	   imaging	   of	   cell	   populations	   in	   vivo	   through	   fluorescence	  microscopy	  (Ignatius	  and	  Langenau,	  2009).	  	  	  
Construct	  a	  Lipid	  Regulatory	  Network	  in	  HSCs	  	   The	  vast	  majority	  of	  literature	  studying	  the	  intrinsic	  and	  extrinsic	  regulators	  of	  hematopoietic	   stem	   cells	   focuses	   on	   macromolecules,	   such	   as	   cytokines,	  chemokines,	   growth	   factors	   and	   transcription	   factors	   (Zon,	   2010).	  However,	   as	   in	  other	  cell	  types,	  HSCs	  are	  exposed	  to	  many	  different	  types	  of	  stimuli	  in	  vivo,	  such	  as	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carbohydrates,	  nucleic	  acids,	  and	  lipids.	  They	  utilize	  these	  non-­‐protein	  components	  to	  signal	  and	  make	  fate	  decisions.	  Cells	  constantly	  metabolize	  and	  secrete	  lipids,	  just	  like	  proteins.	   From	  our	  novel	  discovery	  of	  EETs,	   and	  others’	   previously	  published	  data	   (North	  et	  al,	  2007;	  Kindler	  et	  al.,	  2010),	   it	  has	  become	  clear	   that	  arachidonic	  acid-­‐derived	  eicosanoids,	  or	  bioactive	  lipids	  in	  general,	  play	  an	  important	  role	  in	  the	  regulation	   of	   hematopoietic	   stem	   cells.	   Besides	   extrinsic	   factors,	   lipids	   are	   also	  essential	   intracellular	   signaling	   molecules.	   As	   discussed	   in	   Chapter	   3,	   one	   of	   the	  direct	  downstream	  signaling	  pathways	  responsible	  for	  EET-­‐induced	  engraftment	  is	  the	   PI3K	   pathway.	   PI3K	   is	   a	   lipid	   kinase	   that	   phosphorylates	   phosphoinositides,	  which	  are	  also	  lipids.	  	  	  With	   the	   advancement	   of	   small	   molecule	   analytical	   tools,	   more	   and	   more	  bioactive	   lipids	   are	   being	   identified.	   For	   example,	   eicosanoids	   refer	   to	   the	  oxygenated	  derivatives	   from	   three	  different	  20-­‐carbon	  essential	   fatty	   acids,	  which	  include	  arachidonic	  acid	  (AA),	  eicosapentaenoic	  acid	  (EPA)	  and	  dihomo-­‐γ-­‐linolenic	  acid	  (DGLA).	  EPA	  and	  DGLA	  can	  also	  be	  metabolized	  by	  pathways	  parallel	  to	  the	  AA	  metabolic	  pathways.	  The	  same	  COX	  and	  LOX	  enzymes	  that	  generate	  prostaglandins	  and	  leukotrienes	  from	  AA	  can	  also	  convert	  DGLA	  into	  different	  series	  of	  eicosanoids.	  In	   general,	   AA-­‐derived	   eicosanoids	   have	   pro-­‐inflammatory	   effects,	   while	   DGLA-­‐derived	   eicosanoids	   are	   considered	   to	   be	   anti-­‐inflammatory	   (Kapoor	   and	   Huang,	  2006).	  The	  opposite	  physiological	  effects	  and	  the	  potential	  competition	  for	  the	  same	  enzymes	  between	  AA	  and	  DGLA	  indicate	  that	  the	  balance	  among	  different	  bioactive	  lipids	  might	  be	  important	  for	  the	  biological	  output.	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The	  important	  roles	  of	  eicosanoids,	  or	  lipids	  in	  general,	  on	  regulating	  stem	  cells	  have	  just	  begun	  to	  be	  appreciated.	  AA-­‐derived	  eicosanoids	  are	  much	  better	  studied	  than	  the	  EPA	  and	  DGLA	  derivatives.	  They	  can	  function	   intracellularly,	  as	  autocrine	  or	   paracrine	   factors,	   or	   long-­‐range	   hormones.	   Their	   receptors	   can	   be	   either	  expressed	  on	  the	  cytoplasmic	  membrane	  or	  inside	  cells.	  One	  famous	  example	  is	  the	  essential	   role	   of	   retinoids,	   the	   active	   metabolites	   of	   vitamin	   A,	   during	   embryo	  development.	  Fetal	  Vitamin	  A	  Deficiency	  leads	  to	  multiple	  developmental	  problems,	  including	  hematopoietic	  defects.	  	  	   To	   systematically	   study	   the	   lipid	   regulatory	   network	   in	   stem	   cells,	   gene	  expression	  analysis	  is	  helpful	  for	  profiling	  the	  lipid	  metabolic	  enzymes	  and	  signaling	  pathway	  components	  in	  stem	  cells.	  In	  fact,	  some	  published	  microarray	  analysis	  has	  indicated	   certain	   stem	   cell	   populations	   might	   have	   a	   unique	   lipid	   signature.	   For	  example,	   among	   the	   76	   genes	   highly	   and	   specifically	   enriched	   in	   long-­‐term	  quiescent	  mouse	  HSCs,	   the	   cytochrome	  P450	   family	  member	  Cyp2j6	   is	   on	   the	   list	  (Forsberg	   et	   al.,	   2010).	   With	   the	   improvement	   of	   the	   sensitivity	   of	   mass	  spectrometry	   technology,	   directly	   profiling	   the	   lipid	   components	   among	   different	  types	  of	  hematopoietic	   stem	  and	  progenitor	   cells	  will	  become	   feasible.	  Comparing	  the	  biochemical	  data	  with	  gene	  expression	  profiles	  might	  yield	  a	  systematic	  map	  of	  the	  network.	  	   Functionally	  testing	  the	  roles	  of	   these	  bioactive	   lipids	  on	  stem	  cells	   is	  more	  straightforward	   than	   studying	  protein	   function,	  because	  as	   small	  molecules,	   lipids	  can	  be	  directly	  added	  to	  cells	  or	  administered	  to	  animals.	  Combining	  multiple	  lipids	  that	   might	   potentially	   interplay	   with	   each	   other	   in	   various	   assays	   can	   quickly	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delineate	  the	  functional	  interaction	  among	  them.	  For	  example,	  using	  the	  competitive	  marrow	  transplantation	  assay	  in	  adult	  zebrafish,	  multiple	  different	  eicosanoids	  can	  be	  mixed	  at	  various	  ratios	  and	  used	  for	  pulse-­‐treatment	  of	  the	  marrow	  cells.	  It	  will	  be	   interesting	   to	   examine	   whether	   combining	   members	   of	   the	   AA-­‐derived	  eicosanoids	  can	  have	  additive	  effects,	  or	  mixing	  AA-­‐derived	  eicosanoids	  with	  DGLA-­‐derived	  eicosanoids	  might	  cancel	  the	  effects	  of	  each	  other.	  	  	  
Genetic	  and	  Chemical	  Screening	  with	  Transplantation	  Model	  in	  Zebrafish	  Transplantation	  has	  been	  an	  indispensible	  experimental	  approach	  in	  stem	  cell	  research.	   It	   is	   the	  gold	  standard	  for	   identifying	  adult	  somatic	  stem	  cells,	  as	  well	  as	  the	  cell	  of	  origin	  for	  cancer.	  Zebrafish	  have	  emerged	  as	  an	  important	  animal	  model	  in	  cancer	  studies	  in	  the	  past	  decade.	  Teleost	  fish	  can	  acquire	  spontaneous	  cancers	  in	  almost	   all	   organs	   after	   exposure	   to	   water-­‐borne	   carcinogens	   (Spitsbergen	   et	   al.,	  2000a,	  b).	   In	  addition,	   transgenic	   tumor	  models	  of	   tissue-­‐specific	  promoter-­‐driven	  oncogene	  expression	  have	  been	  developed,	  such	  as	  melanoma	  (Patton	  et	  al.,	  2005),	  T/B	  cell	  acute	  lymphoid	  leukemia	  (Langenau	  et	  al.,	  2003;	  Sabaawy	  et	  al.,	  2006),	  and	  embryonal	  rhabdomyosarcoma	  (Langenau	  et	  al.,	  2007).	  A	  variety	  of	  transplantation	  techniques	  have	  been	  developed	  to	  study	  the	  nature	  of	  these	  tumors	  and	  compare	  them	  with	   human	   tumors;	   for	   example,	   serial	   transplantation	   to	   identify	   the	   self-­‐renewal	   potential	   of	   over-­‐proliferative	   cells,	   limiting	   dilution	   transplantation	   to	  estimate	   the	   frequency	   of	   self-­‐renewing	   cells	   in	   a	   tumor,	   and	   purified	   sub-­‐population	  transplantation	  to	  identify	  specific	  cancer	  stem	  cells	  (Frazer	  et	  al.,	  2009;	  Langenau	  et	  al.,	  2007;	  Smith	  et	  al.,	  2010).	   In	  addition	  to	  zebrafish-­‐derived	  tumors,	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xenotransplantation	  of	  human	  tumor	  cells	   into	   larval	  or	   immune-­‐suppressed	  adult	  zebrafish	   has	   greatly	   broadened	   the	   spectrum	   of	   cancer	   questions	   that	   can	   be	  studied	   in	   zebrafish	   (Topczewska	  et	   al.,	   2006).	  Using	   the	   transparent	   zebrafish	   as	  recipients,	   one	   can	   directly	   visualize	   tumor	   cell	   proliferation	   and	   dissemination	  (White	  et	  al.,	  2008).	  	  Anticancer	  drug	  discovery	  and	  development	  is	  recognized	  as	  having	  been	  highly	  inefficient	   in	   the	   past;	   the	   issues	   root	   in	   the	   high	   rate	   of	   compound	   attrition,	   the	  relatively	   small	   number	   of	   patients	   available	   for	   Phase	   I/II	   testing,	   and	   the	   finite	  R&D	  budgets	  of	  the	  biopharmaceutical	  industry.	  To	  ameliorate	  these	  problems,	  the	  high	  rate	  of	  ineffective	  compounds	  entering	  clinical	  trials	  must	  be	  decreased,	  which	  requires	  a	  better	  way	  of	  preclinical	  screening.	  Mouse	  xenograft	  testing	  has	  been	  an	  invaluable	   step	   in	   almost	   all	   the	   successful	   cancer	   therapies	   developed	   in	   the	  modern	   era.	   However,	   mouse	   xenografts	   have	   very	   poor	   predictive	   value	   on	   the	  outcome	  of	   clinical	   trials	   partially	   because	   of	   a	   failure	   to	   represent	   the	   enormous	  genetic	   diversity	   of	   tumors	   in	   patients	   (Sharpless	   and	   Depinho,	   2006).	   In	   this	  regard,	   a	   zebrafish	   xenotransplantation	   model	   can	   accommodate	   a	   more	   diverse	  range	   of	   tumors	   in	   a	   less	   labor-­‐intensive	   way,	   which	   can	   be	   used	   for	   large-­‐scale	  assessment	   of	   tumor	   response	   and	   modeling	   resistance.	   Such	   large-­‐scale	  approaches	  can	  potentially	  increase	  the	  success	  of	  cancer	  drug	  development.	  A	  high-­‐throughput	   imaging	   system	  based	  on	   the	  LED	   fluorescence	  macroscope	  has	  been	  developed	  for	  screening	  fish	  transplanted	  with	  fluorescently	  labeled	  T-­‐ALL	  (Smith	   et	   al.,	   2010).	   Combining	   the	   imaging	   power	   and	   throughput	   in	   zebrafish,	  tumor	   transplantation-­‐based	   screening	   approaches	   hold	   promise	   for	   accelerating	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the	  discovery	  of	  the	  molecular	  mechanisms	  of	  cancer	  and	  the	  development	  of	  novel	  drugs.	  	  	  
Summary	  of	  Future	  Directions	  In	   summary,	   the	   zebrafish	   competitive	   transplantation	   assay	   is	   still	   in	   its	  primitive	   form.	   More	   technical	   trouble-­‐shooting	   can	   be	   done	   to	   improve	   the	  efficiency	   and	   reproducibility	   of	   this	   assay.	   In	   addition,	   to	   fully	   address	   the	  autonomy	   question,	   developing	   methods	   to	   purify	   HSCs	   in	   zebrafish	   should	   be	  paramount.	   This	   thesis	   documents	   a	   novel	   transplantation-­‐based	   chemical	   screen,	  which	  led	  to	  the	  discovery	  of	  novel	  components	  in	  the	  HSC	  regulatory	  network.	  With	  the	  accumulation	  of	  knowledge	  through	  unbiased	  screening,	  a	  systematic	  study	  on	  the	   relationships	   among	   different	   pathways	   can	   be	   undertaken	   to	   ultimately	  construct	   a	   comprehensive	   signaling	   network	   regulating	   HSPC	   engraftment.	   A	  particularly	   striking	   aspect	   is	   the	   capacity	   for	   different	   bioactive	   lipids	   to	   form	   a	  signaling	  network	  in	  HSCs.	  Systematically	  mapping	  out	  the	  regulatory	  nodules	  will	  tremendously	   benefit	   both	   the	   basic	   understanding	   of	   stem	   cell	   biology	   and	   the	  clinical	   manipulation	   to	   generate	   better	   stem	   cells	   for	   transplantation.	   By	  demonstrating	   the	   feasibility	   of	   transplantation-­‐based	   chemical	   screen,	   we	   hope	  similar	   screening	  will	   be	  done	   in	   adult	   zebrafish,	   to	   study	  different	   types	   of	   adult	  stem	  cells	  and	  cancer	  initiating	  cells.	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Introduction	  Chapter	   3	   has	   been	   compiled	   as	   an	   independent	   manuscript	   for	   submission,	  mainly	  focusing	  on	  the	  effects	  of	  EETs	  (epoxyeicosatrienoic	  acids)	  on	  hematopoiesis.	  However,	  the	  effects	  of	  EETs	  are	  not	  restricted	  to	  the	  hematopoietic	  compartment.	  Additional	  analysis	  on	  EET-­‐caused	  phenotypes	  of	  the	  developing	  zebrafish	  embryo	  tail	   is	   documented	   in	   Appendix	   1.	   This	   part	   includes	   detailed	   description	   of	   the	  cellular	   phenotype,	   signaling	   transduction,	   and	   gene	   transcriptional	   network.	   The	  phenotype	   observed	   here	   is	   closely	   related	   to	   certain	   tumor	   metastasis.	   These	  additional	   results	   will	   contribute	   to	   the	   understanding	   of	   the	   basic	   signaling	   and	  molecular	   mechanism	   of	   EETs,	   especially	   in	   the	   context	   of	   promoting	   tumor	  metastasis.	  	  	  	  
	   	  





EET	  Effect	  Is	  Specific	  for	  Embryos	  Older	  than	  24	  hpf	  	  In	   the	   chemical	   screen,	   both	   11,12-­‐	   and	   14,15-­‐EET	   could	   increase	   zebrafish	  kidney	   marrow	   engraftment.	   Therefore,	   we	   tested	   the	   effects	   of	   both	   EETs	   on	  embryonic	   hematopoiesis.	   Treating	   zebrafish	   embryos	   with	   5 µM	   11,12-­‐EET	  between	  24-­‐36	  hpf	  increased	  both	  AGM	  and	  tail	  runx1	  expression,	  while	  14,15-­‐EET	  increased	  AGM	   runx1	   at	   2 µM	  without	   affecting	   circulation.	   Although	   5 µM	  14,15-­‐EET	  also	   induced	  ectopic	  runx1	  expression	   in	  the	  tail,	   the	  embryos	  had	  circulation	  defects;	   therefore,	   the	   effect	   on	   AGM	   was	   compromised	   (Figure	   A1.1).	   Because	  11,12-­‐EET	  does	  not	  cause	  circulation	  defects	  at	  a	  dose	  that	  can	  induce	  robust	  runx1	  expression,	  we	  only	  used	  11,12-­‐EET	  in	  the	  following	  experiments.	  	  To	  see	  if	  EET	  has	  an	   effect	   on	   younger	   embryos,	  we	   treated	   embryos	   at	   different	   stages,	   and	  did	   in	  situ	   for	   both	   runx1	   and	   mesoderm	   markers,	   such	   as	   eve1	   and	   papc.	   We	   did	   not	  observe	   any	   effect	   of	   EET	   on	   embryos	   younger	   than	   16	   hpf	   (Figure	   A1.2A,	   B).	  However,	  in	  embryos	  older	  than	  24	  hpf,	  EET	  caused	  the	  expansion	  of	  the	  mesoderm	  marker,	   eve1,	   in	   the	   tail	   bud	   (Figure	   A1.2C).	   Therefore,	   EET	   modulates	   specific	  populations	  of	  undifferentiated	  progenitor	  cells	  at	  a	  specific	  developmental	  stage.	  	  	  






Figure	  A1.1	  11,12-­‐	  and	  14,15-­‐EET	  showed	  different	  dose	  response	  dynamics.	  
	  11,12-­‐EET	  induced	  runx1	  expression	  both	  in	  the	  AGM	  and	  tail	  at	  5 µM,	  while	  14,15-­‐EET	  increased	  runx1	  in	  the	  AGM	  at	  2uM,	  and	  tail	  at	  5uM.	  The	  effect	  of	  14,15-­‐EET	  on	  AGM	  runx1	  expression	  at	  5 µM	  is	  compromised	  by	  disrupted	  circulation.	  	  
	  	  	   	  





Figure	  A1.2	  EET	  effect	  is	  specific	  on	  embryos	  older	  than	  24	  hpf.	  
	  (A)	  Embryos	  treated	  with	  5 µM	  11,12-­‐EET	  between	  6-­‐12	  hpf	  and	  fixed	  at	  12	  hpf.	  (B)	  Embryos	  treated	  with	  5 µM	  11,12-­‐EET	  between	  10-­‐16	  hpf	  and	  fixed	  at	  16	  hpf.	  (C)	  Embryos	  treated	  with	  5 µM	  11,12-­‐EET	  between	  24-­‐30	  hpf	  and	  fixed	  at	  30	  hpf.	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One	   of	   the	   simplest	   explanations	   why	   the	   EET	   effect	   is	   so	   time-­‐sensitive	   is	   the	  presence	  or	   absence	  of	   the	  EET	   receptor.	  However,	   because	   the	  EET	   receptor	  has	  not	   been	   identified,	   this	   hypothesis	   is	   difficult	   to	   test.	   Another	   possibility	   is	   the	  specific	  cell	  population	  in	  the	  tail	  bud	  only	  reaches	  a	  certain	  developmental	  stage	  at	  24	  hpf.	  To	  test	  this	  hypothesis,	  the	  ectopic	  runx1+	  cells	  must	  be	  identified.	  Many	  in	  situ	  markers	  were	  tested,	  such	  as	  neural	  crest	  markers	  (snai2,	  c-­‐kit),	  blood	  markers	  
(scl,	  lmo2,	  gata1,	  cmyb),	  endothelial	  marker	  (flk,	  vegf),	  and	  other	  runx	  genes	  (runx2a,	  
runx2b,	   runx3).	   	   None	   of	   the	   above	   genes	   is	   expressed	   by	   these	   runx1+	   cells.	  However,	  we	  did	  find	  that	  the	  runx1+	  cell	  population	  overlaps	  with	  the	  cells	  positive	  for	   cxcr4a,	  a	   chemokine	   receptor	   essential	   for	   HSC	   homing	   and	   tumor	  metastasis	  (Figure	   A1.3)	   (Zlotnik	   et	   al.,	   2011).	   In	   addition,	   one	   of	   the	   cxcr4	   ligands,	   sdf1b,	   is	  expressed	  in	  the	  tail	  bud	  at	  24hpf	  at	  a	  very	  high	  level	  (zfin.org).	  It	  can	  be	  interesting	  to	  see	  if	  EET	  is	  functionally	  interacting	  with	  SDF-­‐1/CXCR4.	  	  
	  
Figure	  A1.3	  runx1+	  cells	  overlap	  with	  cxcr4a+	  cells	  in	  the	  tail	  bud	  
	  Embryos	  were	  treated	  with	  5µM	  11,12-­‐EET	  or	  DMSO	  between	  24-­‐30	  hpf.	  In	  situ	  hybridization	  with	  cxcr4a	  or	  cxcr4b	  probes	  was	  performed	  at	  30	  hpf.	  	  cxcr4a	  had	  high	  expression	  levels	  in	  the	  tail	  bud,	  but	  cxcr4b	  was	  not	  detected	  in	  the	  tail.	  EET	  treatment	  did	  not	  significantly	  change	  the	  mRNA	  level	  of	  cxcr4a.	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Figure	  A1.4	  EET-­‐induced	  cellular	  morphological	  change	  in	  the	  tail	  of	  zebrafish	  
embryo	  	  (A)	  Dose-­‐dependent	  morphological	  changes	  in	  the	  tail.	  Treatment	  started	  at	  24	  hpf.	  	  (B)	  Higher	  resolution	  images	  of	  the	  cells	  rounding	  up	  in	  the	  tail	  within	  1hr	  of	  EET	  treatment.	  	  	  
	  
EET	  Activates	   the	  Stat3/Fosl2/Runx1	   Core	  Transcription	  Program	  Associated	  
with	  Mesenchymal	  Cell	  Features	  	  On	   the	   microarray	   list	   of	   EET-­‐treated	   embryos,	   we	   noticed	   socs3	   is	   also	  upregulated.	  It	  is	  well	  known	  that	  both	  SOCS3	  and	  AP-­‐1	  members	  are	  targets	  of	  STAT	  (Signal	  Transducer	  and	  Activator	  of	  Transcription)	  signaling	  (Ding	  et	  al.,	  2008).	  We	  decided	   to	   investigate	   the	  relationship	  between	  stat3	   and	  AP-­‐1/runx1	   induction	   in	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zebrafish	  embryos.	  stat3	   is	  highly	  expressed	   in	   the	  posterior	  epidermal	  superficial	  stratum	   between	   24-­‐36	   hpf	   (zfin.org).	   Knocking	   down	   stat3	   completely	   abolished	  
runx1	  induced	  fosl2	  and	  runx1	  expression	  in	  the	  tail	  and	  AGM,	  as	  well	  as	  basal	  level	  of	   AGM	   runx1	   expression	   (Figure	   A1.5A,	   B).	   In	   contrast,	   knocking	   down	   stat5.1	  and/or	  stat5.2	  did	  not	  block	  the	  effect	  (data	  not	  shown).	  Based	  on	  the	  genetic	  data,	  we	   propose	   a	   transcriptional	   regulation	  model	   (Figure	   A1.5C).	   A	   recent	   paper	   on	  mesenchymal	   transition	   of	   brain	   tumors	   also	   implicates	   this	   core	   transcription	  program	   as	   part	   of	   the	   network	   regulating	   brain	   tumor	   mesenchymal	   cell-­‐like	  characteristics	   (Carro	   et	   al.,	   2010).	   	   Mesenchymal	   cells	   have	   unique	   adhesion	  properties	   and	   high	   migratory	   capabilities.	   Therefore,	   the	   mesenchymal-­‐like	  phenotype	  induced	  by	  EET	  treatment	  might	  reflect	  a	  change	  in	  the	  cell	  adhesion	  and	  migration	  properties	  of	   the	  specific	  cell	  population	   in	  the	  embryo	  tail.	   	  This	  model	  can	   also	   explain	   the	   previous	   observation	   that	   EET	   has	   pro-­‐tumorigenic,	   pro-­‐metastatic,	  and	  pro-­‐angiogenic	  effects	  (Panigrahy	  et	  al.,	  2011b).	  It	   was	   previously	   reported	   that	   Stat3	   is	   required	   for	   mouse	   AGM	   HSC	  development	  (Takizawa	  et	  al.,	  2003).	  We	  performed	  in	  situ	  hybridization	  to	  analyze	  the	   expression	   pattern	   of	   stat3	   in	   the	   hematopoietic	   tissues	   in	   zebrafish	   embryos	  from	  24	  hpf	  to	  36	  hpf,	  but	  barely	  detected	  the	  expression	  of	  stat3	  in	  the	  AGM	  (data	  not	  shown).	  This	  can	  be	  either	  due	  to	  the	  insufficient	  sensitivity	  of	  the	  stat3	  in	  situ	  probe	  or	  the	  requirement	  for	  stat3	  at	  an	  earlier	  developmental	  stage	  preceding	  the	  AGM	  HSC	  specification.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  






Figure	  A1.5	  EET	  induced	  the	  activation	  of	  a	  mesenchymal	  cell	  transcription	  
network.	  	  (A)	  (B)	  knockdown	  of	  stat3	   in	  zebrafish	  embryos	  blocked	  EET-­‐induced	  expression	  of	  runx1	  and	  fosl2.	  	  2ng	  stat3	  morpholino	  was	  injected	  per	  embryo.	  	  (C)	  The	  mesenchymal	  cell-­‐like	  gene	  transcription	  network.	  	  	  	  
	  
Additional	  Signaling	  Pathways	  Required	  for	  the	  Tail	  Phenotypes	  In	   an	   attempt	   to	   identify	   signaling	   pathways	   downstream	   of	   EETs,	   we	  performed	  a	  chemical	  suppressor	  screen	  in	  zebrafish	  embryos.	  We	  found	  PI3K-­‐AKT	  (LY294002	  and	  Wortmannin)	  is	  required	  for	  the	  induction	  of	  runx1	  both	  in	  the	  AGM	  and	   tail	   (Figure	   3.9).	   In	   addition,	   we	   also	   identified	   a	   few	   inhibitors	   that	   could	  specifically	  block	  the	  runx1	  induction	  in	  the	  tail	  without	  affecting	  AGM.	  For	  example,	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the	   JNK	   inhibitor	   (SP600125)	  blocked	  both	  runx1	   and	  AP-­‐1,	  but	  had	  no	  effects	  on	  the	   cholesterol	  metabolism	   genes	   (Figure	   A1.6A).	   EGFR	   (epidermal	   growth	   factor	  receptor)	   inhibitor	   (AG1498)	   could	   completely	   block	   both	   AP-­‐1/runx1	   and	   the	  cholesterol	  metabolism	  genes	  (Figure	  A1.6A).	  This	  indicates	  EET-­‐induced	  signaling	  requires	  the	  activation	  of	  a	  receptor	  tyrosine	  kinase	  (RTK)	   in	  the	  embryo	  tail	  bud,	  which	  in	  this	  case,	  is	  EGFR.	  One	  explanation	  is	  the	  EGFR	  pathway	  acts	  in	  parallel	  to	  the	  EET	  pathway,	  and	  is	  required	  for	  maintaining	  the	  correct	  identity	  of	  the	  cells	  in	  the	  tail.	  However,	  treating	  the	  embryos	  with	  the	  EGFR	  inhibitor	  by	  itself	  from	  24	  hpf	  did	   not	   cause	   any	   gross	  morphological	   changes	   in	   the	   embryo	   (data	   not	   shown).	  Another	  explanation	   is	  EGFR	  acts	  downstream	  of	  EET.	   It	  has	  been	  shown	  that	   in	  a	  kidney	  epithelial	  cell	  line,	  EET	  can	  transactivate	  EGF	  signaling	  pathway	  and	  result	  in	  the	   phosphorylation	   of	   EGFR	   within	   a	   few	   minutes	   (Burns	   et	   al.,	   1995).	   GPCRs	  transactivating	   RTKs	   have	   been	   reported	   in	   different	   systems	   and	   with	   different	  receptors,	  although	   the	  basic	  mechanism	  of	   transactivation	   is	   still	  unclear.	  So	  EET	  may	  transactivate	  EGFR	  in	  the	  embryo	  tail,	  although	  this	  hypothesis	  requires	  further	  biochemical	  testing.	  	  Beside	   the	   effect	   on	   gene	   expression,	   we	   also	   examined	   what	   roles	   the	  suppressors	   might	   play	   in	   the	   EMT-­‐like	   morphological	   changes	   in	   the	   tail.	   We	  pretreated	   the	   24hpf	   embryos	   with	   the	   suppressors	   and	   incubated	   the	   embryos	  with	   EET	   for	   1hr	   in	   the	   presence	   of	   the	   suppressors.	   We	   found	   JNK	   and	   EGFR	  inhibitors	   completely	   blocked	   the	   cell	   morphology	   change	   (Figure	   A1.6B).	   This	  further	   supports	   the	   hypothesis	   that	   JNK	   is	   downstream	  of	   EGFR.	   The	   translation	  inhibitor,	   cycloheximide,	   did	   not	   block	   the	   cell	   morphology	   change	   at	   all,	   which	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indicates	  that	  EGFR-­‐JNK	  activation	  resulted	  in	  the	  cell	  morphology	  change	  through	  direct	  signal	  transduction,	  without	  de	  novo	  protein	  synthesis.	  	  
	  	  	  	  	  	  	   	  
	  
Figure	  A1.6	  JNK	  and	  EGFR	  inhibitors	  blocked	  the	  tail	  phenotype.	  	  	  Wild	   type	  zebrafish	  embryos	  were	  pre-­‐incubated	  with	   inhibitors	   for	  30	  min	  at	  24	  hpf	  before	  5µM	  11,12-­‐EET	  was	  added.	  	  (A)	  JNK	  inhibitor	   	  (SP600125,	  30µM)	  and	  EGFR	  inhibitor	  (AG1478,	  20µM)	  blocked	  EET-­‐induced	   runx1	   and	   AP-­‐1	   expression	   in	   the	   tail.	   AG1478	   also	   suppressed	   the	  cholesterol	  metabolism	  gene	  expression.	  	  (B)	   JNK	   and	   EGFR	   activation	   are	   required	   for	   the	   EET-­‐induced	   cell	   morphology	  change	   in	   the	   tail	   (SP+EET	   and	   AG+EET),	   which	   is	   translation-­‐independent	  (Cyclo+EET).	  SP,	  SP600125;	  AG,	  AG1478;	  Cyclo,	  cycloheximide.	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JNK	   has	   been	   shown	   to	   promote	   cell	   migration	   through	   regulation	   of	   focal	  adhesion	   partially	   via	   phosphorylation	   of	   paxillin	   which	   changes	   cellular	   focal	  adhesion	   composition	   and	   assembly/disassembly	   dynamics,	   thereby	   leading	   to	  increased	   cell	   motility	   (Huang	   et	   al.,	   2004;	   Huang	   et	   al.,	   2003).	   This	  adhesion/migration	  change	  can	  also	  lead	  to	  transcriptional	  changes.	  	  One	  potential	  factor	   linking	   this	   cell	   morphology	   change	   and	   transcription	   regulation	   is	   Stat3.	  Phosphorylated	   STAT3	   has	   been	   found	   to	   localize	  with	   focal	   adhesion	   complexes	  and	   directly	   interact	   with	   paxillin	   and	   focal	   adhesion	   kinase	   (Silver	   et	   al.,	   2004).	  JNK-­‐mediated	  phosphorylation	  of	  paxillin	  can	  potentially	  exclude	  paxillin	   from	  the	  focal	  adhesion	  complexes,	  and	  lead	  to	  the	  nuclear	  translocation	  of	  p-­‐STAT3.	  In	  fact,	  the	   nuclear	   translocation	   of	   p-­‐STAT3	   has	   been	   observed	   following	   14,15-­‐EET	  treatment	  of	  human	  breast	  cancer	  cell	   lines	  and	  dermal	  microvascular	  endothelial	  cells	   (Cheranov	   et	   al.,	   2008;	  Mitra	   et	   al.,	   2011).	   However,	  whether	   this	   adhesion-­‐transcription	  relationship	  is	  causative	  or	  correlative	  requires	  further	  testing.	  Based	  on	   the	   observation	   above,	   EET-­‐induced	   AP-­‐1/runx1	   mRNA	   upregulation	   requires	  both	  PI3K-­‐AKT	  pathway-­‐dependent	  direct	  transcriptional	  regulation,	  and	  EGFR-­‐JNK	  pathway-­‐dependent	  cell	  adhesion	  changes	  (Figure	  A1.7).	  	  	  











Figure	  A1.7	  Proposed	  signaling	  model	  for	  EET-­‐induced	  tail	  phenotype	  
	  In	   the	   zebrafish	   embryo	   tail	   bud,	   EET	   activates	   Gα12/13	   through	   a	   hypothetical	  receptor,	   which	   crosstalks	   with	   EGFR.	   This	   leads	   to	   the	   activation	   of	   PI3K/AKT	  signaling	  pathway,	  which	  is	  require	  for	  inducing	  AP-­‐1	  transcription.	  EGFR	  signaling	  might	   also	   crosstalk	   with	   adhesion	   complexes,	   potentially	   through	   JNK	   signaling.	  This	   leads	   to	   the	   activation	   of	   Stat3,	  which	   is	   also	   required	   for	   induction	   of	   AP-­‐1	  transcription.	  Upregulated	  AP-­‐1	  levels	  induce	  runx1	  transcription.	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Material	  and	  Methods	  	   The	  chemical	   treatments	   and	   morpholino	   injection	   were	   performed	   under	  the	  same	  conditions	  as	  previously	  described	  in	  Material	  and	  Methods	  in	  Chapter	  3,	  with	   some	   exception	   of	   the	   treatment	   time	   window	   as	   indicated	   in	   Figure	   A1.1	  Additional	   chemicals	   used	   in	   the	   treatment	   are	   included	   in	   Table	   3.5	   with	   their	  corresponding	  concentrations.	  Additional	  morpholino	  sequences	  are	  listed	  in	  Table	  A1.1.	  	  	  
Table	  A1.1	  	  Additional	  Zebrafish	  Morpholino	  Sequences	  
Gene	   Ref	  Seq	   MO	  sequence	  (5’à3’)	   Reference	  
stat3	   NM_131479	   GCCATGTTGACCCCTTAATGTGTCG	   Gene	  Tools	  
stat5.1	   NM_194387	   AATCCACACGGCCATGATCACTCT	   Gene	  Tools	  
stat5.2	   NM_001003984	   CGCCATGCCTGGCTAAGTTTTTAAC	   Gene	  Tools	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Resolving	  the	  controversy	  about	  N-­‐Cadherin	  and	  Hematopoietic	  Stem	  Cells	  	  	   Discrepancies	   in	   published	   results	   about	   the	   role	   of	   N-­‐cadherin	   in	  hematopoietic	  stem	  cells	  have	  led	  to	  confusion	  in	  the	  field.	  Attempting	  to	  settle	  the	  disagreements	   and	   reach	   a	   consensus,	   we	   undertook	   a	   collective	   discussion	  approach.	   This	   process	   clarified	   a	   number	   of	   issues	   but	   left	   some	   questions	   still	  unresolved.	  	  
Background	  	   One	   of	   the	   fundamental	   principles	   in	   biology	   is	   that	   cells	   in	   multicellular	  organisms	  interact	  and	  communicate	  with	  surrounding	  cells	  to	  acquire	  or	  maintain	  certain	  properties.	  This	  principle	  is	  relevant	  for	  stem	  cell	  biologists	  as	  they	  examine	  the	   ‘‘niche’’	   hypothesis.	   The	   ‘‘stem	   cell	   niche’’	   concept	   was	   first	   applied	   to	   the	  mammalian	  hematopoietic	  stem	  cell	   (HSC)	   field	   in	  1978	  (for	  a	  review	  of	   this	  area,	  see	  Voog	  and	   Jones,	  2010);	  however,	  because	  of	   the	  rarity	  and	   low	  accessibility	  of	  HSCs,	  as	  well	  as	  the	  lack	  of	  specific	  HSC	  markers,	  it	  has	  been	  difficult	  to	  examine	  the	  specific	  contact	  of	  HSCs	  with	  niche	  cells.	  	   Drosophila	  researchers	  adopted	  the	  niche	  concept	  and	  demonstrated	  that	  DE-­‐cadherin	  and	  β-­‐catenin	  interact	  at	  the	  interface	  between	  germline	  stem	  cells	  (GSCs)	  and	  niche	  cells.	  Loss	  of	  DE-­‐cadherin	  leads	  to	  the	  loss	  of	  GSCs.	  These	  observations	  in	  Drosophila	   gonads	   encouraged	   the	   mammalian	   HSC	   field	   to	   examine	   the	   role	   of	  cadherin	  in	  the	  marrow	  niche.	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   Bone	  marrow	  contains	  a	  variety	  of	  cells	  that	  make	  up	  stem	  cell	  niche.	  There	  is	  evidence	  suggesting	  that	  some	  cells	  in	  the	  bone	  marrow	  express	  N-­‐cadherin.	  Three	  papers	  published	  in	  2003	  and	  2004	  proposed	  that	  bone	  marrow	  osteoblasts	  are	  HSC	  niche	   cells,	   and	   two	   of	   them	   additionally	   showed	   that	   osteoblasts	   and	   HSCs	   are	  positive	   for	   immunohistochemical	   staining	   with	   a	   polyclonal	   anti-­‐N-­‐cadherin	  antibody	   (YS,	   Japan)	   (Calvi	   et	   al.,	   2003;	   Zhang	   et	   al.,	   2003;	   Arai	   et	   al.,	   2004).	  However,	  none	  of	  the	  studies	  identified	  a	  functional	  role	  for	  N-­‐cadherin	  in	  the	  HSC	  niche.	  Wilson	  et	  al.	  (2004)	  found	  that	  KLS	  (c-­‐kit+lineage-­‐Sca-­‐1+)	  cells	  are	  a	  mixture	  of	  N-­‐cadherin-­‐positive	  and	   -­‐negative	   cells	  based	  on	   staining	  with	   the	  YS	  antibody,	  but	  whether	  those	  YS	  antibody-­‐positive	  cells	  were	  long-­‐term	  repopulating	  HSCs	  was	  unclear.	  In	  their	  model,	  HSCs	  lacking	  c-­‐myc	  maintain	  a	  high	  level	  of	  N-­‐cadherin	  and	  other	   adhesion	   molecules	   to	   enhance	   stem	   cell-­‐niche	   interaction	   and	   therefore	  promote	   HSC	   expansion,	   whereas	   HSCs	   with	   high	   c-­‐myc	   repress	   the	   adhesion	  molecules,	   causing	   the	   loss	   of	   stem	   cell-­‐niche	   interaction	   and	   progressive	  exhaustion	   of	   stem	   cell	   pool.	   Later,	   Hosakawa	   et	   al.	   demonstrated	   that	   reactive	  oxygen	   species	   downregulated	   expression	   of	  N-­‐cadherin	   in	   LSK-­‐SP	   (c-­‐kit+lineage-­‐Sca-­‐1+-­‐side	   population)	   cells	   by	   quantitative	   RT-­‐PCR	   and	   proposed	   a	   role	   of	   N-­‐cadherin	   in	   the	  HSC-­‐niche	   interaction	   (Hosokawa	   et	   al.,	   2007).	   Another	   follow-­‐up	  study	  detected	  N-­‐cadherin	   expression	   in	  Flk2-­‐LSK	  HSCs	  by	   flow	   cytometry	  with	   a	  monoclonal	  N-­‐	  cadherin	  antibody	  (MNCD2)	  that	  was	  verified	  by	  RT-­‐PCR.	  This	  study	  indicated	  that	  the	  YS	  polyclonal	  antibody	  does	  not	  reliably	  indicate	  N-­‐cadherin	  and	  instead	  concluded	  that	  flow	  cytometry	  with	  MNCD2	  can	  be	  used	  to	  identify	  distinct	  subpopulations	  of	  HSCs	   (Haug	  et	  al.,	   2008).	  The	  authors	   concluded	   that	  Flk2 LSK	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cells	   that	   express	   intermediate	   levels	   of	   N-­‐cadherin	   (N-­‐cadherinint)	   are	   quiescent	  HSCs	   that	   lack	   significant	   reconstituting	   potential	   upon	   transplantation	   into	  irradiated	  mice,	   whereas	   cells	   expressing	   low	   levels	   of	   N-­‐cadherin	   (N-­‐cadherinlo)	  are	  primed/active	  HSCs	  with	   the	  capacity	   to	  reconstitute	   irradiated	  mice	  (Haug	  et	  al.,	   2008).	   However,	   two	   other	   papers	   reported	   no	   evidence	   of	   N-­‐cadherin	  expression	  in	  Flk2-­‐LSK	  cells	  or	  a	  further	  enriched	  population,	  SLAM-­‐LSK	  HSCs,	  by	  a	  variety	  of	  techniques,	  including	  antibody	  staining	  and	  RT-­‐PCR	  (Kiel	  et	  al.,	  2009;	  Kiel	  et	  al.,	  2007).	  In	  addition,	  these	  authors	  found	  that	  N-­‐cadherin	  conditional	  knockout	  mice	   had	   no	   observable	   phenotype	   in	   HSC	   frequency,	   hematopoiesis,	   long-­‐term	  competitive	   repopulation,	   or	   serial	   transplantation	   (Kiel	   et	   al.,	   2009).	   The	  observations	  from	  the	  different	  groups	  were	  therefore	  at	  odds	  with	  one	  another.	  	  
A	  Collaborative	  Discussion	  Process	  	   The	  discrepancies	  described	  above	  were	  generating	  confusion	  in	  the	  published	  literature	   and	   thus	   in	   the	   field.	   With	   the	   aim	   of	   resolving	   the	   controversy	   and	  providing	   clarification	   of	   the	   issues	   involved,	   we	   embarked	   on	   an	   interactive	  discussion	  approach.	  At	  our	  (L.I.Z.)	  request,	  the	  principal	  investigators	  from	  the	  two	  groups	  that	  have	  generated	  the	  majority	  of	  the	  conflicting	  published	  data,	  Linheng	  Li	  and	   Sean	   Morrison,	   participated	   in	   a	   telephone	   conference	   in	   which	   each	  investigator	   presented	   and	   discussed	   pertinent	   data	   slides.	   This	   meeting	   also	  included	   another	   investigator,	   Toshio	   Suda,	  who	  has	   published	  work	   suggesting	   a	  positive	   role	   for	  N-­‐cadherin	   in	   the	  bone	  marrow,	   and	   the	   editor	   of	   Cell	   Stem	  Cell,	  Deborah	  Sweet.	  This	  joint	  discussion	  was	  followed	  by	  a	  series	  of	  one-­‐on-­‐one	  phone	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meetings	  and	  two	  other	  telephone	  conferences	  with	  L.I.Z.	  During	  the	  discussion,	   it	  became	  clear	  that	  the	  disagreement	  centered	  on	  three	  major	  questions:	  (1)	  Do	  HSCs	  express	  N-­‐cadherin?	  (2)	  Is	  the	  MNCD2	  monoclonal	  antibody	  specific	  for	  N-­‐cadherin?	  (3)	  Does	  N-­‐cadherin	  play	  a	  role	   in	  HSC	  maintenance	  and	  regulation?	   Involving	  the	  groups	   who	   had	   previously	   come	   to	   differing	   conclusions	   in	   a	   joint	   discussion	  provided	  an	  efficient	  mechanism	  for	  critical	  analysis	  of	  key	  experimental	  data	  and	  honest	  expression	  of	  opinion	  about	  the	  relevant	  issues.	  	   With	   the	   available	   information,	   some	   conclusions	   about	   the	   first	   two	   issues	  became	  clear,	  and	  these	  will	  be	  outlined	  below.	  However,	  we	  were	  not	  able	  to	  reach	  an	   agreement	   on	   the	   third	   question	   on	   the	   basis	   of	   the	   available	   data.	   Upon	   the	  senior	   scientist’s	   suggestion,	   the	   Li	   and	   Morrison	   labs	   agreed	   to	   independently	  perform	   a	   limiting	   dilution	   competitive	   transplantation	   with	   the	   exact	   same	  experimental	  conditions	  and	  N-­‐cadherin	  conditional	  knockout	  mice,	  with	  a	  view	  to	  comparing	  data	  and	  coming	  to	  a	  consensus	  conclusion.	  Several	  emails	  between	  the	  groups	  outlined	  in	  detail	  the	  methods,	  doses	  of	  cells,	  and	  mechanism	  of	  conditional	  inactivation	  of	  N-­‐cadherin.	  Six	  months	  later,	  we	  set	  up	  a	  phone	  call	  to	  examine	  the	  data	  from	  the	  two	  laboratories.	  	   Agreements	   and	   Outstanding	   Issues	   During	   our	   initial	   discussions,	   we	   were	  able	  to	  come	  to	  agreement	  on	  a	  number	  of	  points	  relating	  to	  detection	  of	  N-­‐cadherin	  expression	  in	  bone	  marrow	  cells.	  In	  previous	  studies,	  the	  expression	  of	  N-­‐cadherin	  in	  HSCs	  has	  been	  examined	  at	  the	  mRNA	  level.	  The	  Li	  and	  Suda	  groups	  found	  that	  N-­‐cadherin	   mRNA	   can	   be	   detected	   in	   highly	   enriched	   populations	   of	   stem	   cells	   by	  quantitative	   RT-­‐PCR	   (Haug	   et	   al.,	   2008;	   Hosokawa	   et	   al.,	   2007;	   Hosokawa	   et	   al.,	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2010),	  but	  Morrison	  and	  colleagues	  did	  not	  detect	  any	  expression	  by	  qRT-­‐PCR	  or	  by	  microarray	  analysis	  (Kiel	  et	  al.,	  2007).	  Indeed,	  even	  in	  the	  Li	  and	  Suda	  groups’	  qRT-­‐	  PCR	  assays,	   the	  expression	  level	   in	  HSCs	  was	  found	  to	  be	  very	   low	  compared	  with	  some	  non-­‐HSC	  control	  populations.	  Moreover,	  no	  microarray	  analysis	  by	  any	  group	  has	   ever	   reported	   the	   enrichment	   of	   N-­‐cadherin	   in	  HSCs.	  With	   very	   low	   levels	   of	  expression,	   divergent	   findings	   could	   potentially	   be	   explained	   by	   differences	   in	  experimental	   methods	   and	   assay	   sensitivities.	   The	   overall	   conclusion	   from	   these	  data	  is	  that	  N-­‐cadherin	  RNA	  is	  either	  present	  at	  very	  low	  levels	  or	  absent	  in	  HSCs.	  	   The	   majority	   of	   the	   protein	   expression	   data	   presented	   by	   Haug	   et	   al.	   were	  obtained	   using	   a	   monoclonal	   antibody	   against	   N-­‐cadherin,	   MNCD2	   (Haug	   et	   al.,	  2008).	  Therefore,	  challenges	  to	  the	  conclusion	  that	  HSCs	  might	  express	  varying	  low	  levels	  of	  N-­‐cadherin	  on	  their	  surface	  have	  centered	  on	  concerns	  about	  the	  specificity	  of	  the	  MNCD2	  reagent.	  MNCD2	  was	  originally	  developed	  by	  Matsunami	  and	  Takeichi	  in	   1995	   (Matsunami	   and	   Takeichi,	   1995),	   and	   its	   specificity	   for	   N-­‐cadherin	   in	  western	  blots	  was	  demonstrated	  by	  Radice	  et	  al.,	  who	  compared	  wild-­‐type	  and	  N-­‐cadherin	   null	   mice	   (Radice	   et	   al.,	   1997).	   The	   Morrison	   and	   Li	   groups	   also	  independently	   con-­‐	   firmed	   that	   MNCD2	   was	   specific	   for	   N-­‐cadherin	   by	   western	  blotting	  and	   immunostaining	  using	  neonatal	   forebrain	  cells	  and	  cell	   lines	   in	  which	  N-­‐cadherin	  is	  abundantly	  expressed	  (Kiel	  et	  al.,	  2009;	  Haug	  et	  al.,	  2008).	  To	  examine	  whether	  N-­‐cadherin	   is	  expressed	   in	  enriched	  HSCs,	  Kiel	  et	  al.	  sorted	  105	  LSK	  cells	  and	   carried	   out	   western	   blot	   analysis	   with	   MNCD2.	   They	   failed	   to	   detect	   any	   N-­‐cadherin	  protein	  despite	  readily	  detecting	  N-­‐cadherin	  in	  a	  few	  thousand	  fore-­‐	  brain	  cells	   (Kiel	   et	   al.,	   2009).	   Thus,	   the	   available	   data	   suggest	   that	  MNCD2	   does	   give	   a	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specific	   signal	  by	  Western	  blot	   in	   tissues	   in	  which	  N-­‐cadherin	   is	  highly	  expressed,	  but	   Western	   blotting	   with	   MNCD2	   has	   not	   been	   able	   to	   confirm	   N-­‐cadherin	  expression	  in	  the	  LSK	  cells.	  These	  observations	  provide	  further	  support	  for	  the	  idea	  that	  N-­‐cadherin	  is	  expressed	  in	  a	  very	  limited	  hematopoetic	  cell	  population	  and/or	  at	  extremely	  low	  levels,	  or	  may	  in	  fact	  be	  absent.	  Using	  improved	  Western	  blotting	  techniques	  and	  a	  large	  number	  of	  highly	  purified	  cells	  might	  reveal	  the	  answer.	  	   The	  above	  conclusions	  about	   the	  expression	   level	  of	  N-­‐cadherin	   in	  HSCs	  raise	  the	  possibility	  that	  signals	  obtained	  for	  MNCD2	  with	  other	  assays	  could	  be	  the	  result	  of	  nonspecific	  binding.	  Use	  of	  the	  MNCD2	  antibody	  for	  flow	  cytometry	  with	  enriched	  HSCs	   has	   proved	   problematic.	   Haug	   et	   al.	   did	   see	   a	   shift	   in	  MNCD2	   staining	  with	  Flk2-­‐LSK	   cells	   compared	  with	   the	   control	   omitting	  MNCD2,	  but	   in	   their	  published	  study	   they	   did	   not	   compare	   this	   staining	  with	   isotype	   controls	   to	   assess	   staining	  above	   background	  or	   non-­‐specific	   antibody	  binding	   (Haug	   et	   al.,	   2008).	   Kiel	   et	   al.	  (2007,	   2009)	   were	   unable	   to	   detect	   any	   staining	   of	   SLAM-­‐LSK	   or	   Flk2-­‐LSK	   HSCs	  using	   MNCD2	   or	   other	   commercially	   available	   anti-­‐N-­‐cadherin	   antibodies.	  Moreover,	   both	   Kiel	   et	   al.	   and	   Foudi	   et	   al.	   found	   that	   MNCD2	   strongly	   stained	  surface	  B220+	  B	   cells	   in	   the	   bone	  marrow,	   but	  when	   these	   cells	  were	   sorted	   and	  analyzed	  by	  Western	  blot,	  no	  N-­‐cadherin	  band	  was	  evident	  (Foudi	  et	  al.,	  2009;	  Kiel	  et	   al.,	   2009).	   The	   Morrison	   and	   Hock	   groups	   also	   examined	   HSCs	   enriched	   by	  multiple	   combinations	   of	   markers,	   such	   as	   SLAM-­‐LSK	   and	   Flk2-­‐LSK,	   and	   neither	  group	  observed	  any	  effect	  of	  N-­‐cadherin	  deficiency	  on	  the	  MNCD2	  staining	  of	  HSCs	  or	  other	  bone	  marrow	  cells	  (Foudi	  et	  al.,	  2009;	  Kiel	  et	  al.,	  2009).	  To	  some	  extent	  the	  differences	  in	  results	  could	  be	  due	  to	  variation	  in	  flow	  cytometry	  technique	  between	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the	   labs,	   different	   sub-­‐clones	   of	   hybridoma	   used	   to	   produce	   the	   antibody,	   or	   the	  conditional	  knockout	  efficiency.	  However,	   the	  Morrison	   laboratory	   tested	  multiple	  aliquots	  of	  MNCD2	  antibody	  obtained	  from	  the	  Li	  laboratory	  as	  well	  as	  directly	  from	  the	   Developmental	   Studies	   Hybridoma	   Bank	   and	   confirmed	   in	   all	   of	   their	  experiments	  that	  N-­‐cadherin	  deletion	  was	  complete	  or	  nearly	  complete	  by	  PCR	  (S.M.	  unpublished	  data).	  Concerns	  about	  these	  technical	  differences	  are	  heightened	  by	  the	  very	   low	   level	   of	   proposed	  N-­‐cadherin	   expression	   and	   the	  non-­‐specific	   binding	   of	  MNCD2	   to	   HSCs/progenitors.	   There	   is	   no	   indication	   from	   any	   group	   that	   HSCs	  express	  high	  levels	  of	  N-­‐cadherin,	  and	  instead	  the	  accumulated	  data	  are	  consistent	  with	   a	   low	   level	   of	   expression,	   if	   any	   at	   all,	   that	  might	   be	   limited	   to	   a	   very	   small	  subset	   of	   HSCs.	   Although	   very	   low	   levels	   of	   proteins	   can	   have	   a	   function	   in	   cell	  biology,	  these	  data	  currently	  cannot	  be	  used	  to	  support	  an	  important	  HSC	  function	  of	  N-­‐cadherin.	  These	  conclusions	  formed	  the	  backdrop	  against	  which	  we	  discussed	  our	  viewpoints	  on	  functional	  studies.	  	   To	   address	   the	   question	   of	   whether	   N-­‐cadherin	   is	   required	   for	   HSC	  maintenance,	  Kiel	  et	  al.	  (2009)	  studied	  N-­‐cadherin	  conditional	  knockout	  mice,	  as	  the	  germline	  knockout	  is	  embryonic	  lethal.	  They	  did	  not	  observe	  any	  change	  of	  HSCs	  or	  hematopoiesis	   in	  homeostatic	   situations	  up	   to	  5	  months	  after	  N-­‐cadherin	  deletion	  (using	  Mx-­‐1-­‐Cre).	  To	  further	  challenge	  the	  HSCs,	  they	  transplanted	  106	  bone	  marrow	  cells	   from	  the	  N-­‐cadherin	  conditional	  knockout	  mice	  with	  comparable	  numbers	  of	  competitive	   bone	   marrow	   cells,	   and	   did	   not	   observe	   a	   significant	   difference	   in	  chimerism	   relative	   to	   wild-­‐type	   donor	   cells,	   even	   in	   secondary	   transplantation.	  From	  these	  experiments,	  they	  concluded	  that	  HSCs	  ‘‘do	  not	  depend	  on	  N-­‐cadherin	  to	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regulate	   their	  maintenance.’’	   N-­‐cadherin	   could	   potentially	   still	   be	   required	   during	  regeneration	  or	  the	  response	  to	  certain	  types	  of	  stresses,	  and	  testing	  the	  N-­‐cadherin	  knockout	  animals	  for	  their	  response	  during	  various	  stresses	  or	  irradiation	  could	  be	  interesting.	   However,	   the	   Morrison	   group	   failed	   to	   see	   any	   effect	   of	   N-­‐cadherin	  deletion	  on	  the	  recovery	  of	  mice	  in	  response	  to	  5-­‐fluorouracil	  treatment	  (Kiel	  et	  al.,	  2009),	   indicating	   that	   N-­‐cadherin	   does	   not	   play	   an	   important	   role	   in	   at	   least	   this	  stress	  condition.	  	   During	   the	   discussion,	   the	   transplantation	   data	   by	   Kiel	   et	   al.	   (2009)	   were	  questioned.	  One	  potential	  issue	  related	  to	  the	  knockout	  efficiency	  in	  the	  donor	  mice,	  and	   it	  was	   suggested	   that	   using	   reporter	  mice	   that	   can	   indicate	   the	  Cre-­‐mediated	  recombination	  activity	  could	  be	  helpful.	  However,	  with	  such	  an	  approach	   it	   is	   still	  possible	   that	   the	   recombination	   efficiency	   at	   the	   reporter	   locus	   could	  be	  different	  from	  the	  N-­‐cadherin	  locus,	  or	  could	  vary	  between	  cell	  populations.	  As	  an	  alternative	  approach,	  Morrison’s	  group	  purified	  the	  LT-­‐HSC	  for	  clonal	  culture	  and	  per-­‐	  formed	  PCR	  on	  each	  individual	  colony,	  showing	  the	  knockout	  efficiency	  was	  almost	  100%.	  In	  addition,	   the	  donor-­‐derived	  cells	   in	   the	   recipients’	  peripheral	  blood	  are	  also	  N-­‐cad-­‐/-­‐,	  further	  confirming	  the	  knockout	  efficiency	  (Kiel	  et	  al.,	  2009).	  Based	  on	  these	  results,	   it	   seems	   unlikely	   that	   the	   failure	   to	   observe	   a	   phenotype	   is	   due	   to	  incomplete	  knockout.	  	   Even	   though	   transplantation	   is	   considered	   the	   gold	   standard	   for	   testing	   stem	  cell	   functionality,	   the	   field	  has	  not	  been	  able	  to	  agree	  on	  standardized	  procedures,	  and	   there	   are	   substantial	   inter-­‐lab	   variances	   in	   aspects	   of	   hematopoietic	  transplantation	  protocols	  such	  as	  donor	  cell	  numbers	  and	  the	  cut-­‐off	  for	  long-­‐	  term	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multi-­‐lineage	  reconstitution.	  In	  an	  attempt	  to	  address	  the	  controversy	  in	  a	  rigorous	  way,	   L.I.Z.	   suggested	   that	   both	   groups	   perform	   a	   limiting	   dilution	   competitive	  transplantation	  indepentdently	  and	  compare	  results,	  and	  they	  agreed	  to	  do	  so.	  The	  agreed	   experiment	   was	   that	   20,000,	   60,000	   and	   200,000	   wild-­‐type	   or	   N-­‐cad	  conditional	   knockout	   whole	   bone	  marrow	   cells	   would	   be	   trans-­‐	   planted	   together	  with	   200,000	   competitor	   cells,	   and	   the	   results	   examined	   16	   weeks	   after	  transplantation.	   Six	  months	   later,	   however,	   only	   the	  Morrison	   lab	   presented	   data	  from	  the	  agreed	  experiment	   (M.	  Acar,	  M.	  Kiel,	  and	  S.	  Morrison,	  unpublished	  data).	  We	  examined	   the	   resulting	  data	  with	  a	  biostatistician	  using	   standard	   software	   for	  calculating	   the	   frequency	   of	   hematopoietic	   stem	   cell	   engraftment	   and	   ANOVA	  analysis,	   and	   found	   that	   there	   was	   no	   difference	   between	   the	   wild-­‐type	   and	   N-­‐cadherin	  deficient	  groups,	  consistent	  with	  the	  conclusions	  published	  previously	  by	  Kiel	  et	  al.	  (2009).	  For	  additional	  verification,	  we	  also	  showed	  the	  entire	  analysis	  to	  an	   independent	   investigator	   in	   the	  hematopoietic	   stem	  cell	   field,	  who	  also	  ran	   the	  data	   through	   statistical	   software	   and	   came	   to	   the	   same	   conclusion.	   Complete	   N-­‐cadherin	  deletion	  was	  confirmed	  in	  these	  experiments	  by	  PCR	  of	  genomic	  DNA	  from	  donor	  cells	  sorted	  from	  the	  reconstituted	  mice.	  However,	   instead	  of	  the	  agreed	  set	  of	   experiments	   the	   Li	   lab	   independently	   chose	   to	   undertake	   a	   different	   approach	  involving	   using	   a	   Cre-­‐loxP	   reporter	   system	   to	   indirectly	   indicate	   the	  recombination/knockout	   efficiency	   and	   trans-­‐	   planting	   purified	   reporter	   positive	  and	   reporter	   negative	   cells	   separately.	   They	   observed	   a	   difference	   between	   these	  two	   subsets	   of	   cells,	  which	   they	   interpreted	   as	   indicating	   a	   role	   for	  N-­‐cadherin	   in	  HSCs	   (L.	   Li,	   unpublished	   data).	   However,	   in	   our	   view	   these	   experiments	   are	   not	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straightforward	   to	   interpret	   and	   are	   therefore	   not	   informative	   for	   resolving	   the	  question	   at	   hand.	   Thus,	   at	   this	   point	   our	   conclusion	   is	   that	   no	   substantial	   HSC	  phenotype	   associated	   with	   N-­‐cadherin	   conditional	   deletion	   has	   been	   observed,	  suggesting	  that	  N-­‐cadherin	  does	  not	  play	  an	  essential	  functional	  role	  in	  HSCs.	  	  
Future	  Questions	  	   Although	  the	  data	  available	  at	  this	  point	  do	  not	  indicate	  an	  essential	  role	  of	  N-­‐cadherin	   in	   HSCs,	   redundancy	   in	   cadherin	   function	   in	   HSCs	   remains	   a	   possibility.	  Early	  experiments	  showed	  that	  HSCs	  do	  not	  express	  E-­‐cadherin	  (Zhang	  et	  al.,	  2003).	  However,	   in	   this	   issue	   of	   Cell	   Stem	   Cell	   Toshio	   Suda’s	   group	   show	   that	   the	   N-­‐cadherin	   mRNA	   level	   in	   LSK	   cells	   differs	   between	   mouse	   strains	   by	   qRT-­‐PCR	  (Hosokawa	  et	  al.,	  2010).	  They	  found	  that	  the	  C57BL/6	  strain	  has	  significantly	  higher	  N-­‐cadherin	   level	   than	   the	   129/Sv	   strain,	   from	  which	   the	  N-­‐cadherinfl/-­‐	  mice	  were	  originally	  derived	  (Kostetskii	  et	  al.,	  2005).	  In	  contrast,	  the	  129/Sv	  strain	  has	  higher	  expression	   of	   other	   cadherins	   than	   the	   C57BL/6	   strain.	   This	   could	   indicate	   that	  different	  cadherins	  are	  used	  by	  different	  strains.	  Interestingly,	  the	  Suda	  group	  found	  that	   overexpressing	   a	   dominant-­‐negative	   (DN)	   N-­‐cadherin	   inhibits	   the	   lodgment	  and	   long-­‐term	   repopulating	   activities	   of	   HSCs,	   while	   overexpressing	   wild-­‐type	   N-­‐cadherin	  has	  the	  opposite	  effect	  (Hosokawa	  et	  al.,	  2010).	  Because	  of	  the	  non-­‐specific	  blocking	  of	  cadherin	  family	  members	  by	  the	  DN-­‐N-­‐cadherin	  (Fujimori	  and	  Takeichi,	  1993),	   this	   result	   leaves	   open	   the	   possibility	   that	   cell	   adhesion	   mediated	   by	   the	  redundant	  cadherin	  family	  members	  might	  be	  involved	  in	  HSC	  activities.	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   However,	   it	   is	  worth	  noting	  that	  Kiel	  et	  al.	  were	  not	  able	   to	  detect	  N-­‐cadherin	  mRNA	   in	   C57BL	   HSCs	   and	   studied	   knockout	   mice	   that	   were	   backcrossed	   with	  C57BL/6	   for	   at	   least	   six	   generations,	   arguing	   against	   the	   idea	   that	   strain	   back-­‐	  ground	   is	   a	   basis	   for	   the	   discrepancy	   in	   results	   (Kiel	   et	   al.,	   2009).	   Thus,	   although	  potential	   strain	  differences	   are	   intriguing,	   currently	   it	   does	  not	   appear	   likely	   they	  can	  provide	  an	  explanation	  for	  the	  different	  conclusions	  drawn.	  	   In	  summary,	  therefore,	  although	  there	  are	  still	  differences	  of	  opinion	  among	  the	  investigators	   involved	   in	   this	   process	   regarding	   the	   potential	   for	   N-­‐cadherin	  function	   in	  HSCs,	   it	   is	   our	  view	   that	   to	  move	   the	   research	   in	   the	   field	   forward	  we	  need	  to	  acknowledge	  the	  current	  observations	  and	  set	  a	  common	  foundation	  for	  the	  stem	   cell	   community.	   The	   current	   observations	   on	   the	   N-­‐cadherin	   conditional	  knockout	   model	   indicate	   that	   the	   maintenance	   of	   adult	   HSCs	   does	   not	   appear	   to	  depend	  on	  N-­‐cadherin	  homophilic	  interactions.	  This	  conclusion	  does	  not	  support	  or	  argue	  against	  the	  potential	  role	  of	  osteoblasts	  or	  perivascular	  cells	  in	  the	  HSC	  niche,	  and	   it	   does	   not	   entirely	   rule	   out	   the	   idea	   of	   cadherin-­‐mediated	   niche-­‐HSC	  interaction	  model	  as	  cadherin	  redundancy	  is	  still	  a	  possibility.	  However,	  convincing	  evidence	  to	  support	  this	  idea	  would	  require	  demonstration	  of	  a	  clear	  HSC	  defect	  in	  knockout	  mice,	  either	  alone	  or	  in	  combination	  with	  the	  N-­‐cadherin	  knockout,	  using	  limiting	  dilution	   competitive	   repopulation	   studies	   in	   the	  mouse.	  Our	   conclusion	   is	  that	  until	  clearcut	  data	  along	  these	  lines	  are	  forthcoming,	  the	  field	  should	  not	  base	  further	   experiments	   on	   the	   concept	   that	   there	   is	   a	   functionally	   significant	   cell-­‐autonomous	  role	  for	  N-­‐	  cadherin	  in	  HSCs.	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Bullet	  Point	  Summary	  
	  
• N-­‐cadherin	  expression	  in	  HSCs	  is	  either	  low	  or	  undetectable;	  if	  N-­‐cadherin	  is	  expressed	  in	  HSCs	  it	  is	  present	  at	  a	  very	  low	  level	  and/or	  in	  a	  small	  subset	  of	  cells.	  
• The	  N-­‐cadherin	  monoclonal	  antibody,	  MNCD2,	  is	  not	  specific	  for	  N-­‐cadherin	  expression	  in	  the	  hematopoietic	  compartment.	  This	  antibody	  should	  not	  be	  used	  for	  experiments	  that	  require	  flow-­‐cytometric	  sorting	  of	  HSCs,	  although	  it	   still	   can	   be	   used	   to	   detect	   N-­‐cadherin	   expression	   by	   Western	   blot	   or	  immunostaining	   in	   tissues	   that	   express	   high	   levels	   of	   N-­‐cadherin,	   such	   as	  liver.	  
• Currently	  available	  data	  lead	  to	  the	  conclusion	  that	  the	  maintenance	  of	  adult	  HSCs	   does	   not	   depend	   on	   a	   cell-­‐autonomous	   role	   of	   N-­‐cadherin.	   To	   argue	  against	  this	  conclusion,	  future	  experiments	  would	  need	  to	  demonstrate	  that	  genetic	   deficiency	   of	   another	   component,	   such	   as	   a	   different	   cadherin,	  causes	   a	   substantial	   HSC	   phenotype	   in	   N-­‐cadherin	   conditional	   knockout	  mice.	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